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Antiseptics and Disinfectant Drugs 
 
According to statistics, about 40–50 % of all human diseases are 
caused by different parasites (bacteria, spirochetes, rickettsia, chlamydia, 
fungi, viruses, and protozoa which account about 1,000 cpecies). Besides, 
diseases may be caused by helminths and arthropods. Drugs, which are 
used to combat human pathogens, are divided into 2 groups: 
–  antiseptics and disinfectant drugs; 
–  chemotherapeutic drugs.  
Antiseptics are used to combat human pathogens on the body surface 
(skin and mucosa). Sometimes, antiseptics are used to combat human 
pathogens in gastrointestinal and urinary tracts. 
Disinfectant drugs are used to destruct pathogens in the environment: 
disinfection of medical instruments, medical supplies for nurses, dishes, 
clothes, rooms, and patient care equipment.  
Antiseptics and disinfectants should have marked antibacterial and 
antiparasital effect. Simultaneously, these agents should be safe for human, 
don’t irritate tissues, and don’t damage instruments.  
Division of drugs into antiseptics and disinfectants is somewhat 
relative, because some antiseptics in high concentrations are used for 
disinfection of the environment.  
Chemotherapeutic agents are used to combat human pathogens into the 
organism. These drugs have high selective action upon certain species of 
microorganisms. Chemotherapeutic drugs should not affect the main 
functions of human organism. These drugs are used to prevent and treat 
infections. It should be noted that some chemotherapeutic drugs may be 
used as antiseptics (e.g., furacilinum).  
According to chemical structure, antiseptics and disinfectants are 
classified into the following groups:  
1. Detergents: cerigelum, aetonium, chlorhexidine, 
benzalconium chloride , etc.  
2. Nitrofuran derivatives: furacil inum  (nitrofural ).  
3. Phenol group: phenol ,  resorcin, lysol ,  wood-tar,  and 
ichthyol .  
4. Stains: bril liant green, methylene blue , and ethacridine 
lactate  (Rivanol).  
5. Halogens:  
– chlorine compounds: bleaching powder , chloramine B, and 
pantocide ;  
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– iodine compounds: alcohol solution of  iodine ,  Lugol’s 
solution, iodinol ,  and  iodovidonum .  
6. Oxidisers: hydrogen peroxide  and potassium permanganate .  
7. Heavy metal compounds:   
– silver-containing drugs: silver nitrate ,  Protargolum, and 
Collargolum ; 
– zinc-containing drugs: zinc sulfate  and  zinc oxide ; 
– copper-containing drugs: copper sulfate ; 
– mercury-containing drugs: mercury bichloride, yellow 
mercury oxide,  and  mercury ammonium chloride ; 
– bismuth-containing drugs: bismuth nitrate , xeroform, and 
dermatol .  
8. Alcohols: ethanol .  
9. Aldehydes: formaldehyde and hexamethylenetetramine  
(urotropine).   
10. Acids and alkalies: boric acid, salicylic acid, aqueous 
ammonium solution , and  sodium hydrocarbonate solution .   
 
Detergents  
 
Detergents are synthetic compounds with high surface activity which 
exhibit the marked antiseptic and detergent (washing) properties. Detergent 
drugs include organic substances containing two positively charged 
nitrogen atoms (cationic detergents) and some negatively charged 
compounds (anionic detergents). Detergent molecules accumulate on the 
surface of the phase separation. Antibacterial activity of detergents is due to 
their ability to decrease the surface tension that leads to disruption of cell 
membrane permeability of microorganisms. The ensuing disturbances of 
osmotic balance lead to death of microorganisms. 
Anionic detergents include such agents as green soap  and laundry 
soap . These agents are sodium or potassium salts of fatty acids with long 
hydrocarbon chain. Anionic detergents are less active than cationic 
detergents. Anionic detergents are used for laundry, wet cleaning, 
handwashing, disinfection, etc. Green soap is a component of Wilkinson’s 
ointment. 
Cationic detergents exhibit bactericidal effect against bacteria, fungi, 
viruses, and some protozoa. It should be noted that activity of cationic 
detergents decreases in protein environment (e.g., presence of pus). 
Cationic detergents include such agents as cerigelum, miramistin ,  
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chlorhexidine , etc. These agents are used for surgical hand preparation; 
disinfection of operative field and instruments; washing bladder, wounds, 
infected cavities, etc. Cationic detergents cannot be combined with anionic 
ones, because the antimicrobial activity reduces due to such combination.  
 
Nitrofuran Derivatives 
 
Nitrofuran derivatives exhibit high antimicrobial activity and low 
toxicity. Thereby, these agents are used as both antiseptics and 
chemotherapeutic drugs. Drugs exhibit bacteriostatic or bactericidal effects 
depending on the doses used. Mechanism of nitrofuran’s action is based on 
ability of their nitro groups to reduce into amino groups. Nitrofurans 
compete with natural hydrogen acceptors of microbial cells. Due to this 
ability, the agents slow down the cellular respiration and destroy energetic 
balance of microorganisms. Spectrum of antimicrobial action of nitrofurans 
includes gram-positive and gram-negative bacteria, fungi, and protozoa 
(chlamydia, giardia, and trichomonas).  
Furacil inum  (nitrofural) and furazolidone  are derivatives of 
nitrofuran used as antiseptics. Water solution of furacilinum is used to treat 
wounds, burns, otitis; for nasal and pleural lavage. Eye drops with 
furacilinum are used to treat conjunctivitis and blepharitis. Sometimes, 
furacilinum is used in dysentery treatment. Furacilinum is a component of 
such drugs as Furaplastum  and Liphuzol . Furaplastum is used to treat 
wounds and minor skin injuries (bruises, scratches, cracks, etc.). The agent 
forms protective layer on the damaged surface and improves healing. 
Liphuzol, the drug aerosol, is used to treat wounds.  
Antibacterial activity of furazolidone  against gram-negative 
bacteria, giardia, and trichomonas is significantly higher than activity of 
furacilinum. Furazolidone is used mainly as chemotherapeutic agent. 
Side effects of nitrofurans are dyspepsia, headache, disiness, and 
allergic reactions.  
 
Phenol Group 
 
Phenol  is the oldest antiseptic agent. It is used as a standard to 
estimatie activity of other antiseptics and disinfectants. Phenol in low 
concentrations exhibits bacteriostatic effect. Phenol in high (1–5 %) 
concentrations has bactericidal effect. Phenol destroys the permeability of 
the cell membrane and blocks the activity of dehydrogenase. The agent has 
a wide spectrum of action. Proteins do not reduce the activity of phenol.  
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Phenol easily penetrates through skin and mucous memranes. 
Poisoning by phenol is manifested by disiness, weekness, dyspnea, 
tachycardia, sweating, and sonitus. Collapse and significant disturbances of 
respiration develop in severe cases. If phenol was taken perorally, a 
poisoned patient needs gastric lavage with vegetable oil. Affected regions 
of skin should be washed by 50 % ethyl alcohol or vegetable oil. In case of 
central nervous system depression, stimulating agents should be 
administered. 
Phenol in form of 2–5 % carbolic-soap mixture is used to disinfect 
rooms, supplies for nurses, clothes, and places contaminated with feces. 
With the same end in view, lysol and tricresol are used in medicine. 
Vagothyl  is a 36 % water solution of polyethylene-metacresol-
sulfonic acid. The drug exhibits bactericidal effect and high activity against 
trichomonads. Vagothyl is used to treat cervical erosion, bladder diseases, 
and ulcers of lower extrimities. 
Phenyl  salicylate  is a phenyl ester of salicylic acid. In intestine, 
this agent is cleft with formation of phenol and salicylic acid. The drug is 
used to treat infective diseases of bowels, bile ducts, and urinary tract. 
Resorcin  is a derivative of phenol. Resorcin exhibits both 
keratoplastic (in concentrations about 2 %) and keratolytic (in 
concentrations about 20 %) effects. The drug is used to treat seborrhea, 
eczema, herpes, ringworm, etc.  
Wood tar  and ichthyol  are agents which are also containing phenol 
and its derivatives. These drugs are widely used to treat bacterial and 
parasitic skin diseases. Ointments and liniments with wood tar are used to 
treat eczema, psoriasis, furunculosis, etc. Wood tar is included in 
Vishnevsky ointment  (tretment of wounds, burns, ulcers, and bedsores) 
and Wilkinson ointment  (treatment for scab and fungal diseases).  
Thymol  is a phenol derivative which is included in aerosol 
Gexaspray  and in pastilles Septolete  and Hexadreps . These drugs are 
used to treat the diseases of throat and pharynx.  
      
Dyes 
 
Soluble dyes include such colouring agents as bril l iant green, 
ethacridine lactate , and methylene blue  (Rivanol). Dyes occupy 
the intermediate position between antiseptics and chemotherapeutic drugs. 
Dyes have certain selectivity against microorganisms and are sometimes 
used for resorptive action. All agents are effective in treatment for coccal 
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infections. The dyes are characterised by low toxicity. They affect the 
permeability of bacterial cell membranes which causes osmotic disbalance 
and lysis of microorganisms. Besides, dyes inhibit the activity of catalase, 
galactosidases, and other enzymes. 
Brilliant green is active against staphylococci, corynebacterium 
diphtheriae, and other gramm-positive bacteria. This agent is used as 1–2 % 
alcoholic (or water) solution for the lubrication of wounds, pustular skin 
lesions, blepharitis, etc.  
Methylene blue is characterised by less antibacterial activity than 
brilliant green. But the agent exhibits antimycotic activity. Ability of 
methylene blue to attach and release hydrogen atoms is used in the 
treatment of poisoning by cyanides. In this case, 50–100 ml of a 1 % 
solution of the drug is administered intravenously. Methylene blue 
transforms hemoglobin into methemoglobin. The latter substance interacts 
with cyanides to form non-toxic cyanmethemoglobin. Also, methylene blue 
is used to treat burns, cystitis, uretritis, to wash body cavities, etc.  
Ethacridine lactate (Rivanol) is a bacteriostatic agent with slowly 
developing effect. Rivanol is used in ointments, pastes, and solutions for 
external application. Therapeutic indications for Rivanol are purulent 
wounds, burns, washing body cavities, etc. Ethacridine lactate is a non-
toxic agent.  
 
Halogen-Containing Drugs:  
 
Chlorine-Containing Drugs  
 
Chlorine-releasing agents are chloramine B, chlorhexidine , and 
household  bleach . These agents have high antimicrobial activity and 
broad spectrum of action. Chlorine-containing drugs are active against 
bacteria, viruses, and amoeba. Acid-fast bacilli (e.g., Mycobacterium 
tuberculosis) are less sensitive to chlorine-containing drugs. In an aqueous 
environment, chlorine-containing compounds decompose with the release 
of atomic chlorine which interacts with cytoplasmatic proteins of 
microorganisms. In proteins, chlorine ions replace the hydrogen ions that 
makes hydrogen bond formation between polypeptide chains impossible. 
Due to this fact, secondary structure of proteins is disrupted. Chlorine-
releasing agents also have deodorizing properties. Most agents are used as 
disinfectants.  
Chloramine B is used as an antiseptic. Its effect develops slowly and 
lasts for a long time. Chloramine B has also antimycotic activity. The agent 
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is used to wash infected wounds, operative field, and hands. Chloramine B 
is also used in disinfection of instruments and rooms. 
Chlorhexidine is one of the most effective antiseptics. Water and 
alcoholic solutions of chlorhexidine are used to sterilize instruments, wash 
wounds, burns, bladder, and hands. The agent is also used in room 
disinfection.   
 
Iodine-Containing Drugs 
 
Action mechanism of iodine-containing drugs develops due to 
interaction of N-groups of proteins with iodine. This interaction leads to 
coagulation of microorganism proteins. Antibacterial spectrum of iodine-
containing drugs is very broad. Iodine-containing drugs are used as both 
antiseptics and agents for resorptive action. Thus, radioactive iodine is used 
in diagnostics and treatment of thyroid gland diseases. Radioactive iodine 
compounds are used to diagnose liver, kidney, bronchi, uterus, and vessels 
diseases. 
Alcoholic iodine  solut ion is used in disinfection of a surgeon’s 
hands and an operative area, in the fungal diseases treatment, and in 
lubrication of wounds. Besides, distracting effect of this agent is used in 
treatment for myositis and neuralgia. 
Lugol’s  solution  contains iodine in water solution of potassium 
iodide. The drug is used in mucous membranes of pharynx and larynx 
treatment. 
Today, complex compounds of iodine with macromolecular 
surfactants are introduced in medicine: Iodinol ,  Iodovidonum, 
Iodonatum , etc. These compounds are called iodophors. Their advantage 
over alcoholic iodine solution is that these agents are water-soluble and 
have high bactericidal and absorptive activity, don't irritate skin and don't 
provoke the allergic reactions. Iodophores are used to cleanse mucous 
membranes of mouth and nasopharynx, to disinfect an operative area, treat 
wounds, burns, ulcers, etc.  
Ioddicerinum is a mixture of iodine, dimexidum, and glycerine. The 
drug has a broad spectrum of antimicrobial actions. Ioddicerinum is used in 
the treatment of infections of skin, mucous membranes, wounds, etc., 
caused by Staphylococcus, meningococci, Neisseria gonorrhoeae, 
Klebsiella, Shigella, Proteus, virus of herpes and varicella zoster, 
Chlamydia, etc. 
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Oxidizers  
 
Group of oxidizers contains hydrogen peroxide  and potassium 
permanganate . Oxidizers change redox potential and therefore violate 
the normal physiological redox processes in microorganisms.  
Under the influence of catalase, hydrogen peroxide decomposes with 
the release of molecular oxygen which exhibits low antimicrobial activity. 
Also, the process of decomposition is accompanied by formation of 
significant amount of foam. This foam washes away pus, blood clots, and 
dead tissue from the wounds. Therefore, hydrogen peroxide cleans the 
wounds. A 3% hydrogen peroxide solution is used to rins the mouth and 
throat, in treatment of purulent otitis media, and to stop nasal bleeding 
(release of oxygen accelerates the transformation of fibrinogen into fibrin). 
Potassium permanganate exhibits higher antiseptic activity because it 
releases atomic oxigen which oxidizes biological substances. Also, 
potassium permanganate causes astringent, irritative, deodorant, and 
cauterizing effects. Potassium permanganate is used in gastric lavage in 
treatment of poisoning (0.02–0.1 % solutions) caused by poisons which are 
oxidized by potassium permanganate (e.g., morphine); in cleaning wounds, 
washinh urethra and vagina (0.01–0.5 % water solutions); in treatment of 
burns (2–5 % water solutions).  
 
Heavy Metal Compounds  
 
Heavy metals (silver, mercury, copper, bismuth, etc.) interact with 
proteins of microbial cells with the formation of albuminates. Heavy metals 
preparations exhibit the fast and marked bactericidal effect. Some drugs 
have atypical for other antiseptics activity against certain microorganisms. 
Thus, mercury and bismuth preparations are active against Treponema 
pallidum, silver preparations – against cocci. 
Mechanism of action of heavy metal preparations is the following: 
ions of metal interact with SH2-groups of proteins. Inactivation of SH-
containing enzymes needs significantly less metal concentrations in cells 
than necessary for protein coagulation. This inactivation results in 
disruption of bacterial cell metabolism and growth inhibition of 
microorganisms. Besides, heavy metal salts influence proteins of skin and 
mucous membranes. Depending on concentration and the type of metal, the 
following effects can develop on the place of drug application: astringent, 
irritative, or cauterizing. These effects are based on the ability of salts to 
interact with tissue proteins with the formation of albiminates. The 
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interation with only superficial layers of skin and mucosa is accompanied 
by formation of dense albuminates preventing the penetration of ions into 
the deep layers of tissues. In this case, the astringent effect develops. In 
case of loose albuminate formation, metal ions penetrate into the deep 
layers of tissues that results in cauterizing effect on the tissue, accompanied 
by tissue damage (necrosis). Prof. Schmiedeberg made up a list of metals 
based on albuminate density:    
Pb, Al, ... Fe, Cu, Zn, ... Ag, Hg. 
Metals which are located in the left part of this list have mainly 
astringent and irritative actions. Metals which are located in the right part 
of Schmiedeberg’s list have cauterizing action. Metals which are located in 
the middle part of the list can exhibit all these actions in dependence on 
their concentration. 
In the human organism, salts of heavy metals are distributed 
irregularly: the most of the drug is accumulated in bones, liver, kidneys, 
and bone marrow. Slow ellimination of heavy metal salts is carried out by 
kidneys, sweat and salivary glands, and gastrointestinal mucosa. 
Silver-containing drugs are silver nitrate , protargolum (silver 
proteinate) , and colargolum (colloidal si lver) . These drugs have 
antibacterial, astringent, and anti-inflammatory actions.  
Silver nitrate 1–2 % solution is used in the treatment for conjunctivitis. 
Silver nitrate 5–10 % solution or sticks are used in the treatment of 
trachoma, skin ulcers, erosion, and hypersarcosis. Protargolum and 
colargolum are used to treat conjunctivitis, rhinitis, urethritis, and chronic 
cystitis.  
Zinc and copper salts have astringent, iritative, cauterizing, and 
antibacterial actions. Copper sulfate  is used to treat conjunctivitis, 
uretritis, and vaginitis. Ophthalmic pencils with copper sulfate are used in 
the treatment of trachoma. Eye drops with zinc sulfate  and copper 
sulfate  are used in the treatment of conjunctivitis. Also, zinc sulfate 
solutions are used in the treatment for laryngitis, vaginitis, and urethritis. 
Zinc sulfate is the part of the dusting powders, ointments, and pastes.  
Water-soluble aluminum preparations have an astringent, anti-
inflammatory, and antibacterial actions. Insoluble aluminum salts have an 
absorptive capacity. 
The preparations of lead are used as astringent and antibacterial agents 
in the treatment for pyderma, furunculosis, and carbuncles. 
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Mercury dichloride  and yellow mercury oxide  are used as 
antiseptics. Mercury dichloride is easily soluble in water and has high 
antibacterial activity. The agent is used to disinfect dishes, premises, etc. 
Mercury dichloride isn’t used to disinfect metal surfaces because it causes 
metal corrosion. For skin disinfection, mercury dichloride is used seldom 
due to high irritant effect. Eye ointment with yellow mercury oxide is used 
to treat conjunctivitis and keratitis. 
Bismuth preparations have no astringent and cauterizing effects. 
Antibacterial effect of bismuth salts is manifested due to blockage of HS-
groups of bacterial enzymes. Bismuth, also, has an antidiarrheal effect due 
to its ability to bind hydrogen sulfide in the intestine. Bismuth-containing 
drugs (dermatol  and xeroform) are used for treatment of the skin 
diseases (ulcers, eczema, and dermatitis). Also, bismuth-containing drugs 
are used as chemotherapeutic agents to treat stomach ulcer and syphilis.  
At present, heavy metal salts are used seldom.  
High concentrations of heavy metal salts can cause acute poisoning 
with the initial excitation replaced by inhibition in the central nervous 
system. Simultaneously, the cardiac depression and paralytic dilation of 
capillaries are observed (especially caused in abdominal cavity). 
Chronic poisoning may be caused due to constant intake of heavy 
metal salts. 
The constant contact with lead or its salts can cause the chronic 
poisoning (saturnism) due to the accumulation of lead, mainly in bone 
tissue. Interaction between lead and hydrogen sulfide in the oral cavity 
causes formation of lead sulfide which forms the gray film on the gums. 
Later, blood disorders (anemia), abdominal pain attacks (lead colic), and 
damage to the peripheral nervous system (lead polyneuropathy) are 
observed. Lead polyneuropathy is characterized by a primary lesion of the 
motor fibers of peripheral nerves with the development of lead paralysis. 
The antidote – metal-complexing agent tetacinum-calcium – is used to treat 
lead poisoning. The drug is administered intravenously drop-by-drop. 
Besides, the drug is taken orally in dose 0.5 g 4 times a day. The treatment 
of acute lead poisoning includes subcutaneous administration of atropine 
sulfate solution 0.1 %, subcutaneous omnoponum, intravenous sodium 
bromide, and rectal delivery of magnesium sulfate.  
Acute poisoning by mercury dichloride is accompanied by abdominal 
pain, vomiting, diarrhea, excitation of central nervous system with the 
following depression, and acute cardiovascular failure. In 2–4 days, the 
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renal failure and lesions of gastrointestinal tract are observed. Unithiol is an 
antidote to the toxicity of mercury chloride. The drug is administered 
intramuscularly or subcutaneously. Saline laxatives, activated carbon, 
astringent agents, milk, and egg white are taken orally. The treatment also 
includes gastric lavage, forced diuresis, and hemodialisis. 
Chronic poisoning by mercury salts is called mercurialism. The 
following are symptoms of mercurialism: disorders of central nervous 
system (dementia, tremor), stomatitis, anemia, etc. The treatment of chronic 
poisoning includes the administration of antidotes (unithiol, tetacinum-
calcium, or sodium thiosulfate), the actions to remove the mercury salt 
from the organism, and symptomatic therapy.  
 
Alcohols  
 
Ethyl alcohol  is used in medicine as an antiseptic and disinfectant 
agent. Ethanol antibacterial activity is defined due to its ability to cause 
dehydration and denaturation of proteins. Ethyl alcohol is used to disinfect 
hands of the surger, surgical field, and medical instruments. Disinfection of 
the skin is more effective if 70 % ethanol is used. Higher concentrations of 
ethanol have less antibacterial activity in this case because concentrated 
ethanol seals the epidermis that prevents its diffusion into the ducts of 
sweat and sebaceous glands. 20–40 % ethanol solutions significantly 
irritate the skin and, therefore, they are used in compresses and grinding.  
A 90–95 % ethanol is used to sterilize medical instruments.  
 
Aldehydes  
 
Formaldehyde  is a water-soluble gas with a pungent irritating odor. 
The agent has high antibacterial activity against vegetative and spore forms 
of bacteria. Formaldehyde interacts with aminogroups of bacterial proteins 
that results in their dehydration. Formaldehyde (gas and solutions) is used 
to disinfect rooms, clothes, etc. Dehydrating effects of formaldehyde cause 
epithelial cell irritation. Mucous membranes are especially sensitive to 
formaldehyde. Formaldehyde affects the sweat glands and causes dry skin.  
Formalin  and hexamethylenetetramine  (methenamine,  
urotropin)  are drugs which contain formaldehyde.  
Formalin is a 36.5–37.5 % water solution of formaldehyde. The drug 
is used to dry the skin of hands, in increased sweating of legs  
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(0.5–1 % solutions), to sterilize instruments (0.5 %), and to preserve 
cadaveric material. 
Urotropine  converts into formaldehyde in an acidic environment. 
The drug is taken orally (0.05–1.0 g 5 times a day after meal) or 
administered intravenously (5–10 ml of 40 % solution) for treatment of 
urinary tract infections. The activity of urotropin against Gram-negative 
bacteria is restricted. Also, hexamethylenetetramine (Urotropine) is a part 
of tablets Calcex .  
Inhalation of concentrated formaldehyde vapors can cause the acute 
poisoning with lacrimation, sharp cough, and the feeling of chest tightness. 
Oral intake of formaldehyde results in drooling, epigastric burning, gastric 
pain, nausea, vomiting, diarrhea, inflammation of the kidneys, loss of 
consciousness, and convulsions with the following inhibition of nerve 
centres. The treatment of poisoning includes the gastric lavage with weak 
ammonia solution  and intake of covering agents (milk or egg white). 
 
Acids and Alkalis  
 
Antibacterial effect of acids and alkalis manifests itself due to their 
ability to penetrate (in the form of undissociated molecules) into bacterial 
cells. In bacterial cells, molecules of acids and alkalis dissociate and cause 
the denaturation of bacterial proteins. Boric acid  and salicylic acid  are 
used as anticeptics in medicine.  
Boric acid is used to treat conjunctivitis, otitis, eczema, dermatitis, 
colpitis, pyoderma, etc. The following medicinal forms of boric acid are 
used in medicine: water, alcohol, and glycerol solutions, eye drops, 
ointments, pastes, and antiseptic powders for external use.  
 Preparations of salicylic acid have antiseptic, irritating, keratoplastic 
(in concentrations up to 5 %) or keratolytic (in concentrations 5–10 %) 
effects. Water and alcohol solutions, ointments and pastes with salicylic 
acid are used in the treatment of different inflammatory and infectious skin 
diseases. Indications for its use include burns, blisters, warts, 
hyperkeratosis, excessive sweating of the feet, hair loss, psoriasis, acne 
vulgaris, seborrheic dermatitis, eczema, ichthyosis vulgaris, otitis media, 
etc. 
Ammonia solution  (contains 10 % ammonia) and sodium 
hydrocarbonate are alkalis that act as antiseptics. Ammonia solution is used 
in surgical hand antisepsis. The irritating activity of ammonia solution and 
ability reflexively stimulate the respiratory center give grounds for use in 
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syncope. Sodium hydrocarbonate solution has an expressed detergency. 
The drug is used to rinse mouth and throat in tonsilitis, to wash eyes, and 
sterilize instruments.   
 
Table 1 – Drugs for prescription 
 
 
Drug name 
(Latin) 
Single dose and mode of 
administration 
Drug product 
Chlorhexidini 
bigluconas  
For disinfection of skin or 
mucous membranes 0.05 %, 
0.2 %, or 0. solution;  
for disinfection of surgical 
field 0.5 % aqueous-
alcoholic solution;  
for disinfection of wounds 
and burns 0.5 % water 
solution;  
for hand disinfection 0.5 % 
alcoholic or 1 % water 
solution 
0.05 % water solution in 
bottles 100 ml;  
20 % water solution in 
bottles 100 or 500 ml 
Aethonium For treatment of wounds and 
ulcers: 0.02–1 % solution or 
0.5–2 % ointment; 
for treatment of keratitis, 
corneal ulcers, and other eye 
lesions: 0.1 % eye drops;  
for treatment of stomatitis: 
0.5 % solution;  
for treatment of dermatitis 
and burns: 0.5–2 % ointment    
Pouder for solution 
preparation; 
ointment 0.5 % or 1 % – 
25 g 
 
Sol. Iodi spirituo-
sae 
For external use 5 % solution in bottles 10, 
15 or 25 ml  
Ioddicerinum For external use Bottles 15 ml 
Spiritus aethylicus For skin preparation 70 % 
solution;  
for processing surgical  
instruments 90 % 
Bottles 100 ml  
Acidum boricum Solution or ointment for 
external use 
2–4 % solution; 
5–10 % ointment 
Sol. Viridis nitentis 
spirituosae 
For external use 1 % or 2 % spirituous 
solutions 
 
15 
 
Continuation of Table 1 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product 
Zinci sulfas 1–2 drops in eyes 3–4 times 
daily 
0.25 % or 0.5 % solution of 
eye drops 
Furacilinum Orally 0.1 g 4 times a day; 
ointment for external use; 
solution for washing 
infected cavities and mucous 
membranes  
Tablets 0.1 g (for oral 
intake); 
tablets 0.02 g (for 
preparation of solutions); 
ointment  0.2 % – 25 g; 
water solution 1:5000 (1 part 
of Furacilinum to 5000 parts 
of water);  
alcoholic solution 1:1500 
Sol. Hydrogenii 
peroxydi diluta 
For external use 3 % solution in bottles 50 ml 
Kalii permanganas 0.1–0.5 % solution for pro-
cessing of wounds; 
2–5 % solution for pro-
cessing of burns; 
0.02–0.05 % solution for 
gastric lavage 
Solutions with different 
concentrations 
Aethacridini lactas Solutions, ointment and 
aspersion for external use 
0.1 % or 0.2 % solutions; 
3 % ointment; 
3 % aspersion; 
5–10 % paste  
Unithiolum Intramuscularly 0.25–0.5 g 
2–4 times daily 
Ampoules 5 ml of 5 % 
solution  
 
 
Chemotherapeutic Drugs 
 
Antibiotics  
 
Paul Ehrlich is the founder of the modern chemotherapy.  In 1907, he 
suggested the first effective agent for syphilis treatment – salvarsan. In 
1932, Gerhard Domagk discovered the antibacterial properties of red 
streptocid.  
The first antibiotic penicillin was discovered by Sir Alexander 
Fleming in 1929. In 1940, Sir Howard Walter Florey and Ernst Boris Chain 
produced a pure form of penicillin. In the USSR, the pure penicillin was 
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produced by Z. V. Yermolyeva and T. I. Balyazina in 1942. The significant 
amount of natural and synthetic antibacterial drugs have been created in 
succeeding years. The synthesis of new antibacterial drugs is presently 
going on. 
Chemotherapeutic drugs are characterized by definite spectrum of 
antibacterial action. One of the requirements for drugs is their low toxicity 
for humans and animals. 
There are the following main principles of chemotherapy:  
1. It is necessary to make the precise diagnosis and identify the 
pathogen and its antibiotic sensitivity.  
2. It is necessary to start treatment as early as possible, yet the number 
of agent is low and the serious lesions of internal organs do not develop. 
3. The route of drug administration should be optimal that provides the 
best drug – pathogen interaction.  
4. The drug concentration in human organism should be effective and 
stable throughout the whole therapy. Sometimes, the knockout dose is 
prescribed in early treatment to create a necessary effective concentration 
of the antibacterial agent. 
5. The duration of antibacterial therapy should be optimal (the therapy 
lasts 3–5 days after clinical recovery. 
6. The measures to support the body's defences should be provided 
together with chemotherapy (vitamins, immunomodulators, drugs that 
support the hepatic and renal functions, etc.).  
Chemotherapeutic drugs include the following drug groups:  
1. Antibiotics. 
2. Sulfonamides. 
3. Synthetic antibacterial drugs with different chemical structure 
(quinolones, fluoroquinolones, hydroxyquinolines, nitroimidazole 
derivatives, and nitrofurane derivatives).  
4. Antifungal drugs. 
5. Antiviral drugs. 
6. Antiprotozoal drugs.  
7. Antisyphylitic drugs. 
8. Antituberculosis drugs. 
9. Anthelmintic drugs.  
 
Antibiotics are drugs of bacterial origin and their semi-synthetic and 
synthetic analogues which selectively damage or kill certain microbial 
species. Antibiotics are classified according to their origin, chemical 
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structure, mechanism of action, and character of the influence upon 
bacteria.  
Antibiotic classification according to chemical structure is the 
following:  
1. β-lactam antibiotics: penicillins, cephalosporins, monobactams, and 
carbapenems.  
2. Antibiotics containing the macrocyclic lactone rings in molecules: 
macrolides and azalides.  
3. Tetracyclines (antibiotics containing four condensed six-membered 
rings in molecules).  
4. Chloramphenicol drug group. 
5. Aminoglycosides (antibiotics containing the aminosugars in 
molecules).  
6. Polypeptides (polymyxins and gramicidin C). 
7. Polyenes (amphotericin B, nystatin, and levorin). 
8. Glycopeptides (vancomycin and ristomycin).  
9. Lincosamides (lincomycin and clindamycin).  
10. Ansamycins (rifampicin and rifamycin).  
11. Antibiotics with steroidal structure (fuzidin-sodium). 
12. Different antibiotics (fusafungine).  
According to mechanism of action, antibiotics are classified into the 
following groups:  
1. Antibiotics affecting the synthesis of bacterial cell wall: β-lactams 
and glycopeptides. 
2. Antibiotics affecting the function of bacterial cytoplasmic 
membrane: polypeptides and polyenes.  
3. Antibiotics affecting the synthesis of bacterial proteins: 
aminoglycosides, tetracyclines, chloramphenicols, macrolides, and 
lincosamides.  
4. Antibiotics affecting the synthesis of nucleic acids: ansamycins. 
There are two types of antibacterial action of antibiotics: bactericidal 
and bacteriostatic. Bactericidal antibiotics affect the synthesis of bacterial 
cell wall or the function of cytoplasmic membrane; these agents kill the 
bacteria. Bactericidal antibiotics include β-lactams, glycopeptides, 
polypeptides, and polyenes. Besides, high doses of aminoglycosides, 
rifampicin, and chloramphenicol are cases of bactericidal action. 
Tetracyclines, macrolides, ansamycins, lincosamides, etc. have the 
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bacteriostatic effect. Bacteriostatic antibiotics affect the growth and 
division of bacteria. 
Depending on the number of bacteria species affected by a drug, 
antibiotics are divided into the drugs of broad spectrum and the agents of 
narrow spectrum. The antibiotics of broad spectrum of antibacterial activity 
include tetracyclines, chloramphenicol, aminoglycosides, cephalosporins, 
and semisynthetic penicillins, azalides, and macrolides. Narrow spectrum is 
typical for biosynthetic penicillins, macrolides, lincosamides (these groups 
are active against gram-positive bacteria), and polymyxines (active against 
gram-negative flora).         
  
β-Lactam Antibiotics  
 
It is the dominant group of modern antibiotics which includes 
penicillins, cephalosporins, carbapenems, and monobactams. Β-lactams are 
bactericidal antibiotics. They work by inhibiting cell wall synthesis due to 
the blockage of transpeptidase (an enzyme that crоss-links the 
peptidoglycan chains to form rigid cell walls). It results in lysis of bacterial 
cells.  
 
Penicil l ins 
 
Penicillins are a type of antibiotics that contain the  
6-aminopenicillanic acid in the molecules. Natural penicillins are produced 
by Penicillium molds. The semisynthetic penicillins are synthezied due to 
chemical modification of 6-aminopenicillanic acid.  
Penicillins can be classified as follows:  
1. Biosynthetic penicillins.  
1.1. Drugs for parenteral administration: 
– short-acting penicillins: benzylpenicil l in-sodium  and 
benzylpenicil l in-potassium ;  
– long-acting penicillins: benzylpenicil l in  novocaine salt ,  
bicil l in-1, and bicil l in-5 .  
1.2. Drugs for enteral administration: phenoxymethylpenicil l in .  
2. Semisynthetic penicillins.  
2.1. Drugs for both parenteral and enteral administration:  
– drugs stable to penicillinase: oxacil lin and  nafcill in ; 
– drugs of broad spectrum (aminopenicillins): ampicil l in and  
amoxicil l in . 
2.2. Drugs of broad spectrum for parenteral administration: 
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– carboxypenicillins: carbenicillin-disodium and  ticarcillin; 
– ureidopenicillins: azlocillin,  piperacillin,  and  mezlocillin .  
2.3. Drugs for enteral administration of broad spectrum:  
– carboxypenicillins: carbenicil l in indanyl sodium and  
carfecil l in . 
 
Biosynthetic Penicil l ins  
 
Biosynthetic penicillins are drugs of narrow antibacterial spectrum 
which include mainly Gram-positive bacteria. The following bacteria are 
sensitive to biosynthetic penicillins: staphylococci, streptococci, 
pneumococci, gonococci, meningococci, Clostridia (the causative agents of 
gas gangrene and tetanus), Corynebacterium diphtheria, Bacillus antracis, 
spirochetes (the causative agents of syphilis, relapsing fever, and 
leptospirosis), and actinomycetes.  
Benzylpenicil l in-sodium  and benzylpenicil l in-potassium  are 
the water-soluble salts of monobasic acid. In case of oral intake, these 
drugs are dystroyed by hydrochloric acid, therefore they are administered 
parenterally, mainly intramuscularly. Duration of benzylpenicillin action is 
3–4 hours, therefore drugs are administered 6 times a day. In special cases, 
benzylpenicillin is administered intravenously, intra-arterially, into the 
spinal canal (only sodium salt), joint capsules, and serous cavities, or it is 
used in inhalations. Nearly 60–70 % of administered benzylpenicillin is 
excreted through kidneys in non-modified form. Insignificant part of the 
drug is secreted into biliary ducts and excreted through intestine. The rate 
of drug elimination depends on renal and hepatic functions. The elimination 
of benzylpenicillin in patients with simultaneous damage of renal and 
hepatic functions can be slowed down 10 times.  
There are benzylpenicillin preparations of prolonged action: 
benzylpenicil l in  novocaine, bicil l in-1 , and bicil l in-5 . Water 
suspensions of these drugs are administered intramuscularly. 
Benzylpenicillin novocaine is administered twice a day, bicillin-1 – once in 
1–2 weaks, and bicillin-5 – once a month. Long-acting drugs are prescribed 
only if it is known that a patient has no allergy to penicillins and causative 
agent has high sensitivity to a prescribed drug. Therapeutic indications for 
the long-acting biosynthetic penicillins are rheumatism and syphilis.  
Phenoxymethylpenicil l in  is an acid-stable penicillin because its 
molecules contain the phenoxymethyl groups. Antibacterial spectrum of 
phenoxymethylpenicillin is identical to antibacterial spectrum of 
20 
 
benzylpenicillin. The drug is easily absorbed in gastrointestinal tract but its 
blood concentration is not high. Therefore, phenoxymethylpenicillin is not 
used in treatment of severe infections. The drug is prescribed for oral intake 
4–6 times a day for the teatment of mild to moderate infections, such as 
pharyngitis, tonsillitis, sinusitis, otitis, bronchitis, pneumonia, erysipelas, 
erysipeloid, erythema migrans, lymphadenitis, lymphangitis, scarlet fever, 
etc.  
 
Semisynthetic Penicil l ins  
 
Semisynthetic penicillins are synthesized by the acylation of  
6-aminopenicillanic acid.  
Oxacill in  and nafcill in  are known as antistaphylococcal 
penicillins. The antibacterial spectrum of these drugs is similar to the 
spectrum of benzylpenicillin. But these drugs are stable to penicillinase 
action, therefore they are highly active against different strains of 
Staphylococci, including penicillinase producing strains.  
Oxacillin is taken orally or administered parenterally 4–6 times a day. 
The degree of drug binding to plasma proteins is 90–95%. Oxacillin does 
not penetrate through the blood-brain barrier. The main route of the drug 
excretion is through the kidneys.  
Nafcillin has high antibacterial activity. Nafcillin is administered both 
orally and parenterally. The drug easily penetrates through the blood-brain 
barrier. The drug is mainly excreted with bile. 
Ampicil l in  and amoxicil l in  are aminopenicillins. The drugs have 
the broad spectrum of antibacterial action but are broken by penicillinase. 
The spectrum of antibacterial action of aminopenicillins includes Gram-
positive and Gram-negative bacteria. Aminopenicillins are active against 
Enterococcus, Salmonella, Shigella, Escherichia coli, some strains of 
Proteus, etc. It is significant that activity of aminopenicillins against  
Gram-positive bacteria is 3–4 times less than the activity of biosynthetic 
penicillins. But their activity against Gram-negative bacteria is higher than 
the activity of tetracyclines and chloramphenicol. Aminopenicillins are not 
active against Pseudomonas aureginosa.  
Ampicillin is an acid-stable antibiotic which is easily absorbed in 
gastro-intestinal tract. The degree of binding to plasma proteins is low. The 
drug is excreted from the body through the kidneys and liver and creates the 
high concentration in urine and bile. This allows its use for treatment for 
infections of urinary and biliary tracts. Ampicillin badly penetrates through 
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the blood-brain barrier. The drug is taken orally 3–4 times a day or 
administered intramuscularly 4–6 times a day. Toxicity of ampicillin is 
low.  
Amoxicillin is similar to ampicillin. But the drug is better absorbed in 
gastrointestinal tract with high concentrations in plasma and tissues. 
There are combined penicillin preparations such as Ampiox  
(combination of ampicillin with oxacillin in ratio 2:1). 
Carbenicil l in  is a broad-spectrum semisynthetic penicillin of 
carboxypenicillin group. The drug is active against many Gram-positive 
and Gram-negative bacteria including Pseudomonas aureginosa, Proteus, 
and some bacteroides. Beta-lactamase breaks up carbenicillin, therefore it 
does not influence staphylococci producing penicillinase. Carbenicillin is 
used mainly as a reserve antibiotic in treatment of infectious diseases 
caused by P. aureginosa.            
Carbenicillin is an acid-labile antibiotic, therefore it is administered 
intramuscularly or intravenously. The drug permeability through the blood-
brain barrier is low. The main route of excretion is through the kidneys. 
Duration of carbenicillin action is 4–6 hours. Carbenicillin indanyl sodium 
is an acid-stable form of carbenicillin which is administered orally mainly 
in treatment of urinary tract infections.  
Ticarcil l in  is carboxypenicillin with high activity against  
Pseudomonas aureginosa. The drug is administered parenterally. Such 
carboxypenicillins as carfecillin and carindacillin are to be given orally. 
Their bioavailability in oral intake is above 40 %.  
A group of ureidopenicillins includes such medications as azlocil l in, 
mezlocil l in , and piperacil l in . Ureidopenicillins are characterized by 
high activity against P. aureginosa and fast development of bacterial 
resistance. These drugs are administered only parenterally 3 times a day. 
There are inhibitors of β-lactamase that prevent the destruction of 
penicillins by penicillinase: clavulanic acid , sulbactam , and 
tazobactam . These agents are used in combination with penicillins. For 
example, augmentin consists of amoxicillin and clavulanic acid. The drug 
is administered once a day for treatment of infectious diseases of 
respiratory and urinary tracts, joints, bones, sepsis, etc. Another group of  
combination drugs includes unazinum (ampicillin with sulbactam),  
co-amoxiclav (amoxicillin with clavulanic acid), and tazocin (piperacillin 
with tazobactam). 
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Despite low toxicity and inability to accumulate in the organism, 
penicillins have many side effects.  
Allergic reactions (skin rash, bronchospasm, and anaphylactic shock) 
are the most common side effect of penicillins. To prevent allergy, the test 
for sensitivity to penicillins shoud be performed before the drug 
administration. In the case of anaphylactic shock, intramuscular adrenaline, 
intravenous glucocorticoids and calcium chloride must be administered 
very quickly.  
Other side effects of penicillins are painful injections, infiltrates, and 
aseptic necrosis in the injection site. Oral drug intake can cause nausea, 
diarrhea, stomatitis, and glossitis. Intravenous administration can cause 
phlebitis and trombophlebitis. Large doses of penicillins or their use in 
patients with renal failure can result in development of neurotoxic effects. 
Sometimes, penicillins cause disturbances of cardiac activity and inhibition 
of hepatic enzymes. Semisynthetic broad-spectrum penicillins can cause 
disbiosis and superinfection.  
 
Cephalosporins  
 
Cephalosporins are semisynthetic antibiotics with β-lactame ring in 
molecules. Mechanism of cephalosporins’ action is associated with 
affection of bacterial cell wall synthesis due to inhibition of transpeptidase. 
Cephalosporins have the bactericidal effect and are broad-spectrum 
antibiotics. The drugs are stable to staphyloccocal β-lactamase, but β-
lactamases of Gram-negative bacteria can affect some cephalosporins.  
Cephalosporins are grouped into four generations:  
1.   Cephalosporins, 1st generation.  
1.1. Drugs for parenteral administration: cephaloridine, cefalotin ,  
cefazolin, cefradine, and cefapirine .  
1.2. Drugs for enteral use: cephalexin, cephradine, and 
cefadroxil .  
2.   Cephalosporins, 2nd generation. 
2.1. Drugs for parenteral administration: cefuroxime,  
cefamandole,  cefoxit in,  cefmetazole,  and ceforanide . 
2.2. Drugs for enteral use: cefaclor, cefuroxime, and 
loracarbef . 
3.   Cephalosporins, 3rd generation.  
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3.1. Drugs for parenteral administration: cefotaxime, ceftriaxone,  
ceftazidime, cefoperazone, cefmenoxime, and 
moxalactam . 
3.2. Drugs for enteral use: cefixime, ceft ibuten, and 
cefpodoxime .  
4.   The 4th generation cephalosporins are the drugs for parenteral 
administration: cefepime, cefpirome, cefclidine, and 
cefozopran .  
 
First -Generation Cephalosporins  
 
First-generation cephalosporins are antibiotics with high activity 
against Gram-positive bacteria. Also, some Gram-negative bacteria are 
sensitive to these drugs. Antibacterial spectrum of 1
st
-generation 
cephalosporins includes staphylococci, streptococci, pneumococci, 
meningococci, gonococci, Corynebacterium diphtheria, Clostridium, 
actinomycetes, Proteus mirabilis, Escherichia coli, Klebsiella pneumoniae, 
Salmonella, and Shigella. First-generation cephalosporins have no activity 
against methicillin-resistant staphylococci, Pseudomonas, indole-positive 
Proteus, Bacteroides, Enterococcus, Enterobacter, etc. 
Therapeutic indications for 1st-generation drugs are infectious diseases 
of respiratory tract, pneumonia, peritonitis, osteomyelitis, otitis, 
furunculosis, infected wounds, infections of urinary tract, prevention of 
surgical infections, etc. 
Cefazolin  is 1st-generation cephalosporin for parenteral 
administration. The drug is administered intramuscularly or intravenously 
3–4 times a day. Cefazolin has high antibacterial activity and penetrates in 
the tissues better than other 1st-generation drugs. The high drug 
concentration is created in bile and urine. The nephrotoxicity of cefazolin is 
low. There are the following side effects of the drug: superinfection caused 
by Candida or Pseudomonas aeruginosa, allergic reactions, leukopenia, 
pain and infiltrations in the injection site.   
Cephalexin  is easily absorbable in the gastrointestinal tract. The 
drug is taken orally 4 times a day. Cephalexin is available in the following 
medical forms: capsules, tablets and suspension for oral intake. The drug is 
used to treat infectious diseases of moderate severity. Side effects of 
cephalexin are as follows: disbiosis and leukopenia.   
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Second-Generation Cephalosporins  
 
The antibacterial spectrum of  2nd-generation cephalosporins is 
similar to the 1st-generation cephalosporins. But 2nd-generation has higher 
activity against Gram-negative bacteria and it is less active against Gram-
positive flora. These drugs are not active against Pseudomonas aeruginosa. 
Second-generation cephalosporins are used to treat infectious diseases of 
respiratory tract, abdominal and gynecological infections, septicemia, 
endocarditis, urinary tract infections, infections of bones, joints, skin and 
soft tissues, to prevent postoperative infections.  
Cefoxit in  is active against bacteroids. It is highly active against other 
Gram-negative bacteria (Escherichia coli, Haemophilus influenzae, 
Salmonella, Shigella, Proteus mirabilis, gonococci). Cefoxitin is also active 
against Gram-positive bacteria (Staphylococcus, Streptococcus) and against 
some anaerobic bacteria. The drug is resistant to β-lactamase. Pseudomonas 
aeruginosa, Listeria, many strains of enterococci and methicillin-resistant 
staphylococci, and others are insensitive to cefoxitin. The drug is 
administered intramuscularly or intravenously 2–3 times a day.  
Cefaclor  is the 2nd-generation cephalosporin for peroral use. The 
drug is taken orally 3 times a day. The drug is highly active against Gram-
negative bacteria (Escherichia coli, Haemophilus influenzae, Salmonella, 
Shigella, Proteus mirabilis, Klebsiella, Neisseria gonorrhoeae, 
Citrobacter). Besides, cefaclor is active against Gram-positive bacteria. 
The drug has no activity against anaerobic microorganisms (Bacteroides, 
etc.), Pseudomonas, Enterococcus, Listeria, Serratia, etc.  
Cefuroxime  is available both for peroral and parenteral 
administration. The drug has a higher ability to penetrate through the 
blood-brain barrier than other drugs of the 2nd-generation, and it is used to 
treat meningitis. The drug is administered parenterally or taken orally 2–3 
times a day.    
 
Third-Generation Cephalosporins  
 
Antibacterial spectrum of these drugs is wider, and their activity 
against Gram-negative bacteria is higher compared to preceding drugs. 
Third-generation cephalosporins are stable to Gram-negative β-lactamases. 
Ceftazidime , cefotaxime , and cefoperazone  are active agaisnt 
Pseudomonas aeruginosa.  
All third-generation cephalosporins (except cefoperazone) easily 
penetrate into tissues, including central nervous system. Most of the drugs 
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are excreted through the kidneys in unchanged form. Only ceftriaxone and 
cefoperazone are excreted mainly with bile. Therapeutic indications for the 
third-generation cephalosporins are infections of respiratory tract, bones, 
soft tissues, abdominal cavity, and urinary tract, sepsis, meningitis, 
endocarditis, etc. The drugs should be taken 2–3 times a day, but 
ceftriaxone and cefoperazone – 1–2 times a day.  
 
Fourth-Generation Cephalosporins  
 
All forth-generation cephalosporins are administered only parenterally. 
These drugs have the extended antibacterial spectrum and high activity 
against both Gram-positive and Gram-negative bacteria. These drugs have 
a greater resistance to β-lactamases than the 3rd-generation cephalosporins. 
Fourth-generation cephalosporins affect bacteria insensitive to other 
antibiotics (including carbapenems). It is due to drug ability to penetrate 
through cell membranes and to bind to bacterial penicillin-binding proteins. 
Besides, the 4th-generation cephalosporins create high concentrations in 
periplasmic space. But these drugs are inactive against bacteroides, 
therefore, for expansion of antibacterial spectrum, they are combined with 
metronidazole, carboxypenicillins, and ureidopenicillins. Secondary 
resistance of bacteria to these drugs develops slowly. The therapeutic 
indications for the 4th-generation cephalosporins are infections of 
respiratory and urinary tracts, sepsis, surgical infections, meningitis, etc. 
Cefepime and cefpirome are administered twice a day.  
Therapy with cephalosporins may be accompanied by allergic 
reactions. Cephalosporins are contraindicated to patients with allergy to 
penicillins in anamnesis. Nephrotoxicity is typical mainly for the  
1st-generation cephalosporins. Neurotoxicity (hallucinations, convulsions, 
nystagmus) is due to antagonism between cephalosporins and  
γ-aminobutyric acid. Hematotoxicity (leukopenia, thrombocytopenia, 
neutropeniza) can develop in patients with renal failure or in the case of 
parenteral administration of high doses of cephalosporins. Therapy by 
cephalosporins can be accompanied by elevated liver enzymes in blood. 
Enteral cephalosporin intake can cause disbiosis. Patients treated with 
cephalosporins should avoid alcohol consumption because the drugs have 
Antabuse-like effect. In this case, alcohol intake can result in nausea, 
vomiting, diarrhea, tachycardia, etc.   
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Monobactams 
 
Monobactams are β-lactam antibiotics which are active only against 
aerobic Gram-negative bacteria (e.g., Escherichia coli, Enterobacter, 
Neisseria, Pseudomonas, Proteus, Serratia, Morganella, Salmonella, 
Shigella, Klebsiella, etc.). The representative of monobactams is 
aztreonam . The drug has high stability to β-lactamases of Gram-negative 
bacteria, but it is destroyed by β-lacatamases of Gram-positive 
microorganisms. Therefore, aztreonam has no activity against Gram-
positive bacteria, bacteroides, and other anaerobes. The therapeutic 
indications of aztreonam are severe infections of urinary and respiratiry 
tracts, abdominal cavity, soft tissues, meningitis, sepsis, etc. The drug is 
administered intramuscularly or intravenously 2–3 times a day. The side 
effects of aztreonam are allergic reactions, dysbiosis, dyspepsia, and 
phlebitis. 
 
Carbapenems 
 
It is a modern group of β-lactame antibiotics with high stability to  
β-lactamases and broad antibacterial spectrum. Carbapenems are active 
against both Gram-positive and Gram-negative aerobic and anaerobic 
bacteria, including Pseudomonas aeruginosa. The mechanism of 
carbapenems’ action is identical to other β-lactame antibiotics. These drugs 
are divided into two generations:  
– 1st generation: imipenem, t ienam, primaxin ; 
– 2nd generation: meropenem .    
Imipenem  is a semisynthetic antibiotic with broad spectrum of 
action. The drug is stable to β-lactamases, but is destroyed by 
dehydropeptidase-I (enzyme of proximal tubules of nephron). Tienam  and 
primaxin  are combined drugs which contain imienem and cilastatin in 
ration 1:1. Cilastatin is inhibitor of dehydropeptidase-I. 
Meropenem  is stable to dehydropeptidase-I, therefore it does not 
require the combination with cilastatin. Also, antibiotic is stable to  
β-lactamase action. Antistaphylococcal activity of meropenem is 2–4 times 
less than the activity of tienam. On the other hand, the drug activity against 
Gram-negative enterobacteria and Pseudomonas is higher 2–8 times. 
There are microorganisms with natural resistance to carbapenems. 
They are Chlamydia, Mycoplasma, Corynebacterium, Mycobacterium, 
Flavobacterium, methicillin-resistant staphylococci, fungi, and protozoa.    
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Carabapenems are administered only parenterally. Tienam is 
administered intravenously 4 times a day or intramascularly 2 times a day. 
Meropenem is administered intravenously 3 times a day. Carbapenems are 
reserve antibiotics which are used in treatment of severe infections in case 
of ineffectiveness of other antibiotics. There are the following therapeutic 
indications for carbapenems:  
– intraperitoneal surgical infections;  
– gynecological infections after labor, cesarean section, and surgery;  
– intensive therapy for newborns;  
– complicated infections of urinary tract;  
– complicated infections of bones, joints, skin, and soft tissues;  
– sepsis;  
– pulmonary infections;  
– infectious diseases in patients with neutropenia;  
– meningitis (meropenem is a drug of choice due to higher 
permeability through the blood-brain barrier and less neurotoxicity).  
Side effects of carbapenems are as follows:  
– pain, thrombophlebitis, and  sealing the injection site;  
– allergic reactions;  
– superinfections;  
– nephrotoxicity (more common for imipenem);  
– neurotoxicity: tremor, muscular hypertone, paresthesia, 
encephalopaty, convulsions (in the case of intravenous administration of 
tienam or primaxin, but meropenem).  
 
Macrolides and Azalides 
 
Macrolides are antibiotics containing macrocyclic lactone rings in 
molecules. 
There are three generations of macrolides:  
1st generation: erythromycin and oleandomycin ;  
2nd generation: spiramycin, roxithromycin, clarithromycin , 
and  midecamycin .  
3rd generation (azalides): azithromycin .  
Mechanism of macrolide action is as follows. Drugs bind to  
50S ribosomal subunit that results in violation of ribosome translocation 
along mRNA and inhibition of protein synthesis. The macrolides are 
bacteriostatic antibiotics.  
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First-generation macrolides are drugs with narrow antibacterial 
spectrum. These drugs are active mainly against Gram-positive bacteria 
(streptococci, staphylococci, pneumococci, Corynebacterium diphtheriae, 
etc.). Besides, gonococci, Mycoplasma, Chlamydia, Legionella, 
spirochetes, certain strains of Brucella and Mycobacteria are sensitive to 
1st-generation macrolides. But most Gram-negative microorganisms have 
high resistance to these drugs. 
The second- and third-generation macrolides have the broad 
antibacterial spectrum. These drugs are active against enterococci, 
Escherichia coli, Haemophilus influenzae, Shigella, Salmonella, 
Bacteroides, Helicobacter pylori, etc. Azithromycin has high activity 
against bacteria – causative agents of genital infections (Neisseria 
gonorrhoeae, Chlamydia, spirochetes, and Trichomonas vaginalis). 
Macrolide resistance of bacteria develops readily, therefore a course of 
treatment should not exceed 7 days.  
Erythromycin  is a low toxic antibiotic for oral intake. The drug is 
slowly absorbed in gastrointestinal tract. Erythromycin is partly degraded 
by gastric juice, therefore the drug is used in capsules or specially-coated 
tablets. The bioavailability of erythromycin is higher if taken before a meal. 
The drug esealy penetrates into tissues and body fluids (except central 
nervous system). High concentrations of the drug are created in lungs, liver, 
prostate, and urinary tract. About 60–70 % of the administered dose 
undergo hepatic metabolism. Erythromycin is taken 4–6 times a day before 
a meal or used locally in ointments. Erythromycin phosphate is used in 
intravenous administration 2–3 times a day in a dose of 0.2 g.  
Oleandomycin  has lower antibacterial activity than erythromycin, 
but irritative ability of oleandomycin is higher. The drug is taken orally 4 
times a day. Presently, oleandomycin is not used in monotherapy. It is most 
commonly combined with tetracyclines (oletetrin, tetraolean, etc.).  
Clarithromycin  is 2–4 times more active against staphylococci and 
streptococci than erythromycin. The drug is used in treatment of infectious 
diseases caused by Mycoplasma, Chlamydia, Toxoplasma, and 
Helicobacter pylori. Clarithromycin is easily absorbed in gastrointestinal 
tract. The drug undergoes hepatic metabolism and is excreted through the 
kidneys. Clarithromycin is taken 2 times a day. Course of treatment is 5–14 
days. Side effects are abdominal pain, diarrhea, and nausea.  
In comparison with the 1st and 2nd generations, molecules of the  
3rd-generation macrolides have aromatic group in the structure of 
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macrocyclic lactone ring, and due to this they have new properties. In 
contrast with erythromycin, azithromycin  is 2–4 times less active against 
Gram-positive cocci. But drug activity against Gram-negative bacteria is 
higher. The bioavailability of azithromycin in gastrointestinal tract is low. 
The drug can accumulate in the cells (intracellular concentration may be 
higher than plasma concentration 10–100 times). Azithromycin does not 
penetrate through the blood-brain barrier. The drug is excreted through the 
kidneys in unchanged form. Azithromycin is taken orally once a day. The 
first dose is twice higher than subsequent doses. Therapeutic indications for 
azithromycin are bronchitis, otitis, sinusitis, erysipelas, mastitis, whooping 
cough, diphtheria, chlamydial conjunctivitis, chlamydial pneumonia of 
newborns, pneumonia caused by Mycoplasma pneumoniae, lobar 
pneumonia caused by Legionella pneumophila and Moraxella catarrhalis, 
primary syphilis, gonorrhea, cholecystitis, enteritis, colitis, toxoplasmosis, 
urogenital infections, and ulcer diseases of stomach and duodenum.  
New macrolide antibiotic josamycin  is approved in medicine. The 
drug has broad antibacterial spectrum and causes bacteriostatic or 
bactericidal (in high doses) effect. The resistance of bacteria to josamycin 
develops seldom. 
 
Tetracyclines  
 
Tetracyclines are antibiotics with four condensed 6-member cycles in 
molecules. A classification of tetracycline is as follows:  
1. Biosynthetic tetracyclines: oxytetracycline, tetracycline , and 
demeclocycline .  
2. Semisynthetic tetracyclines: methacycline (rondomycine ),  
doxycycline (vibramycin),  and minocycline . 
The antibacterial spectrum of tetracyclines is broad and includes such 
microorganisms as Gram-positive and Gram-negative cocci, Escherichia 
coli, Chlamydia, Rickettsia, Mycoplasma, Ameba, Plasmodium, 
Helicobacter pylori, Klebsiella, Enterobacter, Spirochaetales, Vibrio 
cholerae, Yersinia pestis, Francisella tularensis, Brucella, Shigella, 
Salmonella, etc. Tetracyclines have no activity against Proteus, 
Pseudomonas aeruginosa, viruses, and fungi. Bacterial resistance to 
tetracyclines develops slowly and can be characterized by cross-resistance.  
Tetracyclines block protein synthesis in bacterial cells. The drugs bind 
to 30S ribosomal subunits and affect the binding of tRNA to them. That 
stops protein synthesis. Besides, tetracyclines form the compounds with 
30 
 
biologically active two valence metals (iron, calcium, zink, etc.). 
Tetracyclines have the bacteriostatic effect. 
Tetracyclines are liposoluble agents, therefore they are easily absorbed 
in gastrointestinal tract. Also, tetracyclines easily penetrate through tissue 
barriers and accumulated in the tissues. It is necessary to notice that the 
drug permeability into mother's milk and amniotic fluid is better than into 
the skin, cerebrospinal fluid, and saliva. The degree of binding to proteins 
for biosynthetic tetracyclines is 20–40 % and for semisynthetic drugs – 60–
95 %. Tetracyclines undergo partial biotransformation in the liver and are 
excreted with urine and bile. The drugs are taken orally. Their absorption is 
higher if the drug is taken 1–1.5 hours before a meal or 3 hours after the 
meal. It is necessary to notice that milk significantly reduces the absorption 
of tetracyclines due to formation of complexes between the drug and two 
valence metals. Semisynthetic tetracyclines are less capable to form such 
compounds, therefore their bioavailability at oral intake is closer to 100 %. 
Oxytetracycline and tetracycline are also used in ointments. Tetracycline is 
administered intramuscularly, and doxycycline – intravenously. 
Oxytetracycline and tetracycline are prescribed to take 4 times a day, 
methacycline – 2–3 times, doxycycline and minocycline – 1–2 times, and 
demeclocycline – once a day. 
Therapeutic indications for tetracyclines are as follows: putrid fever, Q 
fever, trachoma, psittacosis, ornithosis, urogenital chlamydiosis, dysentery, 
leptospirosis, plague, brucellosis, tularemia, anthrax, cholera, bronchitis, 
pneumonia, tonsilitis, otitis, sinusitis, infections of urinary and biliary 
tracts, osteomyelitis, syphilis, gonorrhea, ulcer diseases of stomach and 
duodenum (doxycycline), intestinal amebiasis, etc.  
Presently, t igecycline , a new tetracycline derivative, is approved in 
medicine. The drug has high activity against Gram-positive and Gram-
negative bacteria. Tigecycline is used as a reserve antibiotic when other 
antibiotics are ineffective. The drug is administered intravenously, drop-by-
drop, twice a day.  
It is necessary to notice that tetracyclines affect cell division both in 
microorganisms and in a human organism. Due to this, drugs affect the 
epithelization of the intestine (dyspesia, erosions, ulcers, glossitis) and the 
skin (dermatitis, photosensitization) and suppress the hemopoiesis 
(leukopenia, anemia, thrombocytopenia). Catabolic effect of tetracyclines 
results in inhibition of protein synthesis and immunity.  
Tetracyclines are hepatotoxic and teratogenic drugs. 
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Tetracyclines form the chelates with calcium phosphate in teeth and 
bones that results in the delay of skeletal growth in children, yellow 
coloration of teeth, violation of tooth enamel formation, and caries. Due to 
this, tetracyclines are contraindicated in children aged under 12 years, 
pregnant woman, and nursing mothers. 
Expired tetracyclines form toxic substances. In this case, the following 
intake of expired tetracyclines causes an acute kidney injury (Fanconi's 
syndrome). 
Tetracycline in young children can cause the increase of intracranial 
pressure along with development of meningeal symptoms (headache, 
vomiting, etc.). 
Tetracyclines can cause disbiosis, hypovitaminosis B, candidiasis, and 
enterocolitis. Fast intravenous administration of doxycycline can cause the 
development of acute heart failure. Minocycline causes vestibular 
disturbances. Tetracycline therapy can cause allergic reactions.   
 
Chloramphenicol Group  
 
Levomycetin  (chloramphenicol)  is the main representative of 
this group. Such drugs as levomycetin, levomycetin stearate, levomycetin 
palmitate, and levomycetin succinate are the most commonly used in 
medicine. 
Levomycetin inhibits the protein synthesis in bacterial cells due to 
binding to 50S subunit of ribosomes. Also, the drug inhibits peptidyl 
transferase activity that impedes prolongation of polypeptides. 
Chloramphenicol has a bacteriostatic effect.  
Levomycetin is a broad-spectrum antibiotic. Unfortunately practical 
realization of the drug potential in medicine is impossible due to high drug 
toxicity. Therefore, levomycetin is used as a reserve antibiotic. 
Levomycetin inhibits the growth of the most strains of staphylococci, 
pneumococci, streptococci, meningococci, Haemophilus influenzae, 
Brucella, Rickettsia, Chlamydia, Mycoplasma, Vibrio cholerae, 
Escherichia coli, Shigella, Salmonella, and Enterobacter. It is important 
that chloramphenicol inhibits the growth of such anaerobes as bacteroides, 
anaerobic cocci, and fusobacteriales. The resistance of bacteria to 
chloramphenicol develops slowly. 
Levomycetin is prescribed mainly for oral intake. Levomycetin 
succinate is administered intravenously (seldom – intramuscularly or in the 
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form of an aerosol in lungs). Sometimes levomycetin is administered 
rectally. 
The drug bioavailability in gastrointestinal tract is more than 90 %. 
Parenteral administration of levomycetin is used in treatment of meningitis. 
The degree of drug binding to plasma proteins is 50–60 %. 
Chloramphenicol easily penetrates into different tissues and fluids of the 
body. Nearly 90 % of administered chloramphenicol dose are metabolized 
in the liver. Unchanged 10 % of chloramphenicol is excreted through the 
kidneys that provides the antibacterial effect in the urinary tract.  
Levomycetin is used only in treatment for severe infections caused by 
sensitive to levomycetin bacteria. Therapeutic indications for levomycetin 
are brain abscess, systemic salmonolesis, dysentery, richettsiosis, 
intrzoccular infections (eye burns, trachoma), brucellosis, tularemia, 
reactive arthritis, meningitis caused by Haemophilus influenzae, 
meningococci, and pneumococci. Aerosol thiamphenicol glycinate 
asetylcysteinate (combined levomycetin preparation) is used in treatment of 
respiratory tract infections. 
Chloramphenicol for oral intake is prescribed at 0.25–0.5 g dose given 
4 times a day. A 20 % solution of levomycetin succinate is administered 
parenterally 2–3 times a day. Levomycetin liniment 10 %, or synthomycin 
liniment 10%, is used in treatment of skin infections, burns, fissures, etc. 
Levomycetin is a component of different ointments (“Levomekol”, 
“Levosin”) and aerosols (“Levovinisol”, “Olazol”).  
An accurate calculation of the dosage is based on the body weight of 
the patient in cases of enteral and parenteral administration of 
chloramphenicol. Course of treatment should not exceed 10–14 days. 
Control of the blood and liver function is required.  
Levomycetin is a toxic antibiotic with narrow therapeutic action. The 
drug inhibits haematopoiesis that results in anemia, leukopenia, and 
thrombocytopenia. Chloramphenicol can cause acute drug-induced 
hemolysis in patients with genetically determined deficiency of glucose-6-
phosphate dehydrogenase. Non-hemolytic anemia can develop in patients 
with genetically determined deficiency of uridine-diphosphoglucuronic 
transferase. Levomycetin blocks mitochondrial ferrochelatase (enzyme 
which provides the iron inclusion in the structure of heme) that results in 
iron deficiency anemia, myodystrophy, and hypotrophy.  
Gray baby syndrome is one of the possible complications caused by 
levomycetin in newborn infants and badies under 3 months. The gray baby 
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syndrome is manifested by respiratory disturbances, severe metabolic 
acidosis, and vascular collapse. This complication is caused by 
insufficiency of mitochondrial respiratory enzymes in myocardium, slow 
excretion of drug with urine, and insufficiency of hepatic enzymes.  
Sometimes the complications caused by chemotherapeutic effect of 
levomycetin are possible: aggravation of disease due to massive 
degradation of bacterial cells and release of endotoxins, dysbiosis, 
candidiasis, superinfection caused by Pseudomonas aeruginosa, resistant 
strains of staphylococci, and Proteus. 
 
Aminoglycosides  
 
Aminoglycosides are antibiotics containing aminosugars in molecules. 
These antibiotics are grouped into 4 generations: 
– 1st generation: streptomycin, neomycin,  kanamycin ,  
monomycin .  
– 2nd generation: gentamicin .  
– 3rd generation: tobramycin, sisomicin , amikacin,  
neti lmicin .  
– 4th generation: isepamicin .  
Aminoglycosides irreversibly inhibit 30S subunits of ribosomes that 
results in incorrect reading of mRNA and incorporation of mistaken amino 
acids in the protein structure. Also, aminoglycosides affect the structure 
and function of bacterial cytoplasmic membrane. Aminoglycosides are 
bactericidal antibiotics. 
Aminoglycosides are broad-spectrum antibiotics. These drugs are 
active against Gram-negative aerobic (Escherichia coli, Pseudomonas 
aeruginosa, Klebsiella, Shigella, Proteus, and enterobacteria) and Gram-
positive coccal flora (staphylococci, streptococci, and pneumococci). 
Besides, gentamycin is active against Francisella tularensis; streptomycin, 
amikacin, and kanamycin – against Mycobacterium tuberculosis; 
monomycin – against Entamoeba histolytica, Leishmania, and 
Trichomonas. Isepamicin, besides the above mentioned flora, is active 
against Citrobacter, Acinetobacter, Morganella, Listeria, and Nocardia.  
The bacterial resistance to aminoglycosides develops quickly due to 
the ability of bacteria to synthesize the enzymes which destroy 
aminoglycosides. There are 15 known enzymes that destroy 
aminoglycosides of the 1st generation, 10 enzymes that destroy 2nd-
generation drugs, and only 3 enzymes that destroy aminoglycosides of the 
3rd and 4th generations.  
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The main routes for aminoglycoside administration are intramuscular 
and intravenous (bolus or drop-by-drop). Aminoglycosides have poor 
solubility in lipids and their degree of absorption in gastrointestinal tract is 
low. The degree of aminoglycoside binding to plasma proteins is 10–30 %. 
These drugs have low ability to penetrate inside of the cells. But 
aminoglycosides easily penetrate through placenta, accumulate in the inner 
ear and adrenal cortex. Aminoglycosides do not undergo metabolism in the 
body and are excreted unchanged. 
Presently, clinical use of the 1st-generation aminoglycosides is 
restricted due to bacterial resistance and high drug toxocity. Thus, 
streptomycin is used only in treatment of tuberculosis, tularemia, and 
plaque. Widely used in the past combination of streptomycin and 
benzylpenicillin, nowadays, is used only in treatment of enterococcal 
endocarditis, due to high toxicity. Monomycin is used only in treatment of 
skin leishmaniasis. Tablets of kanamycin and neomycin are used in 
treatment of gastrointestinal infections (enterocolitis and dysentery) and for 
sanitation of intestine before surgery. Also, both agents are used externaly 
in treatment of dermatitis and infectious inflammatory diseases of skin. 
Kanamycin sulfate for parenteral administration is used in treatment of 
tuberculosis. 
Gentamicin is a broad-spectrum aminoglycoside antibiotic of the 2nd 
generation. The most important is its activity against Pseudomonas 
aeruginosa, Proteus, Escherichia coli, Enterobacter, Klebsiella, and 
number of other bacteria, including staphylococci, resistant to the 1st-
generation aminoglycosides and benzylpenicillin. Bacterial resistance to 
gentamicin develops slowly. Normally, gentamicin does not penetrate 
through the blood-brain barrier, but in patients with meningitis the 
permeability of the blood-brain barrier is increased. The therapeutic 
indications for gentamicin are sepsis, urogenital infections, pneumonia, 
bronchitis, infections of central nervous system (including meningitis), 
osteomyelitis, peritonitis, postsurgical infections, infected wounds and 
burns, etc. The drug is administered intramuscularly or intravenously 2–3 
times a day. Also, gentamicin is used topically in treatment of skin and eye 
infections caused by sensitive flora.  
Third-generation aminoglycosides are characterizied by higher activity 
against Pseudomonas aeruginosa, different strains of Proteus, Klebsiella, 
and Enterobacter. Amikacin also is active against Mycobacterium 
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tuberculosis. Secondary resistance of bacteria to gentamicin develops 
significantly slowly than to gentamicin. 
Fourth-generation aminoglycoside isepamicin has longer duration of 
action than previous drugs. Isepamicin is administered intramuscularly or 
intravenously once a day. Toxicity of isepamicin is low. 
Aminoglycoside therapy may be accompannied by development of 
serious side effects and complications.  
Ototoxicity. Aminoglycosides accumulate in the outer and inner hair 
cells within the organ of Corti that results in degenerative changes of hair 
cells. Sensitive nerve fibers of the inner ear also degenerate. In case of 
streptomycin and gentamicin therapy vestibular disfunction develops 
initially. Other aminoglycosides may cause the initial hearing loss. 
Nephrotoxicity occurs due to aminoglycoside accumulation in 
proximal convoluted tubules and functional disturbances of many enzymes 
that cause the development of interstitial nephritis, impaired concentration 
of urine, proteinuria, and leukocyturia. 
Blockage of neuromuscular synapses is accompanied by weakness of 
diaphragm and other respiratory muscles that can cause respiratory 
paralysis. 
Aminoglycosides inhibit the absorption of nutrients in gastrointestinal 
tract. Other possible side effects of aminoglycosides include allergic 
reactions, polyneuritis, and phlebitis in case of intravenous administration. 
 
Polymyxins (Cyclic Polypeptides)  
 
The group is represented by such drugs as polymyxin M, 
polymyxin B, and polymyxin E .  
Polymyxins affect the functions of cytoplasmatic membranes of 
bacteria. Antibiotics interact with phospholipids of membranes that results 
in the increase of membrane permeability. Polymyxins have a bactericidal 
action.  
Antibacterial spectrum of polymyxins is narrow and includes Gram-
negative bacteria: Escherichia coli, Shigella, Salmonella, Klebsiella, 
Enterobacter, Vibrio cholerae, and most strains of Pseudomonas 
aeruginosa.  
Polymyxin M  is taken orally or used topically. The degree of the 
drug absorption in the gastrointestinal tract is about 1–2 %, but in patients 
with intestinal infections drug absorption increases up to 10–15 %. This 
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fact should be considered because polymyxins are drugs with narrow 
therapeutic margin.  
Polymyxin B  and polymyxin E  are administered intramuscularly, 
intravenously, into body cavities, and in aerosols for inhalation. The drugs 
have low degree of binding to plasma proteins. Polymyxins penetrate 
through cell membranes and into pleural and peritoneal fluids poorly. 
Therefore, in relevant cases these drugs are administered directly into the 
foci of the infection or intrathecally. Only 2–4 % of administered dose 
undergoes biotransformation. About 90 % of the dose is excreted 
unchanged through the kidneys. Polymyxins are active in the urinary tract 
only in the acidic urine. The drugs are prescribed to be taken 3–4 times a 
day. For newborn infants, polymyxins should be taken only once a day.  
Therapeutic indications for polymyxins are infections of intestine and 
urinary tract, pneumonia, endocarditis, and sepsis caused by sensitive flora. 
Also, polymyxins are used in treatment of purulent wounds, burns, purulent 
otitis and conjunctivitis, etc. 
Polymyxins have the marked neurotoxicity and nephrotoxicity. These 
drugs can affect neuromuscular transmission (muscular weakness, and 
respiratory disturbances), vision, speech, and hearing. Therapy with 
polymyxins may be accompanied by drowsiness and irritability. Proteins, 
cylinders, and erythrocytes in the urine are manifestations of polymyxin 
nephrotoxicity. 
Daptomycin  is a new antibiotic with chemical structure similar to 
polymyxins. Daptomycin is a semisynthetic antibiotic active against Gram-
positive and Gram-negative bacteria. Therapeutic indications for 
daptomycin include complicated infections of the skin and soft tissues and 
bacteremia caused by Staphylococcus aureus (including endocarditis). The 
drug is used only in the treatment of adults. The drug is administered 
intravenously once daily. Side effects are nausea, vomiting, muscular pain, 
etc. 
 
Rifamycins  
 
 Rifamycin group includes such drugs as rifamycin  (natural 
antibiotic) and rifampicin  (semisynthetic antibiotic).  
Rifamycins block the synthesis of RNA due to inhibition of DNA-
dependent RNA-polymerase. Antibacterial effect of rifamycins is 
bacteriostatic. Spectrum of activity includes mainly Gram-positive bacteria: 
Mycobacterium tuberculosis, staphylococci, streptococci, pneumococci, 
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meningococci, enterococci, gonococci, Haemophilus influenzae, 
Mycobacterium leprae, Bacillus anthrax, etc. Large doses of rifamycins 
affect also Gram-negative bacteria: Escherichia coli, Shigella, Salmonella, 
Rickettsia, Klebsiella, Chlamydia, Brucella, some strains of Pseudomonas 
aeruginosa and Proteus, etc. The bacterial resistance to rifamycins 
develops readily (in few days after the start of treatment). 
Rifampicin  is taken orally or administered intramuscularly or 
intravenously. The drug is easily absorbed in gastrointestinal tract. 
Rifampicin penetrates through tissue barrier, creates high concentrations in 
lungs, pleural cavity, peritoneal exudate, liquor, and bones. About 70 % of 
administered dose is metabolized in the liver. A part of rifampicin dose is 
excreted with bile into intestine where it is absorbed in the blood. About 
30 % of the dose is excreted with the urine unchanged.  
Rifampicin is mainly used to treat tuberculosis. Besides, the drug is 
prescribed to treat leprae, pneumonia, osteomielitis, urinary and biliary 
tract infections, acute gonorrhea, etc. The drug is also used to prevent 
rabies encephalitis in humans and meningitis in the carriers of 
meningococcal infection. 
Rifampicin is a low-toxic antibiotic. Side effects of rifampicin include 
hepatotoxicity, leukopenia, thrombocytopenia, allergic reactions, and 
dispepsia. It is necessary to notice, that rifampicin turns the saliva, urine, 
sweat, feces, and tears an orange-red color. Rifampicin is not recommended 
for intake during first three months of pregnancy. 
 
Lincosamides  
 
The group includes such antibiotics as l incomycin  and 
clindamycin . 
Lincosamides inhibit the protein synthesis on the level of 50S subunit 
of bacterial ribosome. Lincosamides exhibit the bacteriostatic effect. 
Antibacterial spectrum of lincosamides is broad, but preferably 
directed against Gram-positive bacteria: staphylococci, streptococci, 
pneumococci, Corynebacterium diphtheriae, and anaerobes (bacteroides, 
Clostridium, Fusobacterium). The activity of lincosamides against Gram-
negative bacteria is less expressed. The following Gram-negative bacteria 
are sensitive to lincosamides: meningococci, gonococci, some strains of 
Haemophilus influenzae, and Mycoplasma. Clindamycin is also active 
against Toxoplasma gondii, Plasmodium, and some strains of 
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Pneumocystis. Clindamycin is 50 times more active against bacteroides 
than lincomycin.  
Secondary bacterial resistance to lincosamides develops slowly. 
Lincosamides are administered intramuscularly and intravenously or 
taken orally. Bioavailability of the drugs is 50 %. The degree of binding to 
plasma proteins is about 50 %. Lincosamides easily penetrate into different 
tissues and fluids of the body, except cerebrospinal fluid. Also, 
lincosamides are known to accumulate in bones. Nearly 80–90 % of 
administered dose is excreted in inactivated form with bile. Only 10–20 % 
of dose is excreted in unchanged form through the kidneys. Lincosamides 
exhibit the highest activity in alkaline environment. The drugs are 
prescribed to be taken 3–4 times a day. 
Lincosamides are reserve antibiotics. The therapeutic indications for 
lincosamides are sepsis, endocariditis, artritis, osteomyelitis, lower 
respiratory tract infections, otitis, infected wounds, diabetic foot, 
toxoplasmosis, and tropical malaria. These drugs are also used to prevent 
infections after surgery in abdomynal cavity and on the pelvic organs.  
Side effects of lincosamides are nausea, vomiting, abdominal pain, 
allergic reactions, leukopenia, and thrombocytopenia. Fast intravenous 
administration of the drugs can cause a decrease in blood pressure, 
dizziness, and a decrease in skeletal muscle tone. Lincosamides are 
contraindicated during pregnancy and in patients with severe hepatic and 
renal diseases. 
 
Glycopeptides  
 
The main representatives of this group are vancomycin  and 
teicoplanin (Targocid).  
Glycopetides inhibit the synthesis of bacterial cell wall and 
simultaneously affect the function of bacterial cytoplasmatic membrane. 
Glycopeptides are antibiotics with bactericidal activity. 
Antibacterial spectrum includes Staphylococcus (including strains 
with resistance to other antibiotics), Streptococcus, Enterococcus, 
Clostridium difficile, and some other microorganisms.  
Vancomycin  is used in treatment of infections caused by Gram-
positive bacteria: sepsis, endocarditis, meningitis, osteomyelitis, 
pneumonia, and enterocolitis (including pseudomembranous colitis). The 
drug is administered intravenously drop-by-drop 3–4 times a day.  
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Vancomycin is an antibiotic with high nephro- and ototoxicity. The 
fast drug administration can cause a massive release of histamine from 
basophils that results in low blood pressure and skin rashes. Vancomycin 
can cause phlebitis, neutropenia, and thrombocytopenia.  
Teicoplanin  has similar antibacterial spectrum with vancomycin. 
The drug is used in treatment of serious infections caused by sensitive 
bacterial flora (severe infections of respiratory and urinary systems, sepsis, 
peritonitis, etc.). Teicoplanin is administered intramuscularly or 
intravenously once a day.  
 
Table 2 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product 
Benzylpenicillinum-
natrium 
Intramuscularly 250,000–
1,000,000 IU 4–6 times a 
day; 
intravenously slowly 
1,000,000–2,000,000 IU; 
intravenously drop-by-drop 
2,000,000–5,000,000 IU 
Vials 250,000; 500,000 or 
1,000,000 IU, powder for 
injection 
Benzylpenicillinum- 
kalium 
Intramuscularly 250,000–
500,000 IU 4–6 times a day 
Vials 250,000; 500,000 or 
1,000,000 IU, powder for 
injection 
Benzylpenicillinum-
novocainum 
Intramuscularly 300,000–
600,000IU 2–3 times a day 
Vials 300,000 or 600,000 
IU, powder for injection 
Bicillinum-5 Intramuscularly 
1,500,000 IU once a month 
Vials 1,500,000 IU, powder 
for injection 
Oxacillinum-
natrium  
Orally, intramuscularly or 
intravenously 0.25–0.5 g 4–6 
times a day 
Tablets 0.25 or 0.5 g; 
capsules 0.25 g; 
vials 0.25 or 0.5 g of 
powder for parenteral 
administration 
Ampicillinum  Orally 0.5 g 3–6 times a day Capsules and tablets 0.25 g 
Amoxicillinum Orally 0.25–1.0 g 3 times a 
day; 
intramuscularly or 
intravenously 1.0 g 2 times a 
day 
Coated tablets 1.0 g; 
capsules 0.25 or 0.5 g; 
vials 1.0 g of powder for 
injection 
Cefalexinum  Orally 0.25–0.5 g 4 times a 
day 
Capsules 0.25 g; 
tablets 0.5 g 
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Continuation of Table 2 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product 
Cefotaximum  Intramuscularly or 
intravenously 0.5–1.0 g 2–3 
times a day 
Vials 0.5, 1.0 or 2.0 g of 
powder for injection 
Cefoxitinum  Intramuscularly or 
intravenously 1–2 g 2–4 
times a day 
Vials 1.0 or 2.0 g of 
powder for injection 
Ceftriaxone Intramuscularly or 
intravenously 1–2 g once a 
day or 0.5–1.0 g twice a day 
 
Vials 0.5, 1.0 or 2.0 g of 
powder for injection 
Erythromycinum  
 
Orally 0.1–0.25 g 4–6 times 
a day; 
into the lower eyelid pocket 
1 % ointment up to 6 times a 
day 
Tablets 0.1 or 0.25 g; 
 
1 % ophthalmic ointment 
7 g  
Azithromycinum Orally 0.25–1.0 g once a day Capsules 0.125 or 0.25 g; 
tablets 0.5 g 
Tetracyclinum Orally 0.2–0.25 g  4 times a 
day; 
into the lower eyelid pocket 
1 % ointment ointment 2–6 
times daily 
Coated tablets 0.05, 0.1 or 
0.25 g; 
1 % ophthalmic ointment 
3.0 or 10.0 g 
Methacyclini 
hydrochloridum 
Orally 0.3 g 2 times a day Capsules 0.15 or 0.3 g  
Doxycyclinum  Orally 0.1 g 1–2 times a day 
or 0.2 g once a day 
Capsules 0.1 g 
Laevomycetinum Orally 0.25–0.5 g 3–4 times 
a day; 
1–2 drops of 0.25 % solution 
into the eye 
Tablets 0.25 or 0.5 g; 
capsules 0.1, 0.25 or 0.5 g; 
vials 10 ml of 0.25 % 
solution  
Synthomycinum 
 
1–10 % topically 1 %, 5 % or 10 % liniment 
Streptomycini 
sulfas 
Intramuscularly 0.5 g 2 times 
a day 
 
 
 
Vials 0.25, 0.5 or 1.0 g of 
powder for injection 
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Continuation of Table 2 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product 
Gentamycini sulfas Intramuscularly or intra-
venously 0.0004–0.001 g/kg 
2–3 times daily; 
 
 
 
1–2 drops of 0.3 % solution 
into the affected eye(s) 
Ampoules 1 or 2 ml of 4 % 
solution;  
vials 0.08 g of powder for 
injection (for parenteral 
administration, it should be 
dissolved before using); 
ophthalmic solution: 0.3 % 
– 10 ml 
Amikacini sulfas Intramuscularly or intra-
venously (slowly or drop-by-
drop) 0.0075 g/kg twice a 
day or 0.005 g/kg 3 times a 
day 
 
Vials 0.25, 0.5 or 1 g of 
powder for injection; 
ampoules 2 ml of 5 % or 
25 % solution 
Polymyxini M 
sulfas 
Orally 500,000 IU 3–4 times 
daily; 
topically, in liniment 
(10,000 IU/1 g) or in solution 
(10,000–20,000 IU/ml) to 
treat wounds  
Tablets 500,000 IU; 
 
vials 500,000 or 1,000,000 
IU of powder (to prepare 
solution for external use); 
liniment 30,0 g (10,000 IU 
in 1 g) 
 
 
Sulfonamides  
 
Sulfonamides are synthetic chemotherapeutic drugs – derivatives of 
sulfanilic acid.  
Sulfonamides are classified as follows:  
1. Resorptive sulfonamides.  
1.1. Short-acting drugs: streptocid, norsul fazol ,  etazol ,  
sulfadiazine, and sulfadimezine .  
1.2. Intermediate-acting drugs: sulfamethoxazole  and sulfazine .  
1.3. Long-acting drugs: sulfapyridazine  and sulfadimethoxine .  
1.4. Ultra-long-acting drugs: sulfalen and sulfadoxine . 
2. Sulfonamides acting in the intestinal lumen:  
–  phthalazolum (phthalylsulfathiazole),  phthazinum   
(phthalylsulfapyridazine),  and sulginum (sulfaguanidine);  
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–  combined drugs of sulfonamides and 5-aminosalicylic acid: 
salazopyridazine (mesalazine) and salazodimethoxine .   
3. Sulfonamides for topical application: sulfacyl sodium and 
si lver sulfadiazine .  
Chemical structure of sulfonamides is similar to the structure of para-
aminobenzoic acid (PABA). PABA is a component of folic acid. Folic acid 
participates in synthesis of nucleic acids and proteins (transfers the one-
carbon radicals). A significant number of bacteria synthesize folic acid. 
Due to structural resemblance, sulfonamides are competitive antagonists of 
PABA. When concentration of sulfonamides in environment is higher than 
PABA concentration, bacterial cells absorb molecules of sulfonamides 
instead of molecules of PABA. Also, sulfonamides are competitive 
inhibitors of dihydropteroate synthase – a bacterial enzyme involved in 
folate synthesis. As a result, the synthesis of folic acid is violated with the 
following inhibition of protein and nucleic acid synthesis. Sulfonamides are 
bacteriostatic agents.  
It is necessary to notice that human cells do not synthesize folic acid 
but require its dietary intake in the form of vitamin Bc, therefore, 
sulfonamides are not antimetabolites for human organism. 
Sulfonamides have the broad spectrum of antibacterial action. These 
drugs are active against both Gram-positive and Gram-negative cocci 
(staphylococci, streptococci, pneumococci, meningococci, gonococci), as 
well as against Haemophilus influenza, Bacillus anthracis, Jersinia pestis, 
Brucella, Vibrio cholerae, Corinebacterium diphtheriae, Shigella, 
Chlamidia, Toxoplasma, Plasmodium, Pneumocystis, Actinomycetes, etc. 
Resorptive sulfonamides are readily absorbed in gastrointestinal tract. 
The degree of plasma protein binding ranges from 20 % up to 90 %. The 
main step of drug metabolism, acetylation, take place in the liver. 
Acetylated forms have a higher ability to bind to plasma proteins and a low 
ability to penetrate into tissues. Acetylated sulfonamides do not have 
antibacterial properties. These metabolites are excreted through the kidneys 
without the following reabsorption.  
Acetylated forms are badly dissolved in water and can form precipitate 
in the acid urine with the obstruction of renal tubules. This complication 
may be prevented by intake of sodium hydrocarbonate or alkaline mineral 
water (alkalinization of urine). 
Sulfonamides easily penetrate through the blood-brain barrier. 
Significant drug concentrations are observed in kidneys, lungs, liver, skin, 
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peritoneal and pleural fluids, milk, saliva, bile, urine, etc. Sulfonamides do 
not accumulate in the bones.  
Long-acting and ultra-long-acting sulfonamides are slowly inactivated 
in organism. These drugs undergo a significant reabsorption in distal 
convoluted tubules. Therefore, these drugs have long duration of action. 
Short-acting sulfonamides are prescribed to be taken 4–6 times a day 
in a daily dose 4–6 g. Intermediate-acting drugs are prescribed for 2 times a 
day intake in a daily dose 1–3 g. Short-acting and intermediate-acting 
sulfonamides are used to treat acute infections. Long-acting sulfonamides 
are prescribed to take once a day for treatment of chronic infections. Ultra-
long-acting drugs are prescribed to be taken by the scheme (as a rule once a 
week). 
Therapeutic indications for sulfonamides are infections of urinary, 
respiratory or biliary tracts, intestinal infections, infections of skin and soft 
tissues, etc.   
Sulfonamides acting in intestinal lumen are prescribed for 4 times a 
day intake in a daily dose 4–6 g.  
Combined sulfonamides with 5-aminosalicylic acid are called 
salazosulfonamides. Salazopyridazine  (mesalazine) is the most 
commonly used among them. Under the influence of bacterial enzymes in 
large intestine, salazosulfonamides are decomposed to sulfonamide and 5-
aminosalicylic acid that provides the anti-inflammatory effect. 
Salazosulfonamides are used to treat nonspecific ulcerative colitis and 
Crohn’s disease. 
Sulfonamides for topical application are used in solutions, eye drops, 
ointments, pastes, antiseptic powders, or aerosols. Before drug application, 
skin breaks, wounds, or burns should be cleaned from the pus because it 
reduces sulfonamide activity owing to presence of PABA. Eye drops of 
sodium sulfacyl are used in treatment of blepharitis, corneal ulcers, and 
blennophthalmia. 
Sulfonamides seldom cause the development of side effects. As a rule, 
undesirable phenomena develop due to overdose and include the following 
symptoms: central nervous system intoxication (dizziness, headache, 
depression of consciousness, nausea, and vomiting), hemolytic or aplastic 
anemia, granulocytopenia, thrombocytopenia, allergic reactions (dermatitis 
and skin rashes), and nephrotoxicity (proteinuria, erythrocytes and drug 
microcrystals in urine, and low back pain). The formation of microcrystals 
may be prevented by intake of alkaline liquids, because in alkaline 
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environment the ability of sulfonamides and their acetylated metabolites to 
precipitate is low. Sulfonamides should be prescribed with caution for 
patients with diseases of liver and kidney.  
 
Sulfonamide and Trimethoprim Combinations 
 
There is a number of drug combinations comprising sulfonamides and 
trimethoprim: Co-trimoxazole  (Biseptol ,  Bactrim, Groseptol),  
Sulfaton, Lidaprim,  Potesepti l , etc. The optimal ratio of 
trimethoprim to sulfonamide is 1:5. Thus, the most commonly used drug 
Biseptol  contains 400 mg of sulfamethoxazole  and 80 mg of 
trimethoprim .  
A combination of sulfonamides with trimethoprim provides the 
possibility to block the synthesis of tetrahydrofolic acid in two steps:  
– sulfonamide compete with PABA;  
– trimethoprim blocks the enzyme, providing transformation of 
dihydrofolic acid into tetrahydrofolic acid – dihydrofolate reductase. 
Due to this mechanism, combination drugs have bactericidal effect. 
The bacterial resistance to combination drugs develops slowly.  
It is necessary to notice that human dihydrofolate reductase is 50,000 
times less sensitive to trimethoprim than bacterial enzyme. 
Trimethoprim is readily absorbed in gastrointestinal tract and easily 
penetrates into tissues and fluids of the body. Nearly 50–60 % of the 
administered dose is exscreted from the body with urine. The rest is 
excreted with bile, sputum, etc.  
Biseptol is used to treat infections of moderate severity. Children older 
than 12 eyars and adult patients should take 2 tablets of Biseptol twice a 
day. There are Bactrim or Septrin solutions in ampoules for intravenous 
infusion. The content of the ampule should be diluted with 5% dextrose in 
water and administered intravenously drop-by-drop.  
Therapeutic indications for Biseptol are as follows: respiratory tract 
infections (acute bronchitis, pneumonia, icluding pneumonia caused by 
Pneumocystes), urinary tract infections, enteritis, colitis, otitis, meningitis, 
sepsis, toxoplasmosis, and tropical malaria. 
Side effects of combination drugs are allergic reactions, 
nephrotoxicity, hepatotoxicity, methemoglobinemia, hemolytic anemia, 
neuritis, teratogenicity, porphyria (in patients with hereditary metabolic 
disorders), superinfection, deficiency of folic acid that results in anemia, 
hypotrophy, dyspepsia, and disturbances in spermatogenesis. 
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Combination drugs are contraindicated to children under 6 years of 
age, pregnant women, patients with disturbances in haematopoiesis, and in 
diseases of liver and kidneys.  
 
 
Synthetic Antibacterial  Drugs with Different Chemical 
Structure 
 
This group includes antimicrobial drugs with different chemical 
structure which are classified into different groups:  
1. Quinolone derivatives. 
2. Nitrofuran derivatives. 
3. Quinoxaline derivatives.  
4. Oxazolidinones. 
 
Quinolones  
 
There are three generations of quinolones which differ by their 
antibacterial spectrum, activity, and toxicity. 
 
First -Generation Quinolones 
 
First-generation quinolones are nitroxolinum, intestopan,  
chiniofonum, enteroseptol ,  and chlorchinaldolum . There are 
combination drugs containing enteroseptol: Mexaform  (contains 
enteroseptol ,  entobex , and oxyphenonium bromide ) and Mexasa  
(enteroseptol,  entobex, bile acids, pancreatin , and bromelain) . 
Oxyphenonium bromide is a drug with antispasmodic activity. Bromelain 
is a proteolytic enzyme contained in a pineapple. 
First-generation quinolones affect the activity of metal-containing 
bacterial enzymes and inhibit the synthesis of bacterial DNA. Besides, 
molecules of these drugs contain the atoms of I, Cl, or Br and cause the 
denaturation of bacterial proteins. Pharmacological effect of the 1st-
generation quinolones is bactericidal. 
Antibacterial spectrum of the 1st-generation drugs is broad and 
includes Gram-positive and Gram-negative bacteria, protozoa (amoeba, 
lamblia), and Candida. One should have in view that microorganisms 
become resistant to the 1st-generation quinolones very quickly. 
All drugs (except nitroxoline) are almost not absorbed from 
gastrointestinal tract, therefore they act only on microflora of the 
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gastrointestinal tract. Most 1st-generation drugs are taken orally 4 times a 
day. 
About 50 % of orally taken nitroxoline  is absorbed in the blood. 
Nitroxoline binds to plasma proteins, poorly penetrates into fluids and 
tissues of the body (except renal tissue and prostate), and is excreted 
through the kidneys unchanged. Nitroxoline is used in treatment for urinary 
tract infections. The toxicity of nitroxoline is low. Side effects are allergic 
reactions and dispeptic disorders. The drug turns the urine violent yellow. 
Chiniofonum  is used mainly to treat amoebic dysentery. 
Intestopan , enteroseptol , and chlorchinaldolum  are used to treat 
intestinal infections (dysentery, salmonellosis, intestinal disorders caused 
by staphylococci, Proteus, enterobacteria, etc.). Mexaform  is a drug of 
choice in case a patient is concerned about painful spasms of intestinal 
smooth muscles. In case of meteorism, Mexasa  is preferable. Iodine-
containing drugs are contraindicated to patients with hyperthyreosis. 
 
Second-Generation Quinolones 
 
Second-generation quinolones are nalidixic acid, oxolinic acid 
(gramurin),  and pipemidic acid (palin) . These drugs inhibit metal-
containing enzymes of bacterial cells. Depending on concentration, the 
2nd-generation quinolones cause bacteriostatic or bactericidal effect.  
Antibacterial spectrum of the 2nd-generation quinolones directs upon 
Gram-negative bacteria (Escherichia, Shigella, Salmonella, Klebsiella, and 
Proteus). Pseudomonas aeruginosa is resistant to the 2nd-generation drugs. 
Bacteria quickly develop secondary resistance to these drugs.  
The second-generation quinolones are prodrugs, which after 
hydroxylation in liver, are transformed into pharmacologically active 
substances. 
The drugs are taken orally because they have high bioavailability in 
the gastrointestinal tract. The 2nd-generation drugs poorly penetrate into 
tissues and fluids of the body, being excreted through the kidneys. These 
drugs are prescribed to be taken 4 times a day. Therapeutic indications for 
the 2nd-generation quinolones are acute and chronic infections of urinary 
tract. It is necessary to acidify the urine during treatment with these drugs.  
Side effects of the 2nd-generation quinolones are allergic reactions, 
dispetic disorders, headache, photodermatosis, and isomnia. The drugs are 
contraindicated for patients with severe violations of hepatic and renal 
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functions, for pregnant women in first 3 months of pregnancy, and for 
children under 2 years of age. 
 
Third-Generation Quinolones  
(Fluoroquinolones or  Systemic Quinolones)  
 
Molecules of these drugs contain fluorine and piperidine radicals that 
significantly influence upon their antibacterial spectrum and 
pharmacological properties. Fluoroquinolones are classified into the 
following groups:  
– monofluoroquinolones: norfloxacin (f loxacin),  pefloxacin 
(abactal ),  enoxacin,  ofloxacin (tarivid),  ciprofloxacin  
(ciprobay), pufloxacin ; 
– difluoroquinolones: lomefloxacin (maxacvin),  sparfloxacin 
(zagam);  
– trifluoroquinolones: tosufloxacin, f leroxacin (Quinodis ) .  
Fluoroquinolones inhibit DNA gyrase (also known as topoisomerase 
II) activity – an enzyme essential for bacteria viability. DNA gyrase 
paticipates in the process of DNA replication. DNA gyrase provides the 
formation of negative supercoiling in the relaxed circular prokaryotic DNA 
molecules. Interaction between gyrase and DNA leads to DNA winding 
around the enzyme. There is a positive supercoiling in places of DNA 
which is associated with gyrase. Thereafter, the enzyme makes a double-
stranded break in DNA, moves a double strand from inside to outside, and 
stitches segments back together. Thus positive supercoiling of DNA 
transformes into negative supercoiling that promotes the movement of 
DNA polymerase along DNA. 
Bacterial DNA gyrase essentially differs from human DNA gyrase. 
This provides the high selectivity of fluoroquinolones against 
microorganisms and their low toxicity for humans. 
Some fluoroquinolones (ofloxacin, ciprofloxacin, and lomefloxacin) 
have an ability to inhibit the enzyme that provides the synthesis of the 
SOS-system proteins. These proteins protect the bacterial cell from 
unfavorable external factors and are responsible for changes of the rod-
shaped bacteria (filament forms) before cell division. Fluoroquinolones are 
bactericidal agents.  
Fluoroquinolones are ultra-broad-spectrum antibacterial agents. Gram-
negative microflora is more sensitive than Gram-positive bacteria to these 
drugs. Fluoroquinolones are active against gonococci, Escherichia coli, 
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Shigella, Salmonella, Klebsiella, Enterobacter, Haemophilus influenzae, 
Pseudomonas aeruginosa, Mycoplasma, Chlamidia, etc. There are resistsnt 
bacteria to fluoroquinolones: Spirochaetales, fecal enterococci, and 
anaerobes. It is necessary to notice that sparfloxacin has the highest activity 
against Gram-positive cocci, Chlamidia, Mycoplasma, M. tuberculosis and 
M. leprae. 
Moxifloxacin (Avelox ,  Avalox)  exhibits the high activity against 
streptococci, staphylococci, Chlamydia, Mycoplasma, Ureaplasma, and 
anaerobes. In activity against anaerobes, moxifloxacin is similar to 
metronidazole and imipenem. 
Bacteria slowly develop the secondary resistance to fluoroquinolones. 
As soon as bacterial resistance is developed, it spreads to the 1st- and the 
2nd-generation quinolones and a significant amount of antibiotics 
(tetracyclines, chloramphenicol, and β-lactam antibiotics). Therefore 
fluoroquinolones should be used only as reserve drugs. 
There are known such new fluoroquinolones as gatif loxacin, 
gemifloxacin, and levofloxacin . The drugs have high activity against 
Gram-positive and Gram-negative bacteria, especially against pathogens 
causing respiratory tract infection and tuberculosis. These new agents are 
taken orally. 
Fluoroquinolones are taken orally, administered intravenously, or used 
externally. For intravenous administration, the drug (e.g. ciprofloxacin, 
pefloxacin) is diluted ex tempore. Solutions should be protected from light. 
Fluoroquinolones are readily absorbed in the gastrointestinal tract. 
Simultaneous intake of fluoroquinolones with antacids and iron-containing 
drugs should be avoided, because the bioavailability of fluoroquinolones is 
reduced. The degree of fluoroquinolone binding to plasma proteins is about 
40 %. Fluoroquinolones readily penetrate into main tissues and fluids of the 
body, but only some drugs (ofloxacin, pefloxacin, and ciprofloxacin) can 
penetrate through the blood-brain barrier. The main route of drug 
elimination is kidneys. Fluoroquinolones are prescribed to be taken 1–2 
times a day. 
Fluoroquinolones should be prescribed only in cases when broad-
spectrum antibiotics are ineffective. The therapeutic indications for 
fluoroquinolones are infections of urinary tract (foremost caused by 
Pseudomonas aeruginosa), respiratory system, gastrointestinal tract, severe 
purulent surgical infections caused by multiresistant microflora or 
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Staphylococcus aureus, treatment and prevention of infections in patients 
with neutropenia, oncological diseases, and immunodeficiency.  
Fluoroquinolones are low-toxic drugs. Their side effects are dyspepsia, 
skin rash and other allergic reactions, headache, dizziness, insomnia, 
photosensitization, temporal arthralgia, disbiosis, and disturbances of renal 
and hepatic functions.  
 
Nitrofurans  
 
Nitrofurans include such drugs as furacil inum (nitrofural,  
nitrofurazone), furazolidone, furadoninum (nitrofurantoin),  
furaginum (furazidin),  and furazolinum .  
Nitrofurans form the complex compound with bacterial DNA, affect 
the transport of electrons in respiratory chain, violate the redox processes in 
citric acid cycle. It results in the disturbances of cytoplasmic membrane 
function and destruction of bacterial cell wall. Depending on a dose, 
nitrofurans exhibit bacteriostatic or bactericidal effect. Unlike other 
antibacterial drugs which inhibit immunity, nitrofurans slightly increase the 
resistance of macroorganisms to infection (nitrofurans stimulate 
phagocytosis, etc.). Under the nitrofuran influence, the production of toxins 
by bacteria is reduced. Nitrofurans keep their activity in precence of pus 
and other products of tissue disintegration.  
Nitrofuran antibacterial spectrum is broad and includes such 
microorganisms as Gram-positive and Gram-negative bacteria 
(staphylococci, pneumococci, streptococci, Klebsiella, Proteus, 
Enterobacter, meningococci, gonococci, etc.) and protosoa (Trichomonas 
and Giardia lamblia).  
The bacterial resistance to nitrofurans develops slowly and is not 
cross-reactive with sulfonamides and antibiotics. 
Nitrofurans are taken orally after a meal. Furaginum is also used for 
intravenous administration. Furacilinum and furaginum are used topically. 
The degree of nitrofuran absorption in gastrointestinal tract is about 50 % 
(for furazolidone – only 30 %). The degree of binding with plasma proteins 
is very low. Nitrofurans readily penetrate into lymph and accumulate in the 
bile duct. Only 10 % of administered nitrofuran dose undergoes 
biotransformation. Nitrofurans are excreted from the body through the 
kidneys. The intensity of excretion is higher in alkaline urine. In acid urine, 
nitrofurans undergo reabsorption that provides for their accumulation. 
Nitrofurans are prescribed to be taken 4 times a day.  
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Furadoninum (nitrofurantoin)  is mainly used in treatment of 
urinary tract infections (pyelonephritis, cystitis, and uretritis). Also, 
furadoninum is used to prevent infection in cystoscopy and prolonged 
catheterization. 
Furazolidone  is poorly absorbed in the gastrointestinal tract that 
allows it to be used in enterocolitis treatment. The drug is also used to treat 
lambliasis and colpitis caused by Trichomonas. Furazolidone is taken orally 
and applied intravaginally or rectally. 
Furacil inum (nitrofural)  is known as antiseptic for external use. 
The drug is used for antiseptic rinsing, washing of wounds, burns, and 
bedsores. Also, furacilin is used in form of eye and ear drops. 
Side effects of nitrofurans are expressed by loss of appetite, nausea, 
epigastric pain, allergic reactions (skin rash, bronchospasm, fever, etc.), 
disturbances of renal function, neuritis, and methemoglobinemia. Drinking 
plenty of fluids and taking in H2-receptor antagonists and vitamins of group 
B are prescribed when treating by nitrofurans to prevent or diminish their 
side effects. 
 
Quinoxaline Derivatives 
 
Quinoxaline derivatives are quinoxidine  and dioxidine . 
Quinoxalines are synthetic agents with bactericidal effect. The mechanism 
of their action is poorly understood. Antibacterial spectrum includes 
Proteus, Pseudomonas aeruginosa, Klebsiella, Escherichia coli, Shigella, 
Salmonella, staphylococci, streptococci, Clostridium, and Bacteroides. 
Bacteria slowly develop secondary resistance to quinoxalines.  
Quinoxidine is taken orally 3–4 times a day after a meal. The drug is 
readily absorbed in the gastrointestinal tract. Dioxidine is administered 
intravenously drop-by-drop (0.1–0.2 % sterile solutions) or administered in 
body cavities. Also, solutions or ointments with dioxidine are used 
topically. Quinoxaline derivatives are excreted through the kidneys 
unchanged. 
Quinoxaline derivatives are used as reserve drugs in treatment of 
purulent inflammatory processes of different localization: purulent 
pleuritis, lung abscess, peritonitis, pyelonephritis, cholecystitis, and severe 
sepsis.  
Quinoxalines are quite toxic drugs. Their side effects are expressed by 
dispepsia, dizziness, headache, allergic reactions, candidiasis, muscle 
twitching, carcinogenesis, teratogenicity, etc. 
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Oxazolidinones  
 
The representative of this new antibacterial group is l inezolid  
(Zyvox) . Linezolid affects the syntheisis of nucleic acids and protein 
synthesis on ribosomes. As a rule, linezolid exhibits bacteriostatic effect, 
but against Gram-positive cocci the drug can produce the bactericidal 
effect. 
Antibacterial spectrum of linezolid is broad and includes such 
microorganisms as aerobic Gram-positive bacteria and cocci, some Gram-
negative bacteria, Mycobacterium tuberculosis, and many anaerobes.  
Linezolid is administered intravenously or taken orally 1–2 times a 
day. The drug is readily absorbed in the gastrointestinal tract. Its 
bioavailability is about 100 %. The degree of binding to plasma proteins is 
about 30 %. Inactivated linezolid is excreted through the kidneys (30 %) 
and liver (70 %). 
The therapeutic indications for linezolid are sepsis, endocarditis, 
pneumonia, infections of skin and soft tissues, and other severe infections 
caused by Gram-positive cocci. 
The side effects of linezolid are dysbiosis, candidiasis, nausea, 
vomiting, headache, and changes in gustatory perception. The prolonged 
drug use can cause thrombocytopenia, peripheral neuropathy (including 
optic nerve), allergic reactions, pancreatitis, and liver damage.  
 
Table 3 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product  
Sulfadimezinum Orally 1st administration – 
2.0 g; all subsequent admi-
nistrations 1.0 g 4–6 times 
daily 
Tablets 0.25 or 0.5 g 
Aethazolum Orally 1.0 g 4–6 times daily Tablets 0.25 or 0.5 g 
Sulfacylum-natrium Intravenously slowly 3–5 ml 
of 30 % solution twice a 
day; 
1–2 drops into eyes 2–6 
times daily 
Ampoules 5 ml of 30 % 
solution;  
 
eye drops: bottles 10 ml of 
20 % or 30 % solution   
Sulfadimethoxinum Orally 1st administration – 
1.0–2.0 g; all subsequent 
administrations 0.5–1.0 g 1–
2 times a day 
Tablets 0.2 or 0.5 g 
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Continuation of Table 3 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product  
Phthalazolum Orally 1.0 g 4–6 times daily  Tablets 0.5 g 
Biseptol-480 
 
Orally 2 tablets 2 times 
daily; 
 
intravenously drop-by-drop 
10 ml deluted in 250 ml of 
isotonic solution of NaCl 
twice a day 
Tablets containing 0.4 g of 
sulfamethoxazole and 
0.08 g of trimethoprom; 
ampoules 5 ml 
Nitroxolinum Orally 0.1 g 4 times a day Coated tablets 0.05 g 
Acidum nalidixicum Orally 0.5–1.0 g 4 times 
daily 
Tablets or capsules 0.5 g 
Ciprofloxacinum Orally 0.25–0.75 g 2 times 
daily; 
intravenously drop-by-drop 
0.2–0.4 g with 50 ml of iso-
tonic sodium chloride solu-
tion 2 times a day 
Tablets 0.25; 0.5 or 0.75 g; 
 
ampoules 10 ml of 1 % 
solution 
  
Furazolidonum Orally 0.1 g 4 times daily Tablets 0.05 g 
 
 
Antisyphylitic Drugs 
 
Antisyphylitic drugs are used to treat syphilis. The infectious agent 
causing syphilis is Treponema pallidum. The antisyphylitic therapy is 
complex and requires pill-dosing regimen. 
Presently, three groups of drugs are most commonly used to treat 
syphilis: antibiotics, fluoroquinolones, and bismuth preparations. 
Classification of antisyphylitic drugs is as follows: 
1. Antibiotics:  
– penicillins: benzylpenicil l in  sodium, benzylpenicil l in 
potassium, benzylpenicil l in  novocaine salt ,  bicil l in-1, 
bicil l in-5, ampicil l in ,  oxacil l in ; 
– macrolides and azalides: erythromycin, oleandomycin,  
azithromycin ;  
– cephalosporines: cefazolin, ceftriaxone , etc.; 
– tetracyclines: doxycycline, tetracycline . 
2. Fluoroquiniolones: ofloxacin , etc.  
3. Bismuth-containing drugs: biiochinol ,  bismoverol . 
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Both short-acting and long-acting penicillins are used to treat syphilis. 
Penicillins are the most efficient drugs for syphilis therapy and are active 
against Treponema palidum in all stages of the disease. Penicillins are 
especially effective if used in combination with bismuth preparations.  
In case of individual intolerance to penicillins, other effective 
antibiotics (macrolides, tetracyclines, and cephalosporins) are prescribed 
for syphilis treatment. But all of them are less active against Treponema 
pallidum. 
Bismuth-containing drugs are biiochinolum and bismoverolum. Both 
drugs are the suspensions of bismuth-containing substances in peach-kernel 
oil. These drugs are active only against Treponema pallidum. Bismuth 
blocks the thiol enzymes of Treponema. The activity of bismuth-containing 
drugs is less then penicillin activity, and their effect develops slower. 
Bismuth-containing drugs are especially effective in neurosyphilis. Both 
drugs are non-absorbable in gastrointestinal tract, therefore they are 
administered intramuscularly. Bismuth-containing drugs accumulate in the 
body with a significant accumulation in the bones, kidneys, liver, and 
nervous tissue. The routes of drug excretion are kidneys and intestine. 
Bismuth-containing drugs are used in treatment of all forms of syphilis. 
The common complication of bismuth therapy is so-called “bismuth 
flu”: generalized weakness, fever, and fatigue. These symptoms appear 
right after drug administration: gray colored border around the edge of the 
gums, dermatitis, gingivitis, colitis, stomatitis, and dark spots on the cheeks 
appear subsequently. Sometimes, leukopenia and disturbances of hepatic 
and renal functions are observed. 
Iodine preparations are used in resorption of intracranial  gummas in 
the tertiary stage of syphilis. 
 
Table 4 – Drugs for prescription 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product 
Benzylpenicillinum-
natrium  
 
Intramuscularly 250,000–
1,000,000 IU 4–6 times daily 
Vials 250,000; 500,000 
or 1,000,000 IU of 
powder for injection 
Bicillinum-5 Intramuscularly 1,500,000 IU  
1 time per month  
Vials 1,500,000 IU of 
powder for injection 
Biiochinolum Intramuscularly 2–3 ml 1 time 
per 3 days  
Vials 100 ml 
Bismoverolum Intramuscularly 1.5 ml 2 times 
per week 
Vials 100 ml 
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Antituberculosis  Drugs  
 
Tuberculosis is an infective disease caused by three species of 
Mycobacterium: M. tuberculosis, M. bolis and M. avium. M. tuberculosis  
is a so-called “human” specie which is transmitted only from human to 
human. M. bolis and M. avium (bovine and avian species) can infect both 
humans and animals. 
Modern tuberculosis is characterized by mainly bronchopulmonary 
localization (about 80 % of cases). According to WHO, there are about 20 
million sick people with active tuberculosis around the world. Annually, 
from 50 to 100 million people are infected and more than 3 million people 
die. The risk of falling ill is significantly increased in people with 
immunodeficiency: AIDS/HIV patients, smokers, patients with chronic 
bronchopulmonary diseases, and in malnutrition. The stress is not the least 
among health risk factors. Thus, the incidence of tuberculosis is sharply 
increased in times of crises and wars. 
Antituberculosis drugs include both antibiotics and synthetic agents. 
Synthetic drugs are active only against species of Mycobacterium causing 
tuberculosis. Some of them are also active against Mycobacterium leprae. 
Antibiotics which are used to treat tuberculosis are broad spectrum 
antibiotics of rifamycin and aminoglycoside groups. 
According to reccomendations of the International Union Against 
Tuberculosis and Lung Disease (1997), antituberculosis drugs are classified 
into the following groups based on their activity: 
 
1.    Most effective antituberculosis drugs.  
1.1. Isonicotinic acid derivatives: isoniazid, f t ivazide, 
saluzidum .  
1.2. Rifamicins: rifampicin, ri fabutin, ri faximin .  
2.    Drugs with high antituberculosis activity:  
2.1. Aminoglycosides: streptomycin, kanamycin , amikacin .   
2.2. Isonicotinic acid derivatives: ethionamide, prothionamide,  
pyrazinamide .  
2.3. Aminobutanol derivatives: ethambutol .  
2.4. Fluoroquinolones: ofloxacin, lomefloxacin , ciprofloxacin, 
sparfloxacin . 
2.5. Antibiotics of different groups: cycloserine, capreomycin,  
f lorimycin .  
3.    Drugs with moderate antituberculosis activity:  
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3.1. Para-aminobenzoic acid derivatives: sodium para-
aminosalicylate (PAS) and  calcium para-petrolyl-  
aminosalicylate (Bepascum) .  
3.2. Thiosemicarbazone derivatives: thioacetazone . 
 
According to the degree and reliability of action upon Mycobacteria, 
antituberculosis drugs are divided into two groups:  
 1. First-line drugs: isoniazid, ri fampicin,  ethambutol ,  
pyrazinamide,  and streptomycin .  
 2. Second-line drugs: ethionamide, prothionamide,  
cycloserine, f lorimycin, capreomycin,  amikacin,  
kanamycin, lomefloxacin, ofloxacin, ciprofloxacin, and 
PAS .  
 
There are several populations of M. tuberculosis. First-population 
mycobacteria are located outside the cells, have intensive metabolism and 
rapidly grow in the acidic environment. This population is predominant in 
acute phase of disease. Moreover, bacteria are highly sensitive to 
antituberculosis drugs; the resistant strains are often found between them. 
Therefore, the treatment of tuberculosis starts with the use of 3–5 drugs.  
Second-population mycobacteria are located inside the cells (mainly 
within macrophages) and characterized by low metabolic rate and slow 
growth in the acidic environment. This population is typical for chronic 
forms of tuberculosis. Second-population mycobacteria are sensitive to 
pyrazinamide, isoniazid, and rifampicin. Aminoglycosides do not penetrate 
into the cells, therefore, they do not significantly affect this population. 
Third-population mycobacteria are characterized by slow growth and 
location in caseous foci. This population is sensitive only to pyrazinamide 
and rifampicin. Second- and third-population mycobacterium can transform 
into latent forms. In unfavourable conditions (reduction of immunity, 
deterioration of the living conditions of the patient), these latent forms 
cause the disease recurrence. The latent forms of mycobacteria are sensitive 
to rifampicin and pyrazinamide. 
There are some peculiarities of tuberculosis treatment. It is necessary 
to choose the drugs to which mycobacteria are sensitive. The course of 
treatment can take from several months to several years. Pharmacotherapy 
includes simultaneous intake of several drugs. A prolonged antituberculosis 
therapy is accompanied by the development of bacterial resistance and 
toxic effects in the human body. The combined pharmacotherapy with 3–5 
antituberculosis drugs prevents the bacterial resistance. The efficacy of 
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tuberculosis therapy increases if antituberculosis drugs are used together 
with immunomodulators. Also ambenum is used because this drug prevents 
the lungs’ fibrosis. In prolonged antituberculosis therapy, such agents as 
insulin (8 IU a day), glucocorticoids (20 mg a day), folic acid, and 
stimulator of phagocytosis flurenizid are used. Hepatoprotectors are 
prescribed to prevent liver damage (LIV 52, Essentiale, Solcoseryl, etc.). 
From the clinical point of view, all tuberculosis patients are divided 
into 4 groups. The first group includes the patients who release 
mycobacteria into the external environment. The short-term therapeutic 
regimen (during 6 months) is used to treat such patients. The treatment is 
performed in two phases. A combination of four drugs is prescribed in the 
initial phase of treatment. This combination includes isoniazid, rifampicin, 
pyrazinamide, and ethambutol or streptomycin. The duration of this phase 
is 2 months. The second phase lasts four months. Two drugs – isoniazid 
and rifampicin – are prescribed in this phase. As a result of therapy, the 
release of mycobacteria is terminated in 100 % of patients and closing of 
caverns is observed in 89 %.  
The second group includes tuberculosis patients who do not release 
mycobacteria. These patients are treated by 4-drug combination (isoniazid, 
rifampicin, pyrazinamide, and ethambutol or streptomycin) during four 
months.  
The third group includes elderly patients. A so-called “mild” regimen 
of intermittent therapy is used in their treatment. According to this regimen, 
three drugs are prescribed to be taken two times a week during the first 
half-year.  
The fourth group includes healthy people at high risk for tuberculosis: 
persons who contact sick people releasing mycobacteria, patients with 
hyperergic tuberculin reaction (more than 6 mm), healthcare workers of TB 
dispensary, etc. They take isoniazid once a day after a meal during 2–3 
moonths or three times a week (intermittent method). 
 
Most Effective Antituberculosis Drugs:  
 
Isonicotinic  Acid Derivatives  
 
Hydrazides of isonicotinic acids include such drugs as isoniazid, 
f t ivazide, saluzidum, ethionamide, and prothionamide .  
Isoniazid  is most commonly used among them. The drug has high 
activity against Mycobacterium tuberculosis. Isoniazid acts upon both 
extracellular and intracellular mycobacteria.  
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A mechanism of isoniazid action is not clear enough. The drug affects 
synthesis of mycolic acids which are essential for the cell wall of 
mycobacteria, because mycolic acids are structural components of the cell 
wall only for mycobacteria, therefore isoniazid action is highly specific and 
it is active only against mycobacteria. Besides, there is a viewpoint that 
isoniazid also inhibits the nucleic acid synthesis. Effect of isoniazid is 
bactericidal. 
Isoniazid is taken orally or administered intramuscularly, 
intravenoulsly, by inhalation, and into cavernas. Orally, isoniazid is taken 
1–3 times a day after a meal. The drug is readily absorbed in the 
gastrointestinal tract. Isoniazid easily penetrates through tissue barriers 
including the blood-brain barrier.  
The rate of isoniazid inactivation (hepatic acetylation) significantly 
differs in different patients. This fact should be taken into account for drug 
dosing. The speed of hepatic acetylation is genetically determined, and 
about 50% of European population has a low speed of this reaction. In 
these patients (so-called “slow acetylators”), plasma drug concentration 
reduces 2–2.5 times slower than in ”fast acetylators”. The main route of 
isoniazid excretion is kidneys.  
Intramuscular or intravenous routes of isoniazid administration are 
used in severe forms of tuberculosis. After intravenous drug administration, 
a patient should lie at least during 1–1.5 hours. As a rule, intravenous 
administration of isoniazid improves the pulmonary blood circulation. 
Therapy with isoniazid is accompanied by significant side effects and 
complications. Neurotic effects are the first among them: neuritis, damage 
of ocular nerve, insomnia, psychic disturbances, dizziness, and memory 
loss. Nausea, vomiting, constipation, dry mouth, and allergic skin rash are 
possible due to the drug intake. Isoniazid affects the synthesis of vitamin B6 
active form – pyridoxal phosphate. The last one is the essential co-enzyme 
for deamination and transamination of amino acids and participates in 
protein synthesis. Therefore, isoniazid can cause disturbances of protein 
synthesis with the following muscular atrophy and anemia. Also, 
gynecomastia in males and menorrhagia in females are possible side effects 
of isoniazid. Pyridoxine, glutamic acid, thiamine, and ATP-Long are used 
for reduction of isoniazid toxicity. 
Isoniazid contraindications are epilepsy and other convulsive diseases, 
disturbances of hepatic and renal functions, marked atherosclerosis, and 
phlebitis.  
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Other derivatives of isonicotinic acid (ftivazide, saluzid, ethionamide, 
prothionamide) are less active in comparison with isoniazid. These drugs 
are used in case of isoniazid intolerance. 
 
Rifamicins  
 
The main representative of this antibiotic group is rifampicin . This 
broad spectrum antibiotic is active against mycobacteria, Gram-positive 
and Gram-negative bacteria, including some strains of Pseudomonas 
aeruginosa, Proteus, and capsular bacteria. 
Rifampicin inhibits the RNA synthesis due to blockage of DNA-
dependent RNA-polymerase. Depending on the used dose, antibacterial 
effect of rifampicin is either bacteriostatic or bactericidal. Bacterial 
resistance to rifampicin develops quickly. 
Rifampicin is taken orally 1–2 times a day 0.5–1 hour before a meal. 
The drug is easily absorbed from gastrointestinal tract. Maximum blood 
concentration is achieved in 2–2.5 hours. Also, rifampicin is administered 
intravenously drop-by-drop (only for adults). Duration of the drug action is 
8–12 hours. Rifampicin readily penetrates through the histohematic barrier 
and is excreted with bile, urine, and bronchial secret. The drug can turn 
urine, tears, saliva, and other body fluids red.  
As a rule, rifampicin is prescribed together with other antituberculosis 
agents. Also, rifampicin is used as a reserve drug for treatment of other 
infectious diseases. Sometimes, rifampicin is used to treat lepra and rabies 
(in incubation period, because the drug inhibits the development of rabies 
encephalitis).  
Rifampicin is hepatotoxic and immunosupressive agent. To prevent 
immunodeficiency, immunocorrectors (levamisole, T-activin, etc.) are used 
during therapy with rifampicin.  
Rifampicin therapy may be complicated by leukopenia, dyspepsia, and 
allergic reactions. The drug is contraindicated for pregnant women, infants, 
and in severe hepatic and renal diseases.    
 
Drugs with High Antituberculosis Activity:  
 
Aminoglycosides  
 
Streptomycin  is an antibiotic of broad antibacterial spectrum. The 
drug is active against mycobacteria and most Gram-positive and Gram-
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negative bacteria. Anaerobes, spirochetes, rickettsia, viruses, fungi, and 
protozoa are not sensitive to streptomycin.  
Streptomycin inhibits the protein synthesis and affects the 
permeability of the bacterial cell membrane. Streptomycin is a bactericidal 
medication. 
Streptomycin is badly absorbed in the gastrointestinal tract and 
therefore it is administered intramuscularly. Maximum blood concentration 
of streptomycin is achieved in 1–2 hours after administration. For 
tuberculosis treatment, the drug is administered 1–2 times a day. For 
treatment of other infections, streptomycin may be administered 3–4 times 
a day. Sometimes, streptomycin is administered intratrachealy (aerosol) or 
into cavernas (10 % solution, once a day, only in hospital). Streptomycin is 
excreted unchanged through the kidneys.  
Ototoxic effect of streptomycin arises due to the damage to the 
vestibular branch of the 8th cranial nerve (vestibulocochlear nerve). The 
auditory branch is affected less frequently. The disturbances start from 
noise in ears. At that moment, the drug use should be stopped. 
Streptomycin is a nephrotoxic agent. Also, the drug inhibits 
neuromyscular transmission that can result in respiratory depression. 
Streptomycin is contraindicated in severe forms of cardiovascular 
failure, renal failure, disorders of cerebrovascular circulation, myasthenia 
gravis, and diseases of vestibulocochlear nerve.  
Vitamins of A, B group, and C are prescribed for prevention or 
reduction of streptomycin neurotoxicity. Also, streptomycin pantotenate or 
streptomycin ascorbate are used with the same purpose. Streptomycin is 
prescribed only for inpatients.  
Kanamycin  is another representative of aminoglycosides. The drug 
has broad antibacterial spectrum of action. Kanamycin is used in 
tuberculosis treatment in the case when other antituberculous drugs are 
ineffective.  
 
Other Antibiotics  
 
Cycloserine  is an antibiotic with broad antibacterial spectrum, 
including Gram-positive and Gram-negative bacteria. The most valuable 
property of cycloserine is its activity against mycobacteria. The drug is 
active against both extracellular and intracellular mycobacteria. 
Cycloserine is used to treat tuberculosis as a reserve agent when other 
antituberculosis drugs become ineffective. Cycloserine is the drug with 
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high neurotoxicity. Side effects of the drug are headache, dizziness, 
insomnia, irritability, memory loss, paresthesia, peripheral neuritis, anxiety, 
psychasthenic state (a condition characterized by rapid mood changes, 
suicidality, depression, etc.), epileptiform seizures, loss of consciousness, 
etc.  
Florimycin (viomycin)  is a polypeptide antibiotic. Florimycin 
affects protein synthesis that results in bacteriostatic effect. The drug is 
characterized by low absorbability in the gastrointestinal tract, therefore it 
is administered intramuscularly. Florimycin easily penetrates through the  
tissue barriers. Viomycin is used to treat different forms of tuberculosis 
when other drugs are ineffective. The side effects of florimycin are the 
damage to 8th cranial nerve, disturbances of renal function, allergic 
reactions, and electrolyte disturbances.  
 
Synthetic Drugs  
 
Ethambutol  is a synthetic agent with high antituberculosis activity. 
The drug affects only mycobacteria and is active in cases of bacterial 
resistance to isoniazid, streptomycin, and other drugs. Mechanism of action 
is based on ethambutol ability to inhibit the synthesis of RNA and proteins 
and the ability to interact with divalent metal ions. Also, ethambutol affects 
the ribosome structure. Ethambutol is bacteriostatic antitubercular agent. 
The drug is taken orally once a day after a meal. Ethambutol is easily 
absorbed from the gastrointestinal tract and excreted unchanged through the 
kidneys. Insignificant amount of the drug is excreted unchanged in feces. 
Ethambutol is used in combination with other antituberculosis agents 
in treatment of different forms of tuberculosis. Side effects of ethambutol 
are dispepsia, dizziness, depression, allergic reactions, and visual field loss. 
Drug intake during 2–6 months may be accompanied by disturbances of 
color vision (especially perception of red and green colors). The vision is 
restored after drug removal. 
Pyrazinamide  is a derivative of pyrazincarbonic acid. The value of 
the drug is its ability to affect mycobacteria with resistance to other 
antituberculosis drugs. Antituberculosis activity of pyrazinamide is lower 
than the activity of isoniazid, rifampicin and aminoglycosides. Mechanism 
of pyrazinamide action is not completely known. It is apparent that the drug 
inhibits mycobacteria development on the stage of intracellular division.  
Pyrazinamide is easily absorbed in the gastrointestinal tract, penetrates 
into tuberculous foci and exhibits high activity in the acidic environment of 
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caseous masses. Pyrazinamide is excreted through the kidneys. The drug is 
taken orally 3–4 times a day after a meal. Bacterial resistance to 
pyrazinamide develops readily. The drug is used to treat tuberculosis in 
combination with other antituberculosis drugs. Side effects are dispepsia, 
disturbances of liver functions, allergic reactions, artralgia, gout 
exacerbation, and photosensitization. Cyanocobalamin, methionine, and 
glucose are used to diminish pyrazinamide toxicity.  
Ethionamide  and prothionamide  are isonicotinic acid derivatives. 
The properties of these drugs are close to the properties of isoniazid, but 
antituberculosis activity is low. The value of these drugs is their ability to 
affect mycobacteria which are isoniazid-resistant. The mechanism of action 
is the same as that with isoniazid. Ethionamide and prothionamide are 
bacteriostatic agents, they are active against both extracellular and 
intracellular mycobacteria. Both drugs stimulate phagocytosis in the 
inflammatory foci. The drugs are taken orally or administered rectally 3–4 
times a day, but in case of poor tolerance – 2 times a day. It is necessary to 
notice that patients tolerate prothionamide better. The side effects of 
ethionamide and prothionamide are nausea, vomiting, diarrhea, liver 
function disturbances, allergic reactions, insomnia, and orthostatic 
hypotension. For prevention or reduction of these side effects, pyridoxine 
and nicotinamide are used. Ethionamide and prothionamide are 
contraindicated in pregnancy.  
 
Drugs with Moderate Antituberculosis Activity: 
 
Para-Aminosalycil ic Acid Derivatives  
 
Sodium para-aminosalicylate (PAS)  and calcium para-
petrolylaminosalicylate (Bepascum)  exhibit bacteriostatic effect 
against mycobacteria. The molecular structure of these drugs is similar to 
the structure of para-aminobenzoic acid (PABA). Therefore, para-
aminosalycilic acid derivatives are competitive antagonists of PABA. It is 
known that PABA is used by mycobacteria for protein synthesis. Inhibition 
of protein synthesis by PAS and Bepascum slows down the growth and 
division of bacteria.  
PAS is taken orally after meal (with milk or alkaline mineral water). 
The drug is easily absorbed from the gastrointestinal tract. After absorption, 
the drug quickly penetrates into tissues of the internal organs. About 90 % 
of the taken dose is excreted through the kidneys, 10 % – with bile in an 
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inactive form. The main route of PAS inactivation is acetylation. 
Sometimes PASA is administered intravenously drop-by-drop.  
Bepascum is a drug with prolonged action which releases para-
aminosalycilic acid. The drug is taken orally.  
Both drugs can cause such side effects as dispepsia (nausea, vomiting, 
diarrhea, and abdominal pain), allergic reactions (skin rash), hepatotoxicity, 
crystalluria, agranulocytosis, increased growth of the thyroid gland, and 
hypothiroidism.   
 
Thiosemicarbazone Derivatives  
 
Thiacetazone is a synthetic agent which is active against mycobacteria 
tuberculosis and leprosy. The drug exerts its bacteriostatic activity. 
Thiacetazone is taken orally after a meal. The clinical use of thiacetazone is 
restricted by its high toxicity. The drug is used only in combination with 
other antituberculosis agents in treatment of extrapulmonary tuberculosis: 
tuberculosis of mucous and serous membranes, lymphadenitis, specific 
fistulas, etc.  
Side effects of thiacetazone are headache, nausea, dermatitis, blood 
dyscrasias (anemia, thrombocytopenia, leukopenia, and agranulocytosis), 
and disturbances of liver and renal functions.  
 
Table 5 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product  
Isoniazidum 
 
Orally 0.3 g 2–3 times daily; 
intramuscularly 0.3–0.9 g or 
intravenously drop-by-drop 
0.01 g/kg (as 0.2 % solution)  
daily 
Tablets 0.1 or 0.3 g; 
ampoules 5 ml of 10 % 
solution  
Rifampicinum  
 
Orally 0.45 g daily; 
intravenously drop-by-drop 
0.45 g daily 
Capsules 0.15 g; 
ampoules 0.15 g of powder 
Natrii para-aminosa-
licylas  
 
Orally 3–4 g 3–4 times daily 
(1–2 teaspoons of granules); 
intravenously drop-by-drop 
7.5–15 g daily (as 3 % solu-
tion) 
Tablets 0.5 g; 
granules 100 g; 
vials 250 or 500 ml of 3 % 
solution  
Ethambutolum  Orally 0.025 g/kg daily Tablets 0.1 or 0.4 g 
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Continuation of Table 5 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product  
Streptomycini sulfas  Intramuscularly 0.5 g 2 times 
daily 
Vials 0.5 g of powder 
Pirazinamidum Orally 0.015–0.025 g/kg 
once a day or 0.05–0.07 g/kg 
2–3 times per week   
 
Tablets 0.5 or 0.75 g 
 
 
Antiviral Drugs  
 
Antiviral drugs are agents of different chemical structure which 
interfere with viral penetration into the cells, synthesis of viral nucleic acids 
and proteins, and viral replication. 
The following mechanisms of action are typical for different antiviral 
drugs:  
1) inhibition of viral absorption and penetration into the host cell:  
γ-globulin, enfuvirt ide ;  
2) impairment of the efficient release of the viral genome: 
amantadine (midantanum), rimantadine ;  
3) violation of viral protein synthesis: guanidine, saquinavir ;  
4) violation of nucleic acid synthesis: zidovudine, acyclovir ,  
vidarabine, idoxuridine ;  
5) violation of the virion assembly: metisazon .  
Nowadays, about 30 antiviral drugs are used in medicine. Except 
interferons, all of them are synthetic agents.  
There are the following groups of antiviral drugs:  
– drugs for influenza treatment;  
– drugs active against herpes simplex virus and against 
cytomegalovirus;  
– drugs active against human immunodeficiency virus (HIV);  
– drugs active against retrovirus and picornavirus;  
– drugs affecting variola virus; 
– drugs active against Hepatitis B and Hepatitis C viruses.    
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Drugs for Influenza Treatment  
 
This group includes the following drugs:  
1. Drugs which block viral M2 proton channel: rimantadine,  
amantadine,  and adaprominum .  
2. Drugs which inhibit viral enzyme neuraminidase: zanamivir ,  
oseltamivir .  
3. Drugs which inhibit viral RNA-polymerase: ribavirin .  
4. Other drugs: arbidol ,  oxoline .  
 
The Matrix-2 (M2) protein is a specific protein of influenza virus. This 
protein is located in viral membrane and functions as an ionic channel. 
Drugs blocking this protein affect the disassembling of the virus and 
prevent the release of the viral genome in the host cells. Due to this, viral 
replication is abolished. 
Amantadine (midantanum)  is used to prevent influenza type A. 
However, the drug has low efficiancy to use it with that end in view. The 
drug is taken in dose 100 mg twice a day (every 12 hours). Amantadine is 
readily absorbed in the gastrointestinal tract and excreted from the body 
with urine. 
Adapromine  and rimantadine  are more effective agents. 
Rimantadine is active against influenza type A virus (especially type A2). 
Adapromine is active against influenza A and B type viruses. Also, 
rimantadine affects the tick borne encephalitis virus. For prevention of 
influenza, rimantadine is taken orally in dose 0.05 g, adapromine – in dose 
0.1 g once a day during 10–20 days. Timely drug intake reduces the 
frequency of the disease incidence by 50 % and more. In case of taking  
influenza, it is mild. It is necessary to notice that intake of the drugs in 2–3 
days after the disease onset has low efficiency. The drug intake in 5 days 
after the start of the disease is completly ineffective. For prevention of tick 
borne encephalitis, rimantadine is taken twice a day in dose 0.1 g during 3–
5 days. Preventive drug intake starts immediately after a tick bite. 
Rimantadine is readily absorbed in the gastrointestinal tract, metabolized in 
the liver, and excreted through the kidneys. As a rule, the drug is well 
tolerated by patients. Side effects include dyspepsia, headache, insomnia, 
dizziness, and irritability. Rimantadine has teratogenic and embryotoxic 
effects. Adapromine is a less toxic agent. Both drugs are contraindicated in 
acute hepatic and renal diseases and during pregnancy.  
Influenza viruses quickly develop resistance to the drugs of this group. 
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Neuraminidase is a glycoprotein which is located on the surface of the 
influenza viruses types A and B. The enzyme promotes penetration of the 
virus into the target cells in the respiratory tract. The drugs, blocking 
neuraminidase, violate the virus propagation and affect the viral replication. 
Zanamivir  and oseltamivir  are drugs with such mechanism of action.  
Zanamivir  is used for intranasal application or for inhalations. About 
15 % of administered dose of zanamivir penetrates into the systemic blood 
circulation. The drug is excreted through the kidneys.  
Oseltamivir (Tamiflu )  is taken orally. The drug is active against 
influenza viruses types A and B, including virus АН4N2. Oseltamivir is 
readily absorbed in the gastrointestinal tract. The drug undergoes fast 
hydrolysis in the intestine, liver, and blood. Bioavailability of its active 
metabolites is about 80 %. The main route of excretion is the kidneys. The 
half-life period is 6–10 hours. Side effects of oseltamivir are nausea, 
vomiting, and nephrotoxicity.  
Ribavirin  is a derivative of guanosine. The drug is phosphorylated in 
the body into ribavirin monophosphate and ribavirin triphosphate. 
Ribavirin monophosphate inhibits the synthesis of guanine nucleotides. 
Ribavirin triphosphate inhibits viral RNA-polymerase and affects the 
formation of iRNA. Ribavirin is active against influenza viruses A and B. 
Also, the drug is used in treatment of severe infections caused by 
respiratory syncytial virus and hemorrhagic fever with renal syndrome. 
Side effects of ribavirin are skin rash and conjunctivitis. Ribavirin has 
mutagenic, teratogenic, and cancerogenic properties.  
Arbidol  is used to prevent and treat influenza type A and B, acute 
respiratory viral infections, and herpes recurrent infection. Arbidol exhibits 
interferonogenic activity, stimulates cellular and humoral immunity. The 
drug is taken orally and tolerated by patients well.  
Oxoline  is used to prevent influenza and to treat viral rhinitis, 
adenoviral keratoconjunctivitis, herpetic keratitis, and some viral skin 
diseases (shingles, etc.). Oxolinic ointment is used to lubricate nasal 
mucosa, to apply over the lower eyelid, or on the skin.  
 
Antiherpethetical Drugs and Drugs for Cytomegalovirus 
Infection Treatment 
 
The following drugs are used to treat herpes: 
1. Drugs for resorbtive action: acyclovir , valacyclovir ,  
famcyclovir ,  vidarabine .  
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2. Drugs for topical use: tri f luridine, idoxuridine, megosin,  
gossypol .  
Acyclovir (Zovirax)  is a drug of high activity. It is a synthetic 
purine nucleoside analogue. In a human body, acyclovir is phosphorylated 
with active metabolite formation. Phosphorylated acyclovir inhibits DNA-
polymerase. It results in violation of nucleic acid synthesis and inhibition of 
viral replication. Viral DNA-polymerase is 100 times more sensitive to 
acyclovir action than human DNA-polymerase. The oral bioavailability of 
acyclovir is about 20 %. Acyclovir has satisfactory permeability through 
the blood-brain barrier. The therapeutic indications for acyclovir are herpes 
simplex, herpetic lesions of eyes and genitalia, and cytomegalovirus 
infection. The drug is taken orally, administered intravenously, or applied 
topically (5 % skin cream, or 3 % ophthalmic ointment which are used 5 
times a day). In case of significant skin damage, acyclovir is taken orally 5 
times a day in dose 0.2–0.4 g. Intravenous acyclovir is used to treat herpetic 
infections in patients with immunodeficiency or to treat severe herpetic 
lesions of genitalia. Side effects develop seldom. During acyclovir therapy 
the following side effects are observed: nausea, vomiting, diarrhea, 
headache, and allergic reactions. Intravenous acyclovir administration can 
cause the reversible neurological complications (hallucination, excitement, 
and confusion), renal dysfunction, phlebitis, and skin rash. External 
acyclovir application can cause dry and peeling skin.  
Valacyclovir  is a new agent for treatment of herpetic infection. Oral 
bioavailability of valacyclovir is about 54 %. It is necessary to notice that 
valacyclovir has no antiviral activity. Valacyclovir is converted to acyclovir 
in the intestine and liver.  
Famcyclovir  and gancyclovir  are similar to acyclovir. 
Vidarabine  is phosphorylated by kinases into the active metabolite. 
Phosphorylated metabolite inhibits viral DNA-polymerase and suppresses 
the virus replication. Vidarabine is used to treat herpetic encephalitis. The 
drug decreases the mortality from this disease by 30–70 %. Sometimes, 
vidarabine is used to treat shingles and herpetic keratoconjunctivitis. Also, 
vidarabine is used to treat patients suffering from allergic reactions to 
idoxuridine. Side effects of vidarabine are dyspepsia, tremor, psychosis, 
allergic reactions, blood clots on the injection site.  
Idoxuridine  and tri f luridine  are antiherpetic drugs which are used 
topically. Therapeutic indications for their use are herpetic keratitis and 
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keratoconjunctivitis. Side effects are irritation of mucous membranes and 
eyelid oedema.  
Gancyclovir,  valgancyclovir,  foscarnet , and Vitravene 
(fomivirsen)  are drugs for treatment of cytomegalovirus infection.  
Mechanism of action of gancyclovir is similar to acyclovir. The drug 
is used to treat cytomegalovirus retinitis, colitis, esophagitis, pneumonia, 
etc. Gancyclovir is administered intravenously or used topically in 
conjunctival cavity. The side effects of gancyclovir are headache, 
psychosis, convulsions, granulocytopenia, thrombocytopenia, skin rash, 
and liver damage. Gancyclovir is a drug with teratogenic activity.  
Valgancyclovir is metabolized to gancyclovir in the intestine and liver. 
The bioavailability of valgancyclovir is about 60 % (in 10–12 times higher 
than gancyclovir).   
Foscarnet is a drug with the same mechanism of action. The drug is 
used to treat cytomegalovirus retinitis in patients with AIDS. Also, 
foscarnet may be used as an alternative to acyclovir to treat herpes simplex 
and shingles. Foscarnet is administered intravenously or applied topically 
in ointment. The toxicity of foscarnet is higher than gancyclovir toxicity. 
But foscarnet inhibits the leukopoiesis to a lesser degree than gancyclovir. 
Side effects of foscarnet are fever, headache, convulsions, nephrotoxicity, 
cardiac arrhythmias, encephalopathy, disturbances of mineral and 
electrolyte balance, etc.  
Vitraven is used to treat cytomegalovirus rhinitis and retinitis. 
 
Drugs Active Against Human Immunodeficiency Virus  
(Antiretroviral Drugs) 
 
The following drugs are used to treat HIV-infection: 
1.    Reverse transcriptase inhibitors. 
1.1. Nucleosides: zidovudine, didanosine, stavudine, and 
zalcitabine .  
1.2. Non-nucleoside compounds: nevirapine, delavirdine, and 
efavirenz .  
2.   HIV protease inhibitors: indinavir ,  ri tonavir,  saquinavir,  
and nelf inavir . 
The synthesis of viral DNA on the matrix (viral RNA) occurs after 
penetration of AIDS virus into lymphocytes. This synthesis is controlled by 
reverse transcriptase. After phosphorylation, zidovudine blocks reverse 
transcriptase and inhibits DNA synthesis. This results in inhibition of  
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iRNA and viral protein synthesis. Zidovudine  is effective mainly against 
virus carriers (before the appearance of AIDS symptoms). In sick patients, 
zidovudine slows down the disease progression, prolongs the duration of life, 
and reduces the frequency and severity of infectious complications. But 
recovery does not complete. Zidovudine is taken orally 0.1 g 5–6 times a day 
or 0.2 g 3 times a day. The drug is readily absorbed in the gastrointestinal 
tract. Zidovudine readily penetrates through the blood-brain barrier. About 
75 % of administered dose is metabolized in the liver. The main route of 
zidovudine excretion is through the kidneys. The prolonged therapy with 
zidovudine (more than 6 months) results in development of antiviral drug 
resistance. Side effects of zidovudine are anemia, neutropenia, 
thrombocytopenia, pancytopenia, headache, diarrhea, fever, and renal 
dysfunction. After prolonged use of zidovudine, the following drugs may be 
prescribed to a patient: didanozine, zalcitabine, stavudine, lamivudine, or 
abacavir. These drugs have an identical mechanism of action with 
zidovudine. All drugs are taken orally and undergo hepatic metabolism with 
the subsequent renal excretion. Hematotoxicity (anemia, leukopenia, and 
thrombocytopenia), neurotoxicity (headache and insomnia), and renal, 
pancreatic and hepatic dysfunctions are typical side effects of these drugs.  
The non-nucleoside agents for AIDS treatment are nevirapine,  
delavirdine, and efavirenz . These drugs also block reverse 
transcriptase, but bind to enzyme in another site than nucleosides. There is 
an evidence that these drugs also simultaneously inhibit DNA-polymerase. 
Non-nucleoside drugs are taken orally and used only in HIV-1 infection.  
HIV protease inhibitors (indinavir ,  ri tonavir ,  saquinavir ,  
nelf inavir) block enzymes regulating formation of structural proteins and 
enzymes which are necessary for virus replication. The deficit of these 
proteins results in formation of virus immature precursors and slows down 
the development of infection. Saquinavir is the most commonly used HIV 
protease inhibitor. The drug is effective against both HIV-1 and HIV-2 
infections. Saquinavir is taken orally. The bioavailability of the drug is very 
low (about 4 %), but blood concentration of the drug is enough to inhibit 
retroviral replication. The side effects of saquinavir are dyspepsia, 
disturbances of lipid and carbohydrate metabolism, anemia, and dysuria. 
The prolonged drug intake causes the development of antiviral drug 
resistance.  
Combined drug use is the most effective in HIV therapy: zidovudine + 
zalcitabine + saquinavir, zidovudine + saquinavir, etc.  
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Drugs Active Against Variola Virus 
 
Metisazon  is used to prevent smallpox and to decrease the risk of 
vaccine complication. Metisazon may act by inhibiting viral structural 
protein synthesis or blocking late stages of virus assembly. The drug is 
taken orally. Side effects include dyspeptic disorders and dizziness.  
 
Broad Spectrum Antiviral Drugs  
(Including Hepatitis B and C Viruses)  
 
Interferons are recovered from the cultures of human leukocytes (α-
interferon), fibroblasts (β-interferon), or lymphocytes (γ-
interferon). Recombinant interferons are derived by means of 
implantation of correspondent human genes to Escherichia coli.  
Interferons are species-specific low molecular weight glycoproteins. 
Interferons are not themselves antiviral active. Interferon interacts with a 
specific receptor located on the cellular surface that results in activation of 
protein kinase and formation of low-molecular inhibitor of protein 
synthesis. This inhibitor acts due to stimulation of enzymes which destroy 
RNA of viruses and host cells.  
Besides antiviral and antibacterial effects, interferons also activate the 
immunity (phagocytic activity of macrophages and toxicity of killers 
increase), exhibit antitumor and radioprotective activity, and influence 
functions of different systems of the body, including CNS.  
There is the following classification of interferon preparations:  
– α-2A-interferons: Reaferon, Roferon-A, Laferon ; 
– α-2B-inteferons: Intron-A, Viferon ; 
– α-2C-interferons: Berofor, Wellferon ;  
– β-interferons: Betaseron (Betaferon),  Feron ; 
– γ-interferons: Gammaferon, Imunoferon .  
Alfa-interferons (-2А, -2В) are used mainly as antiviral drugs. 
These drugs are effective in treatment of herpetic keratitis, herpetic lessions 
of the skin and sex organs, acute respiratory viral infection, shingles, viral 
hepatitis B and C, and AIDS.  
Laferon  and Reaferon  are used topically as nasal or eye drops (to 
prevent a disease – 2–3 drops in nose or in conjunctival cavity 1–2 times a 
day; to treat the disease – 4–6 times a day). The drugs are also used 
topically to treat shingles.  
There are high-purified interferons (1 mg – 5,000,000 IU) for oral 
intake or for parenteral administration (intravenously, intramuscularly, 
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intraosseously, endolumbarly, and endolymphatically). Interferons are 
quickly inactivated, therefore they are administered 4-6 times a day. High-
purified interferons are used in treatment for systemic viral infections or 
malignant neoplasms. Recombinant interferons (Reaferon, Roferon,  
Intron-A, Viferon, and Wellferon) are administered 2–3 times a day. 
Moreover, the drugs may be administered rectally. Side effects are possible 
in case of parenteral interferon administration and include fever, headache, 
muscular pain, reduction of blood pressure, cardiac arrhythmias, paresis 
and paralisis, blood dyscrasias, and dyspepsia.  
A disadvantage of interferon therapy is the development of drug 
resistance after 1–2 injections. The combined use of several inductors of 
interferons is recommended to prevent it. 
Interferon inductors  are drugs which stimulate the formation of 
interferons. There are natural (bacteria, viruses, rickettsia, fungi, etc.) and 
synthetic (vitamins, synthetic polynucleotides, polyanions, and some low-
molecular-wheight and high-molecular-wheigh compounds). The 
representatives of synthetic low-molecular-wheight interferon inductors are 
Amixin (t i lorone) , megosin, mefenamic acid , etc. The 
representative of high-molecular-wheight interferon inductors is 
poludanum . Poludanum is used in eye drops for treatment of viral lesions 
of mucous membranes of the eyes. Also, poludanum is administered 
subcutaneously once a week in treatment for chronic hepatitis C. 
Mefenamic acid is used to treat influenza. Megosin is applied topically to 
treat viral skin diseases. Tilorone is used to treat influenza, acute 
respiratory viral diseases, hepatitis B and C, herpes, cytomegalovirus 
infections, neurotropic viral infections, tuberculosis, and chlamydiosis. 
This drug is contraindicated for pregnant women.  
Some drugs of other pharmacological groups also exhibit the property 
to induce interferon formation. They are levamisole, isoprinozin,  
dipyradamole,  theophyll ine , Trental  (pentoxifyll ine),  dibazol  
(bendazol) , etc.  
Beta-interferon  is used in treatment of multiple sclerosis. It is a 
disease caused by demyelination of nervous fibers in the central nervous 
system. Multiple sclerosis occurs to young people, progressively worses, 
and results in disability. Recently, Betaseron  was established by means of 
gene engineering. The drug significantly reduces the frequency and severity 
of the exacerbations and slows down the disease progressing. Betaseron is 
administered subcutaneously once every 48 hours. Side effects of betaseron 
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are pain and redness on the injection site, fever, weakness, muscle pain, 
anemia, thrombocytopenia, neutropenia, lymphopenia, and menstrual 
irregularities. 
 
Table 6 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product 
Oxolinum Topically to apply to the nasal 
mucosa 2 times daily; 
1–2 drops into each eye 5–6 
times daily 
Ointment 0.25 % or 
0.5 % 10.0 or 15.0 g; 
eye drops: 0.1 % solution 
10 ml 
Remantadinum Orally 0.1 g  1–3 times daily Tablets 0.05 g 
Azidothimidinum 
(Zidovudine) 
Orally 0.1–0.25 g twice a day Capsules 0.1 or 0.25 g 
Aciclovir Orally 0.2–0.8 g 4–5 times a 
day; 
intravenously slowly 0.0005–
0.001 g/kg 3 times daily; 
topically to treat skin infections; 
for instillation into a lower 
conjunctival sac 5 times a day 
Tablets 0.2; 0.4 or 0.8 g; 
 
vials 0.25 g of powder 
for injections; 
ointment 5 % 5 g; 
eye ointment 3 % 4.5 g 
or 5 g 
Laferon For instillation into the nose (3–
6 drops) or eyes (1–2 drops)  
(before using, the powder of the 
ampoule should be dissolved in 
2 ml of sterile water) 3–6 times 
daily; 
intramuscularly, subcutaneously 
or intravenously 1,000,000–
5,000,000 IU 1–2 times daily  
Ampoules or vials with 
powder 1,000,000; 
3,000,000 or  
5,000,000 IU (dissolved 
before administration) 
 
 
Antileprosy Drugs 
Leprosy is an infectious disease caused by Mycobacterium leprae 
(Hansen’s bacillus). Drugs for leprosy treatment (antileprosy drugs) are 
classified into the following groups: 
1. Derivatives of aromatic sulfones: DDS – diaminophenyl  
sulfone (dapsone ,  avlosulfon),  solusulfonum 
(sulphedrone, cimedone), dimociphone, diuciphone .  
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2. Antibiotics:  
– rifamicins:  ri fampicin ; 
– macrolides: clarithromycin ; 
– tetracyclines: minocycline .  
3. Fluoroquinolones: ofloxacin (Tarivid) .  
4. Synthetic antituberculosis drugs: ethionamide, prothionamide,  
thioacetazone .  
5. Phenazine derivatives: clofazimine (lamprene) .  
Diaphenylsulfone (dapsone)  is one of the main drugs for leprosy 
treatment. Dapsone is a competitive antagonist of para-aminobenzoic acid 
and due to this fact it influences the synthesis of folic acid by 
Mycobacterium leprae. Also, the drug activates lysosomes of macrophages. 
The drug is taken 0.05–0.1 g once a day six days a week. The drug is 
rapidly and almost completely absorbed from the gastrointestinal tract. The 
half-live for dapsone in the body is 24 hours. Side effects of dapsone are 
weakness, headache, dyspepsia, toxic hepatitis, precordialgia, hemolysis, 
and agranulocytosis. The toxicity of the drug is limited due to reduction of 
the dose and intake of B group vitamins and iron-preparations.  
Diuciphone  is a diphenyl sulfone derivative containing two residues 
of methyluracil. The drug has antileprosy and immunomodulating effects.  
As a rule, antibiotics, ofloxacin, and synthetic antituberculosis agents 
in combination with sulfones are used to treat leprosy. The rapid effect is 
typical for rifampicin. Rifampicin is taken every day or twice a week (in 
combination with other antileprosy agents). Being located in the skin, 
Mycobacterium leprae lose their viability in 5 days. Synthetic 
antituberculosis drugs are less effective in leprosy treatment, but more 
toxic.   
Clofazimine  is a lipid-soluble phenazine derivative. The drug 
accumulates in the skin, gastrointestinal tract, and in the cells of monocyte 
macrophage sprout. Side effects are skin dyschromia (red-brown skin), 
ichthyosis, diarrhea, intestinal colic, etc. Clofazimine is contraindicated in 
pregnancy.  
The chemotherapy of leprosy is a long-term cure. Mycobacterium 
leprae resistance and disease relaspse are common problems. A relapse in 
leprosy occurs due to persistent Mycobacterium leprae in bone marrow, 
nervous and muscular tissues. The combined antileprosy chemotherapy by 
means of 2–3 drugs with different chemical structure is used to prevent 
leprosy prolapse and antileprosy drug resistance. The most common drug 
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combination includes diphenyl sulfone, rifampicin, and clofazimine. 
Besides, the use of immunomodulators and vitamins in treatment of leprosy 
is advisable.  
 
 
Antiprotozoal Drugs 
 
It is known that more than 1000 species of protozoa are pathogenic for 
humans. Antiprotozoal drugs are selectively active against protozoa – 
causative agents of malaria, amoebiasis, giardiasis, toxoplasmosis, 
leishmaniasis, trichomoniasis, and balantidiasis. Antiprotozoal drugs 
include synthetic agents and some antibiotics, and they are classified into 
the following groups: 
1. Antimalarial drugs. 
2. Drugs for giardiasis treatment.  
3. Drugs for toxoplasmosis treatment.  
4. Drugs for balatidiasis treatment.  
5. Drugs for trichomoniasis treatment.  
6. Drugs for leishmaniasis treatment.  
  
Antimalarial  Drugs 
 
In the past, malaria was one of the most common diseases in the 
world. About one million peple were dying every year. In 50–60-s of the 
20
th
 century, malaria morbidity was significantly reduced due to the 
broadest antimalarial actions under UN auspices. Unfortunatelly, last years 
the formation of drug resistant strains of Plasmodium results in the increase 
of malaria morbidity.  
A source of malaria infection is the sick person or a gamete carrier. A 
person can get infection through the bite of infected mosquitoes (seldom – 
due to blood transfusion from the sick person). Thus malaria parasites enter 
the blood.  
There are 4 species of malaria parasites: 
– Plasmodium vivax, and Plasmodium ovale – the causative agents of 
vivax (three-day malaria); 
– Plasmodium malaria – the causative agent of quartan (four-day 
malaria);  
– Plasmodium falciparum – the causative agent of tropical malaria.  
 Plasmodium ovale is found only in the tropics. 
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The Plasmodium parasite undergoes two cycles of replication: asexual 
cycle (schizogony) takes place in the human body, and sexual cycle 
(sporogony) occurs in the mosquito. Due to infected mosquito bite, the 
sporozoites enter the blood of the person, then quickly enter hepatocytes. 
Inside hepatocites multiplication occurs: pre-erythrocytic or exo-
erythrocytic schizogony stage. Tens of thousands of merozoites are formed 
due to multiple division of one sporozoit. Pre-erythrocytic schizogony is 
asymptomatic. After completion of pre-erythrocytic schizogony, 
merozoites penetrate into erythrocytes and undergo the stage of 
erythrocytic schizogony. This stage is accompanied by erythrocyte rupture 
and fever attacks. Erythrocytic merozoites again penetrate into erythrocytes 
and repeat the erythrocytic cycle. In infection with Pl. vivax and Pl. ovale, 
these cyclical fevers occur every 48 hours, in infection with  Pl. falciparum 
– every 6 hours, and in infection with Pl. malarie – every 72 hours. Along 
with asexual division, the sexual forms of Plasmodium are formed in the 
human blood. These sexual forms are called gametocytes (gamonts). Their 
presence in the blood is not accompanied by the disease symptoms, but 
gamonts are dangerous in the context of epidemiology. Such patients are 
the source of mosquito infection.  
In the tropical and four-day malaria, after the completion of pre-
erythrocytic schizogony, merozoites enter the blood and their following 
development occurs only in the erythrocytes. In the three-day malaria, the 
infection by genetically heterogeneous set of parasites occurs. A part of 
them (tachysporozoites or primary forms) pass the stage of tissue 
schizogony after penetration into hepatocytes and are released from the 
liver after completion of this stage. Another part of sporozoites 
(bradysporozoites or secondary forms) are capable to be in liver in dormant 
form from 8–9 months up to 2 years. After completion of the latent period, 
these dormant sporozoites undergo exoerythrocytic schizogony which 
finishes when parasites enter the blood and develop primary malaria or its 
relapse.  
The duration of sporogony, exo- and erythrocytic schizogony, the 
ability of drug-resistant Plasmodium to appear are different for different 
species of Plasmodium. 
Presently, the following chemical groups of drugs are used to treat 
malaria:  
1. Quinoline derivatives: quinine, chingaminum (chloroquine),  
mefloquine, primaquine, and quinocide .  
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2. Biguanides: bigumal . 
3. Pyrimidine derivatives: chloridinum (pyrimethamine) . 
4. 9-aminoacridine derivatives: quinacrine . 
5. Sulfonamides. 
6. Sulfones. 
7. Tetracyclines.  
 
Pharmaceutical industry produces a lot of combined drugs: 
Metakelf in  (contains pyrimethamine  and sulfalen), Fansidar  
(contains pyrimethamine  and sulfadoxine), Fansimef  (contains 
mefloquine, sulfadoxine, and pyrimethamine ), etc.  
 
According to antimalarial action, the drugs are divided into the 
following groups:  
1. Blood schizont icides are the drugs active against erythrocytic 
forms of Plasmodium: chingaminum (chloroquine),  mefloquine ,  
quinine . Also, the following agents are used in combined drugs: 
hydroxychloroquine , chloridinum, bigumal ,  sulfadoxine, and 
doxycycline .  
These drugs eliminate schizonts from the peripheral blood after  
3–5 days treatment. These drugs prevent and interrupt malaria attacks in the 
acute phase of the disease.  
2. Tissue schizont icides are the drugs which affect tissue forms of 
Plasmodium. These drugs are divided into two groups:  
– tachysporozoites  are tissue schizonticides which are active 
against pre-erythrocytic forms: bigumal and chloridinum ; these drugs 
are used to prevent malaria; 
– bradysporozoites  are tissue schizonticides which are active 
against para-erythrocytic forms of Plasmodium: primaquine  and 
quinocide ; these drugs are used to prevent malaria relapses.  
3. Gametocides  are the drugs which are active against sexual forms 
of Plasmodium. These drugs are divided into two groups: 
– gametocides acting upon sexual forms  of Plasmodium in 
human erythrocytes: primaquine  and quinocide ; 
– drugs inhibit ing the sporogony in the body of mosquito: 
bigumal  and chloridinum .  
These drugs are used for collective protection against malaria – 
prevention of disease transmission from the sick to healthy person through 
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a mosquito bite. Due to the use of these agents, sporozoites are not formed 
in the mosquito body.  
 
Blood Schizonticides 
 
Quinine  is an alkaloid found in the bark of the cinchona tree. 
Different species of cinchona tree are native to South America. In the 17
th
 
century, the bark of the cinchona tree was brought to Europe and since then 
it was used to treat malaria as well as fever. In 1816 quinine was isolated 
from the bark by J. E. F. Giese. Other antimalarial drugs were synthezied 
later on. 
Quinine affects erythrocytic schizonts of Plasmodium, gamonts, pre-
erythrocytic forms of P. falciparum, and the causative agent of 
toxoplasmosis. The drug is readily absorbed from the gastrointestinal tract 
and quickly excreted from the body. Quinine inhibits the center of 
thermoregulation and decreases the body temperature in fever. Also, 
quinine inhibits the excitability of myocardium, exhibits negative 
chronotropic effect, stimulates uterine contractions in pregnant women, and 
stimulates the spleen to contract. Mechanism of action of quinine is 
identical with chingaminum, primaquine, quinocide, and mefloquine. This 
mechanism is associated with violation of DNA synthesis both in 
Plasmodium cells and in host cells. Besides, quinine seals the lysosomal 
membranes, resulting in impaired assimilation of hemoglobin by 
Plasmodium.  
Therapy with quinine is commonly accompanied by side effects: 
dizziness, vomiting, headache, collapse, tinnitus, etc. Presently, quinine is 
once again being used to treat tropical malaria, because Plasmodium 
infections became resistant to other drugs. 
Chingaminum (chloroquine)  hes been suggested for malaria 
treatment in 1943. The drug is one of the best blood schizonticides. 
Chloroquine interrupts the acute malarial fever within 24–48 hours. 
Plasmodium infections disappear from the peripheral blood in 2–3 weeks 
after the start of therapy with chingaminum. The drug is used to prevent 
and treat all types of malaria.   
Along with antimalarial effect, chloroquine exhibits the anti-
inflammatory activity and is widely used to treat polyarthritis, systemic 
lupus erythematosus, scleroderma, and other collagen-vascular diseases. 
Also, chingaminum is used to treat amebiasis.  
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Chingaminum is taken orally and administered intramuscularly or 
intravenously. The drug is readily absorbed from the gastrointestinal tract. 
About 50 % of the drug bind to plasma proteins. The elimination rate for 
the drug is low. Kidneys are the main route of chingaminum excretion. 
Chloroquine side effects are headache, nausea, dermatitis, and loss of 
appetite. Overdose of chingaminum can cause dystrophy of myocardium 
and liver, disturbances of accommodation, tinnitus, and leukopenia.  
Mefloquine  is an active antimalarial agent. In tropical malaria, the 
single use of the drug interrupts malarial fever and kills chloroquine-
resistant strains of Plasmodium. Mefloquine is also effective in three-day 
malaria but does not prevent relapse. The toxicity of mefloquine is low. 
Sometimes, therapy with mefloquine can result in nausea, vomiting, 
abdominal pain, and drowsiness. Central nervous system disorders are 
seldom possible (depression, halucinations, convulsions, and 
disorientation).  
Chloridinum  (pyrimethamine)  is a synthetic agent – derivative of 
pyrimidine. The drug violates the synthesis of dihydrofolic acid due to the 
inhibition of dihydrofolate reductase. Pyrimethamine is active against 
erythrocytic and pre-erythrocytic forms of Plasmodium, and also inhibits 
the sporogony in the body of mosquito. Pyrimethamine is taken orally and 
easily absorbed from the gastrointestinal tract. The drug is able to 
accumulate in tissues and, therefore, has the prolonged effect. The 
therapeutic indications for chloridinum are treatment of malaria, 
toxoplasmosis, and leishmaniasis. Also, the drug is used for personal 
protection against malaria. The side effects include headache, dizziness, 
discomfort in the heart area, hepatic disfunction, megaloblastic anemia, 
leukopenia, and teratogenic effect.  
Sulfonamides and sulfones are also blood schizonticides. These drugs 
affect utilization of benzoic acid by Plasmodium. The activity of these 
agents are relatively low and their antimalarial effect develops slowly. 
Sulfonamides and sulfones in combination with other drugs are used to 
treat malaria.  
 
Tissue Schizonticides  
 
Chloridinum  (pyrimethamine)  and bigumal are active against 
pre-erythrocytic forms (tachysporozoites). Both drugs inhibit dihydrofolic 
acid reductase that results in violation of terahydrofolic acid and nucleic 
acid synthesis.  
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Bigumal  is a biguanide derivative. The drug is active against pre-
erythrocytic forms and gamonts of Plasmodium. The activity of bigumal is 
lower than the activity of chloridinum. Bigumal is taken orally, readily 
absorbed from the gastrointestinal tract, and is readily excreted from the 
body. The therapeutic effect of bigumal develops slowly. The side effects 
are leukocytosis and erythrocyturia. It is necessary to notice that 
Plasmodium quickly develops the tolerance to bigumal.  
Primaquine  and quinocide  are tissue schizonticides which are 
active against para-erythrocytic forms of Plasmodium (bradysporozoites). 
Primaquine affects bradysporozoites of Plasmodium vivax and Plasmodium 
ovale which cause the relapse. Also, primaquine affects the sexual forms of 
Pl. vivax, Pl. ovale, and Pl. falciparum in human erythrocytes. Primaquine 
is taken orally and well absorbed from the gastrointestinal tract. Maximal 
concentration in the blood is observed in 2 hours after drug intake. The 
drug is metabolized in the body and excreted through the kidneys. 
Therapeutic indications for primaquine are prevention of relapses of three-
day malaria and prevention of malaria spreading through the carrier. 
Primaquine is commonly combined with other antimalarial drugs. Side 
effects of primaquine are dyspepsia, methemoglobinemia, leukocytosis or 
leukopenia.  
Quinocide is more toxic than primaquine. Other antimalarial agents 
increase its toxicity, therefore, combined use of quinocide with them is 
impossible. Quinocide is taken orally 1–2 times a day after a meal. Side 
effects of quinocide are nausea, cyanosis, fever, irritation of bladder, 
leukopenia or leukocytosis. These complications disappear after giving up 
the drug.   
 
Gametocides  
 
Gametocides are drugs which are active against sexual forms of 
Plasmodium. Gametocides which inhibit the sexual forms of Plasmodium 
in human erythrocytes are primaquine  and quinocide . Gametocides 
inhibiting the sporogony in the body of mosquito are bigumal and 
chloridinum. Pharmacology of these drugs is described above.  
 
Selection Criteria for Antimalarial  Drugs  
 
Antimalarial drugs are used to treat and prevent malaria. In acute 
period (malarial fever, malarial coma), blood schizonticides are used 
(chingaminum (chloroquine), mefloquine, quinine, etc.). These drugs 
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readily penetrate human erythrocytes and facilitate the fast improvement in 
clinical findings. The resistance of Plasmodium to these drugs develops 
relatively slow. In malarial coma, chloroquine and quinine are administered 
parenterally.  
 
The reserve group (used in case of Plasmodium resistance to the main 
drugs) includes such drugs as pyrimethamine, bigumal, primaquine, 
quinocide, sulfonamides, sulfones, and tetracyclines. These drugs are less 
effective in comparison with main drugs. Their effect develops slowly, 
while resistance of Plasmodium develops quickly. Therefore, drug 
combinations with different mechanism of action are commonly used.  
Primaquine is used to prevent relapse of three-day and four-day 
malaria.  
The drugs influencing upon pre-erythrocytic forms of Plasmodium (for 
instance, pyrimethamine) are used for individual preventive chemotherapy 
in people who live in or travel to malaria risk areas. Blood schizonticides 
(chloroquine, mefloquine, etc.) are also sometimes used with this end in 
view.  
The total preventive chemotherapy of malaria suggests the prevention 
of malaria transmission from the sick person to healthy people through 
mosquito bite. Gametocides (primaquine, pyrimethamine, and quinocide) 
are used for this purpose – to prevent formation of sporozoites in mosquito.  
 
Drugs for Amebiasis Treatment  
 
The causative agent of amebiasis is Entamoeba histolytica, which 
exists in two forms: vegetative and cystic. The transformation of vegetative 
form into cystic occurs in the presence of anaerobic bacterial flora 
(clostridium). Cystic forms, in turn, transform into vegetative amoeba, 
living in the intestinal lumen (without symptoms) and feeding on the 
organic wastes of bacterial origin. Under the influence of aerobic bacteria 
(E. coli), amoeba takes on pathogenic properties. Vegetative forms of 
amoeba secrete proteolytic enzyme which dissolves tissues. It provides the 
formation of invasive forms of amoeba – hematophagous amoebas. A 
significant amount of erythrocytes is observed in the endoplasma of 
invasive forms of amoeba. At this stage, the invasive amoebiasis develops 
when amoeba is present both in the intestinal lumen and in the intestinal 
wall. By hematogenic way, amoeba can penetrate into the liver, lungs, and 
other organs.  
Treatment of amebiasis differs depending on amoeba localization. 
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The drugs which are used to treat amoebiasis are classified as follows:  
1. Drugs which are effective in any localization of amoeba: 
metronidazole .  
2. Drugs of dirrect action which are effective against amoeba localized 
in the intestinal lumen: chiniofonum and intetrix .  
3. Drugs of indirect action which are effective against amoeba 
localized in the both intestinal lumen and intestinal wall: 
tetracyclines .  
4. Drugs acting upon amoeba which is mainly located in the intestinal 
wall and liver: emetine hydrochloride .  
5. Drugs which are mainly effective against amoeba localized in the 
liver: chloroquine .  
Metronidazole  is a drug which is effective in any localization of 
amoeba. The drug was introduced in the medical practice in 1951 as an 
agent for the treatment of trichomoniasis. Metronidazole is also active 
against amoeba, giardia, balantidium, and Helicobacter pylori. 
Metronidazole is not active against cystic forms of amoeba. The drug is 
taken orally 0.25–0.5 g three times a day after a meal. Metronidazole is 
readily absorbed from the gastrointestinal tract and is well metabolized. 
The main route for drug excretion is via kidneys. Insignificant amount of 
metronidazole is excreted by salivary glands, intestine, and mammary 
glands. Metronidazole is manufactured in tablets, solution for intravenous 
administration, and vaginal suppositories. Side effects of metronidazole are 
nausea, diarrhea, metallic taste in mouth, appetite loss, tremor, and 
disturbances of accommodation. Sometime, lesions of skin and mucous 
membranes are possible. Efficacy of metronidazole is low in localization of 
amoeba in the intestinal lumen. In this case, metronidazole is combined 
with chiniofonum. It is necessary to notice that metronidazole inhibits the 
activity of acetaldehyde dehydrogenase and causes accumulation of 
acetaldehyde that results in alcohol intolerance.  
Chiniofonum (yatren)  affects the vegetative and cystic forms of 
amoeba located in the intestinal lumen. The drug is taken orally. 
Gastrointestinal absorption of chiniofonum is low (about 10–15 %), 
therefore, high drug concentration is created in the intestinal lumen. 
Toxicity of yatren is low. Chiniofonum also exhibits significant 
antibacterial and antifungal activity. The drug is used to treat amebic 
dysentery, colitis, and uretritis. Ointments and solutions of chiniofonum are 
used externally in treatment for purulent wound, burns, ulcers, etc.  
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Intetrix  is active against amoeba, Candida, Gram-positive and Gram-
negative bacteria. The drug is used in treatment of intestinal amoebiasis and 
diarrhea. Toxicity of intetrix is low.  
Tetracycline  is an antibiotic which has indirect influence upon 
amoeba. Tetracycline affects the bacterial intestinal microflora which 
utilizes oxygen. Since species of amoeba are anaerobic, they can not live in 
the presense of oxigen. Therefore, tetracycline is an indirect amoebicide. 
Efficacy of tetracycline is lower than the efficacy of direct amoebicides. 
Aminoglycoside monomicine  is also used to treat acute intestinal 
amoebiasis.  
Emetine hydrochloride  is an alkaloid of ipecacuanha. In 
therapeutic doses, emetine inhibits vegetative forms of amoeba but 
practically does not influence upon its cystic forms. The drug quickly 
eliminates the symptoms of amoebic dysentery, but does not prevent the 
relapses. Emetine is administered intramuscularly because oral intake of 
emetine significantly irritates the gastrointestinal mucosa. Emetine is 
eliminated very slowly (more than a month), therefore, the drug is able to 
acummulate in the body. The main sites of emetine accumulation are the 
liver, lungs, and intestinal wall. Emetine does not penetrate the blood-brain 
barrier. Emetine is used in treatment for hepatic, pulmonary, and intestinal 
amoebiasis. The drug does not influence upon amoeba which is located in 
the intestinal lumen or in the brain. The side effects of emetine are nausea, 
vomiting, diarrhea, tachycardia, hypotension, precordialgia, polyneuritis, 
abnormal hepatic and renal functions, etc. 
Chingaminum  (chloroquine) is active against amoeba which is 
located in the liver, bacause the liver can accumulate a high concentration 
of the drug. The characteristics of chingaminum are given in subsection 
“Antimalarial drugs”.  
 
Drugs for Lambliasis  Treatment  
 
Lambliasis (guardiasis) is caused by Lamblia intestinalis. Parasites can 
damage the intestine with the following development of duodenitis and 
enteritis. Also, Lamblia can penetrate into the bile and pancreatic ducts. 
The following drugs are used to treat lambliasis: metronidazole ,  
furazolidone, aminoquinol ,  and albendazole  (Vormil ) .  
Aminoquinol  is a derivative of quinoline. The drug is used in 
treatment of lambliosis, toxoplasmosis, skin leishmaniasis, and systemic 
collagenosis. In lambliasis, aminoquinol is taken orally 20–30 minutes after 
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a meal. After absorption, the drug is excreted with bile into the intestine. 
Simple drug intake results in excretion of the agent with bile during one 
month. The side effects of aminoquinol are dyspepsia, weakness, headache, 
tinnitus, insomnia, leukopenia, liver and kidney failure. 
Pharmacology of albendazole is given in “Anthelmintic drugs”.  
 
Drugs for Trichomoniasis Treatment  
 
 A causative agent of trichomoniasis is Trichomonas vaginalis. The 
disease occurs in the form of colpitis or vulvovaginitis (in women), cystitis, 
stomatitis, colitis, and urethritis. The following drugs are used for 
trichomoniasis treatment:  
– nitroimidazole derivatives: metronidazole , t inidazole ,  
ornidazole ; 
– aminoquinoline derivatives: trichomonacide ; 
– imidazole derivatives: econazole,  miconazole ,  clotrimazole , 
nitazole ; 
– nitrofuran derivatives: furazolidone .  
Tinidazole (Fasigyn)  exhibits high activity against Trichomonas 
vaginalis. Besides, the drug is active against obligate anaerobes. Tinidazole 
is readily absorbed from the gastrointestinal tract. The blood concentration 
of tinidazole is higher than the concentration of metronidazole. The 
duration of tinidazole action is much longer.  
Trichomonacide  has high activity against Trichomonas vaginalis. 
The drug is readily absorbed from the gastrointestinal tract. 
Trichomonacide is mainly used in treatment of urogenital trichomoniasis. 
The drug is taken orally or used topically in the form of suppositories or 
globules. Trichomonacide irritates the mucous membranes.  
The pharmacological characteristics of imidazole derivatives 
(ornidazole, miconazole, econazole, clotrimazole) is given in “Antifungal 
drugs”. Pharmacology of furazolidone is described in “Nitrofuranes”.  
 
Drugs for Toxoplasmosis Treatment  
 
A causative agent of toxoplasmosis is Toxoplasma gondii. There are 
several forms of the disease which are accompanied by lessions of lymph 
nodes, intestine, lungs, eyes, central nervous system, and other organs. 
Toxoplasmosis can result in premature labor, abortion, congenital 
malformations, and stillbirth. To prevent congenital toxoplasmosis, 
chloridinum  and aminoquinol  in combination with sulfonamides  are 
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prescribed to pregnant women. Preventive use of chloridinum and 
aminoquinole is contraindicated during the first 9 weeks of pregnancy due 
to their toxic influence upon the fetus. During this period, sulfonamides are 
used for prevention of fetal infection. Chingaminum  and pentamidine  
are also used to treat toxoplasmosis.  
 
Drugs for Balantidiasis Treatment  
 
A causative agent of balantidiasis is infusorium Balantidium coli 
parasitizing the large intestine. Tetracyclines  and chiniofonum  are 
used to treat balantidiasis. Pharmacological characteristics of these agents 
are given in the corresponding sections.  
 
Drugs for Leishmaniasis Treatment  
 
Leishmaniasis is a protozoal disease which is caused by Leishmania 
donovani (the causative agent of visceral leishmaniasis – kalaazar) and 
Leishmania tronica (the causative agent of skin leishmaniasis). Visceral 
leishmaniasis is accompanied by high temperature, anemia, leukopenia, and 
splenomegaly. Initialy, leishmania parasites cause skin sores or ulcers at the 
site of the bite. If the disease progressies, it attacks the immune system. 
Solusurminum  is the most commonly used agent to treat visceral 
leishmaniasis. It is a preparation of pentavalent antimony. The drug is 
administered intravenously. Solusurminum blocks thiol groups of 
Leishmania enzymes that affects their growth and division. Side effects of 
solusurminum are nausea, headache, skin rash, and agranulocytosis. After 
an overdose of solusurminum, unithiol is administered as an antidote.  
Sodium stibogluconate  is also a preparation of pentavalent 
antimony. The drug is administered intramuscularly or intravenously. Its 
side effects are dyspepsia, vomiting, appetite loss, arterial hypotension, and 
chest pain. 
Glukantim,  pentakarinate  (pentamidine),  neostibazine, 
and pentostim  are also preparations of pentavalent antimony for visceral 
leishmaniasis treatment.  
Pentakarinat  (pentamidine)  is administered intramuscularly and 
in inhalations. Mechanism of drug action is associated with blocking 
thymidylate synthetase that inhibits of DNA synthesis. Pentakarinat is used 
to treat visceral and skin leishmaniasis, to prevent pneumonia in AIDS 
patients, and to treat trypanosomiasis, also known as African sleeping 
sickness. Side effects of pentakarinat are cough, dyspnea, bronchospasm, 
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skin rash, metallic taste in the mouth, dizziness, arterial hypotension, acute 
pancreatitis, anemia, leukopenia, thrombocytopenia, increased blood urea 
nitrogen level and creatinine. 
All above preparations of pentavalent antimony may be used to treat 
skin leishmaniasis. Also, the following agents are used to treat skin 
leishmaniasis: quinacrine, monomycin, neomycin, metronidazole, 
and aminoquinol.     
  
Drugs for Trypanosomiasis Treatment  
 
Causative agents of trypanosomosis are Tripanosoma gambiense and 
Trypanosoma brucei rhodesiense (sleeping sickness) and Trypanosoma 
cruzi (Chagas disease).  
Melarsoprol is used as a primery agent for treatment of sleeping 
sickness. It is arsenicum derivative which easily penetrates through blood-
brain barrier. Besides, pentakarinat (pentamidine) and suramin are used to 
treat African trypanosomosis. But these drugs do not penetrate into the 
central nervous system and, therefore, are effective only at early stages of 
the disease (when the brain is not affected by Trypanosoma). All these 
drugs are toxic and cause a large number of side effects.  
To treat Chagas disease (spread in South America), primaquine and 
antibiotic puromycin are used.  
 
Drugs for Chlamydiosis Treatment  
 
Chlamydia are intracellular parasites of humans and animals. There 
are three species of Chlamydia which are causative agents for humans: 
Chlamydia trachomatis, Chlamydia psittici and Chlamydia pneumonia. 
Chlamydia trachomatis is the most common sexually transmitted infection. 
Chlamydia pneumonia causes pneumonia. Chlamydia psittici mainly 
affects birds.  
Chlamydia trachomatis can cause a recurrent ocular infection – 
trachoma. Other serological forms of Chlamydia cause lymphogranuloma 
venereum, conjunctivitis, child pneumonia, urethritis, endometritis, 
salpingitis, cervicitis, and epididymitis (inflammation of the epididymis). 
During pregnancy, Chlamydia can commonly cause premature labor and 
endometritis. Moreover, chlamydial infection may be associated with septic 
arthritis.  
To treat chlamydiosis, tetracycline  and erythromycin  are aminly 
used. Penicillin is ineffective in that disease. Also, rifampicin, 
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chloramphenicol,  and sulfonamides  are used. Doxycycline  and 
azithromycin  are drugs of choice for the treatment of urogenital 
chlamydiosis.    
 
Table 7 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product  
Chingaminum Orally 0.25–0.5 g 1–2 times 
daily; 
intramuscularly or intra-
venously 0.5 g  
Tablets 0.25 g; 
ampoules 5 ml of 5 % 
solution  
Chloridinum 0.01 g 3 times daily (for 
malaria treatment); 
0.025 g 2–3 times daily (for 
toxoplasmosis treatment) 
Tablets 0.01 or 0.025 g 
Chinini 
hydrochloridum 
Orally 0.5 g  2 times daily; 
subcutaneously 1.0 g  2 times 
daily; 
intravenously 1 ml in 20 ml 
of 40 % glucose solution  
Tablets 0.25 or 0.5 g; 
ampoules 1 ml of 50 % 
solution  
Primachinum Orally 0.009 g 3 times daily Tablets 0.009 g 
Metronidazolum Orally 0.25–0.5 g 2–3 times 
daily; 
intravenously drop-by-drop 
0.5 g 3 times daily 
Tablets 0.25 g; 
 
bottles 100 ml of 0.5 % 
solution  
Emethini 
hydrochloridum 
Intramuscularly or subcuta-
neously 0.015 g twice a day 
Ampoules 1 ml of 1 % 
solution  
Furazolidonum Orally 0.1 g 4 times daily Tablets 0.05 g 
Solusurminum Intravenously slowly, 
intramuscularly or subcuta-
neously 0.1–0.12 g/kg once 
a day 
Ampoules 10 ml of 20 % 
solution  
 
 
Antifungal Drugs 
 
Fungal infections (mycoses) are very common. Sick people, animals, 
and environment (plants, soil, etc.) can be the source of infection. Infection 
occurs through the injured skin, gastrointestinal tract, respiratory tract. 
Besides, potential pathogens, especially of the genus Candida, are located 
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on the skin, in the upper respiratory system, on the mucous membranes of 
sex organs, and in the gastrointestinal tract. The cause of saprophytic flora 
transformation into pathogens is the reduction of the human body resistance 
due to immunodeficiency (at severe diseases, hormonal therapy, and the 
use of cytostatic drugs or some antibiotics). 
 
Antifungal drugs are classified into the following groups:  
1. Drugs for treatment of systemic or deep mycoses: 
 – antibiotics: amphotericin B, mycogeptin, and amphogluca-
minum ; 
 – azole derivatives: miconazole, ketoconazole  (nizoral ),  
clotrimazole , i traconazole ,  and  f luconazole ; 
2. Drugs for treatment of dermatomycoses:  
 – antibiotics: griseofulvin ; 
 – azole derivatives: ketoconazole (nizoral) ,  i traconazole ,  
miconazole, f luconazole ,  and  clotrimazole ; 
– N-methylnaphthaline derivatives: terbinafine (Lamisil ); 
 – nitrophenol derivatives: nitrofungin ;  
 – thiocarbamate derivatives: chinofungin ; 
 – undecylenic acid derivatives: ointments “Zincundanum”  and 
“Undecinum” ;   
 – iodine preparations: alcohol solution of  iodine  and 
potassium iodide .  
3. Drugs for treatment of mycoses caused by fungi Candida:  
 – antibiotics: nystatin, levorin, amphotericin B, and 
natamycin (Pimafucin) ; 
 – azole derivatives: i traconazole, clotrimazole ,  ketoconazole ,  
and  miconazole ; 
 – bis-quaternary ammonium salts: decaminum ; 
 – halogens, non-organic acids, and alkalis.  
 
Drugs for Systemic or Deep Mycosis Treatment 
 
Systemic or deep mycoses affect the liver, bones and joints, 
gastrointestinal tract, brain and meninges, lymph nodes, etc. Sometimes, 
systemic mycoses develop in septic form. The deep mycoses are rare and 
difficult to treat. More than half of them are caused by saprophytic Candida 
activity. Lesser are deep mycoses caused by the causative agents of 
coccidioidomycosis, paracoccidioidomycosis, histoplasmosis, cryptoco-
ccosis, blastomycosis, etc.  
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Amphotericin B  is one of the main drugs for treatment of deep 
mycoses. It is a polyen antibiotic which is produced by Streptomyces 
nodosum. Amphotericin B does not affect bacteria, rickettsia, and viruses. 
Mechanism of action is associated with violation of transport function and 
permeability of fungi cell membrane. Selectivity of antifungal action occurs 
due to the fact that amphotericin B interacts with the main lipid of fungal 
cell wall – ergosterol. The main lipid of human and bacterial cells is 
cholesterol. Antifungal effect of amphotericin B is characterized as 
fungistatic. This antibiotic is practically not absorbed in the gastrointestinal 
tract. Amphotericin B is administered intravenously and into body cavities, 
applied topically, and used in inhalations. The drug does not penetrate 
through the blood-brain barrier. About 95 % of the drug, circulating in the 
blood, bind to plasma proteins. The main organ of amphotericin B 
biotransformation is the liver. The drug elimination from the body is slow 
(about 20–40 % of administered dose during a week). The therapeutic 
indications for amphotericin B are hystomycosis, coccidioidomycosis, 
visceral candidomycosis, blastomycosis, and deep generalized 
trichophytosis. 
Amphotericin B is a very toxic drug. Therefore, the drug is 
administered intravenously only in cases of life threatening mycosis. 
Amphotericin B is dissolved by 5 % glucose solution and administered 
intravenously drop-by-drop during 3–6 hours. The drug is administered 
once in two days or twice a week. Side effects are headache, fever, 
dyspepsia, hypotension, nephrotoxicity, anemia, hypokalemia, disturbances 
of hepatic function, nephrotoxicity, thrombophlebitis, and allergic 
reactions. Amphotericin B is contraindicated in hepatic and renal diseases. 
Despite identical mechanism of action, amphoglucaminum  is a less 
toxic drug than amphotericin B. Amphoglucaminum is used to treat 
mycoses of the urinary, gastrointestinal, and respiratory tracts. The drug is 
administered during 10–14 days. To treat chronic (granulomatous) 
candidiasis and deep mycoses, amphoglucaminum is used during 3–4 
weeks. Amphoglucaminum is taken orally. The drug is gradually absorbed 
from the gastrointestinal tract with maximum blood concentration in 2–3 
days. Amphoglucaminum is excreted with urine during 10 days. Side 
effects are identical with amphotericin B but less expressed.  
Mycogeptin  has similar properties with amphotericin B. Mycogeptin 
is taken orally during 10–14 days or applied topically. The drug is partially 
absorbed in the gastrointestinal tract and excreted with urine. The 
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therapeutic indications for mycogeptin are visceral mycoses, sepsis caused 
by Candida, aspergilosis, and geotrichosis. Side effects are gastrointestinal 
distress, renal disfunction, and allergic reactions.  
Miconazole  is a derivative of imidazole. The drug is taken orally and 
administered intravenously or subarachnoidally to treat deep mycoses. 
Also, miconazole is applied topically to treat vaginal mucosa damage 
caused by Candida and for the treatment of dermatomycoses. The side 
effects of miconazole are thrombophlebitis, nausea, anemia, 
hyperlipidemia, hyponatremia, leukopenia, and allergic reactions.  
Ketoconazole (Nizoral)  is readily absorbed from the 
gastrointestinal tract. About 90 % of the absorbed drug bind to plasma 
proteins. The permeability of the drug through the blood-brain barrier is 
low. Ketoconazole is metabolized in the liver and excreted with urine and 
bile. The drug is used to treat deep mycoses and lesions of mucous 
membranes by Candida. Mechanism of action is associated with inhibition 
of ergosterol, triglyceride, and phospholipid biosynthesis that violates the 
structure of the fungal cell membrane. Side effects of ketoconazole are 
dyspepsia and hepatic dysfunction.  
Itraconazole  is a triazole derivative. The drug is taken orally. The 
drug absorption from the gastrointestinal tract is high, but permeability 
through the blood-brain barrier is low. Itraconazole is extensively 
metabolized by the liver. A large number of metabolites and unchanged 
itraconazole are excreted through the kidneys. Side effects are dyspepsia, 
headache, hepatic dysfunction, and allergic reactions. 
Fluconazole  is also a derivative of triazole. Fluconazole is one the 
most effective antifungal drugs. The drug is taken orally. Fluconazole 
easily penetrates through the blood-brain barrier. Unchanged fluconazole is 
excreted from the body through the kidneys. The therapeutic indications for 
fluconazole are fungal meningitis, coccidioidomycosis, candidomycosis, 
etc. Side effects of fluconazole are dyspepsia, hepatotoxicity, and skin 
allergy.  
 
Drugs for Dermatomycosis Treatment  
 
In dermatomycoses, the skin, nails, and hair are affected. The 
causative agents of dermatomycoses are Trichophyton violaceum, 
Microsporum lanosum, Achorion schonlein, different species of 
Epidermophyton, etc. Onichomycoses (fungal lesions of nails) are widely 
spreaded. Onichomycoses are caused by dermatophytes (most commonly 
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by Trichophyton rubrum), Candida, and mild fungi (Scopulariopsis 
brevicaulis, Aspergillus spp., etc.). The fungi of the genus Candida and 
sometimes molds (causative agents of aspergillosis) are the most common 
pathogens among saprophytic fungi.  
The most effective drugs for dermatomycoses treatment are 
terbinafine (Lamisil) ,  i traconazole , ketoconazole (Nizoral),  
and griseofulvin . Micospor , cyclopirox , amorolfine , and 
t ioconazole  are used topically. 
Griseofulvin  is an antibiotic which is produced by mold-forming 
fungi Penicillium nigricans. The drug has narrow antifungal spectrum and 
is active against such causative agents of dermatomycoses as Trichophyton, 
epidermofiton, mikrosporum, and favus. Griseofulvin is ineffective against 
Candida and causative agents of deep mycoses. Mechanism of action is 
associated with violation of nucleic acid synthesis due to griseofulvin 
interaction with guanidine bases of RNA. The fungal resistance to 
griseofulvin does not develop in general. Griseofulvin is taken orally. The 
drug is readily absorbed from the gastrointestinal tract. Griseofulvin 
accumulates in the tissues, synthesizing keratin. Therefore, stratum 
corneum, nails, and hair become resistant to dermatomycetes. But in the 
upper epidermal layers, griseofulvin is determined only in 1–2 months after 
the start of therapy. Moreover, griseofulvin does not penetrate into the nail 
plates. Therefore, nail avulsion involves application of keratolytic agents. 
The daily dose of griseofulvin is divided into 4 intakes to provide the stable 
high drug concentration in the blood. Although a single drug intake of the 
daily dose is also possible. The duration of treatment with griseofulvin is 
1–8 months. Also, liniment with griseofulvin is used topically.  
The main routes of griseofulvin excretion from the body are kidneys 
and an intestine. A main part of the antibiotic dose undergoes the drug 
biotransformation in the liver. 
The side effects of griseofulvin are headache, nausea, insomnia, 
disorientation, photodermatosis, fear, leukopenia, eosinophilia, etc. It is 
necessary to notice that nowadays the clinical use of griseofulvin is 
significantly restricted due to its cancerogenic property. 
Terbinafine (Lamisil)  is a derivative of N-methylnaphthalene. The 
drug affects ergosterol synthesis and formation of fungal membranes due to 
the influence upon the early steps of synthesis and violation of squalene 
accumulation. Lamisil exhibits the fungicidal effect. The spectrum of 
antifungal action includes dermatophytes and Candida. Terbinafine is taken 
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orally. The drug is readily absorbed from the gastrointestinal tract and 
accumulates in the skin, subcutaneous fat, nail plates, hair follicles, and 
sebaceous glands. Terbinafine is metabolized in the liver and excreted 
through the kidneys. Lamisil cream is used topically twice a day.  
The therapeutic indications for terbinafine are dermatomycosis of 
different localization and candidiasis. Most commonly the drug is used to 
treat onychomycosis and candidiasis of mucous membranes. The course of 
treatment lasts from 2 to 6 months. Lamisil is not recommended for 
pregnant women and for nursing mothers. The side effects of terbinafine 
are dyspepsia and allergic reactions. External drug use can cause itching 
and red skin. 
Nitrofungin  is a nitrophenol derivative. The drug is used topically as 
an alcoholic solution. Antifungal activity of nitrofungin is low.  
The following drugs are also used topically for treatment of mycoses: 
miconazole, clotrimazole , preparations of undecylenic acid (ointments 
“Zincundanum”, “Mycoseptin”, “Undecinum”), and iodine 
preparations (alcoholic iodine solution, and potassium iodide).  
 
Drugs for Candidiasis  Treatment  
 
Candidiasis most commonly affects mucous membranes of the 
gastrointestinal tract, bronchi, sex organs, and skin. The main causative 
agent of candidiasis is Candida albicans.  
Antibiotics nystatin  and levorin  exhibit fungiostatic and fungicidal 
effects. These drugs violate permeability of the fungal cell membrane. 
These drugs are characterized by low intestinal absorption. Nystatin and 
levorin are used orally to treat gastrointestinal candidiasis or to prevent 
candidiasis in patients treated by antibacterial drugs of broad spectrum. To 
treat candidiasis of oral cavity of sex organs, nystatin and levorin are used 
in solutions for syringing or in suppositories.  
Toxicity of nystatin is very low. Its side effects are dyspepsia and 
allergic reactions. Levorin has a higher toxicity. But resistance of Candida 
to levorin develops more slowly. Levorin is also used in treatment of 
trichomoniasis and in therapy of patients with prostate adenoma.  
Natamycin (pimafucin)  is a polyene antibiotic with broad 
spectrum of antifungal action. Candida is especially highly sensitive to 
natamycin. Dermatophytes are less sensitive to natamycin. Pimafucin is 
used topically in treatment for candidiasis of the skin and mucous 
membranes. Suppositories with natamycin are used in treatment for vaginal 
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candidiasis, and tablets – in treatment for intestinal candidiasis (drug is 
taken orally 4 times a day). To treat dermatomycoses, pimafucin is used in 
combination with griseofulvin. Toxicity of pimafucin is low. The side 
effects are dyspepsia and irritation and burning in case of local use. 
Clotrimazole  is imidazole derivative. It is a highly toxic agent 
which is used topically to treat candidiasis, resistant to polyene antibiotics.  
Decaminum  is bis-quaternary ammonium salt. It is a detergent with 
high surface activity. Decaminum violates permeability of fungal 
cytoplasmic membrane and due to this exhibits bactericidal, fungistatic, and 
fungicidal effects. The ointment with decaminum is used to treat fungal 
lesions of skin 1–2 times a day during 2–3 weeks. Decaminum is also 
effective in inflammatory lesions of the oral cavity, throat, and vagina.  
 
Table 8 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product  
Nystatinum Orally 500,000 IU 3–4 times 
daily; 
for rectal or vaginal 
introduction 1 suppository 2 
times daily; 
ointment for applying on the 
skin 
Tablets 250,000 or 500,000 
IU; 
suppositories 250,000 or 
500,000 IU; 
 
ointment 1 % – 15.0 g  
Amphotericinum B Intravenously drop-by-drop 
100–1,000 IU/kg (in 450 ml 
of 5 % glucose solution) 2–3 
times per week; 
ointment for applying on 
injured parts of the skin 
Vials with 50,000 IU of 
powder for injection; 
 
 
ointment 15.0 or 30.0 g (1 g 
contains 30,000 IU of 
amphotericinum B) 
Griseofulvinum Orally 1 tablet 4 times daily; 
liniment for applying on 
injured parts of the skin 
Tablets 0.125 g; 
liniment 2.5 % – 30.0 g 
Fluconazole Orally or intravenously drop-
by-drop 0.05–0.4 g once a day 
Capsules 0.05; 0.1; 0.2 g; 
vials 50; 100 or 200 ml  of 
0.2 % solution 
Ketoconazole Orally 0.2–0.4 g once a day Tablets 0.2 g 
Itraconazole Orally 0.1–0.2 g once a day Capsules 0.1 g 
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Anthelmintic Drugs 
 
More than 250 species of worms can parasitize in a human body. The 
worms cause an enormous damage for the host organism due to the release 
of toxins and mechanical damage of the internal organs. Helminthiases can 
cause anemia, allergic reactions, disordes of the central nervous system 
activity, gastrointestinal distress, functional disturbances of the liver, lungs, 
eyes, blood and lymphatic vessels, etc. The incidence of worm infections is 
quite high.  
Depending on localization of worms in the human organism, there are 
intestinal and extraintestinal helminthiases. Depending on the types of 
worms, which cause the disease, helminthiases are divided into 
nematodiasis (causative agents are roundworms or nematodes), cestodiasis 
(causative agents are flatworms or cestodes), and trematodiasis (causative 
agents are flukes or trematodes).  
 
Drugs for Intestinal Helminthiasis Treatment 
 
Drugs for Intestinal  Nematodiasis Treatment  
 
The following drugs are used to treat intestinal nematodiasis: 
mebendazole , albendazole , medamin, levamisole, piperazine, 
naftamon,  pervinium pamoate , and pyrantel  pamoate .  
Mebendazole (Vermox)  is a benzimidazole derivative. The drug 
has a broad spectrum of anthelmintic action which includes main types of 
roundworms: Ascaris lumbricoides (causative agent of ascariasis), 
Enterobius vermicularis (enterobiasis), Trichocephalus trichiurus 
(trichocephaliasis), Ancylostoma duodenale (ankylostomiasis), and 
Strongyloides stercoralis (strongyloidiasis). Mebendazole is active against 
infections, caused by cestodes Taeniarhynchus saginatus (bovine 
tapeworm), Hymenolepis nana (dwarf tapeworm), and Taenia solium (pork 
tapeworm). Vermox affects both worms and their eggs.  
The mechanism of mebendazole action is associated with violation of 
glucose absorption by worms that results in disturbances of energy 
metabolism. At the same time, the violation of glucose absorption by 
mammalian cells is not observed. The inhibition of motor activity and death 
of helminths develop gradually. The excretion of dead parasites with feces 
is observed during several days. 
Mebendazole is taken orally during or after meals. Gastrointestinal 
absorption of mebendazole is low (not more than 10 %). The absorbed part 
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of the drug undergoes hepatic metabolism and is excreted by the kidneys 
within 1–2 days. For better absorption, an intake of mebendazole 
suspension in sunflower oil is recommended. The treatment with 
mebendazole does not require a special diet. The single mebendazole intake 
is used in case of invasion by Ascaris lumbricoides or Enterobius 
vermicularis. Repeated intake of the drug is recommended in two weeks. 
To treat other helminthiases, the course of treatment with mebendazole 
varies depending on the type of helminth.  
The therapeutic indications for mebendazole are intestinal 
nematodiasis (ascariasis, enterobiasis, ankylostomiasis, trichocephaliasis, 
and strongyloidiasis), intestinal cestodiasis (teniasis, teniarinchiasis, and 
hymenolepiasis), extraintestinal nematodiasis (filariasis and trichinelliasis), 
and extraintestinal cestodiasis (cysticercosis and echinococcosis). 
 
Albendazole (Vormil)  is effective in intestinal nematodiasis,  
cysticercosis, and echinococcosis. Vormil also affects the eggs of Ascaris 
lumbricoides, Ancylostoma duodenale, and Trichocephalus trichiurus 
(whipworm). The drug violates glucose utilization by helminths. Taken 
orally, albendazole is easily absorbed from the gastrointestinal tract and 
metabolized in the liver. The drug metabolites are excreted mainly by the 
kidneys. The side effects of albendazole are headache, diarrhea, dizziness, 
and insomnia. Prolonged intake of albendazole can cause leukopenia, 
vomiting, skin rash, abdominal pain, and alopecia.  
 
Pyrantel  pamoate  is a pyrimidine derivative. The drug is used at 
invasion by roundworms. Pyrantel violates neuro-muscular transmission 
due to cholinesterase inhibition. It results in spastic paralysis of helminths. 
Pyrantel is taken orally. The degree of intestinal drug absorption is about 
50 %. The main route of excretion is the intestine. The therapeutic 
indications for pyrantel are ascariasis, enterobiasis, ancylostomiasis, and 
trichostrongyliasis. Side effects of pyrantel are dyspepsia, loss of appetite, 
and headache. 
 
Levamisole (decaris )  is commonly used in ascariasis treatment. 
The drug causes depolarization of helminth muscular membranes that 
results in muscular paralysis. Besides, levamisole inhibits the activity of 
fumaratereductase and violates metabolism of the helminths. Simple drug 
intake provides the full dehelminthization in 90–100 % of patients with 
ascariasis. Levamisole activity is lower in ancylostomiasis and 
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strongyloidiasis. Levamisole effects positively in patients with 
extraintestinal helminthiasis, for instance with filariasis. 
The side effects of levamisole are abdominal pain, nausea, vomiting, 
and headache.  
Levamisole also has immunomodulatory effect. The drug normalizes 
function of macrophages and T-lymphocytes in patients with 
immunodeficiency. The course of treatment with levamisole lasts from 2–3 
weeks up to a year. Prolonged therapy with levamisole can be aggreveted 
by a lot of serious side effects: insomnia, disorders of taste and smell, skin 
rash, and agranulocytosis.   
Pyperazine adipinate  is widely used to treat ascariasis and 
enterobiasis. Pyperazine paralyzes the neuromuscular systems of helminths 
that prevents their movement through the intestine and penetration into the 
bile ducts. Also, pyperazine stimulates the intestinal peristalsis that 
provides favorable conditions for evacuation of helminths from the 
intestine. The drug is readily absorbed from the intestine, its metabolites are 
excreted with the urine. The treatment with pyperasine does not require a 
special diet and intake of laxative drugs. An efficacy of pyperazine in 
ascariasis is 90–100 %. Pyperazine is a low toxic drug. Its side effects are 
dyspepsia and headache.  
Naftamon  is a monoquaternary ammonium compound. The drug is 
highly effective in ascariasis, enterobiasis, ankylostomiasis, and 
trichostrongyliasis. Mechanism of action is associated with inhibition of 
neuromuscular transmission of helminths. Naftamon is characterized by 
low ability to absorb from gastrointestinal tract and laxative activity. A 
very bitter taste of naftamon is the cause of nausea and vomiting. Naftamon 
is prescribed for oral intake for 1–2 hours before a meal.  
Pervinium pamoate  is mainly used to treat enterobiasis and 
strongyloidiasis. The drug inhibits aerobic respiration of helminths and 
violates the utilization of exogenic glucose. The absorption from 
gastrointestinal tract is low. Pervinium seldom causes the side effects.  
 
Drugs for Intestinal  Cestodiasis Treatment  
 
The drugs to treat intestinal cestodiasis are praziquantel ,  
niclosamide (phenasalum), extract of  male fern , pumpkin 
seeds , etc.  
Niclosamide (phenasalum)  is active against Taenia solium, 
Taeniarincus saginatus, Diphyllobothrium latum, etc. The drug inhibits 
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phosphorylation in mitochondria of cestodes, utilization of oxigen and 
glucose by helminths, and paralyzes their neuromuscular system. Besides, 
niclosamide decreases the resistance of helminths to proteolytic enzymes of 
the gastrointestinal tract that provokes degradation of the coating tissues of 
helminths. The treatment with niclosamide requires a specific patient 
preparation – carbohydrate diet because proteins bind to drug and inactivate 
it. Overnight, the patient drinks only tea and fruit juice and gets an enema. 
Niclosamide is taken in the morning on an empty stomach. Laxative drugs 
are given only in case of teniasis (to prevent cysticercosis). Niclosamide is 
readily absorbed from the gastrointestinal tract. About 25–30 % of the drug 
is excreted from the body in urine, another part – in feces. Side effects of 
niclosamide are nausea, vomiting, and abdominal pain.  
Praziquantel  (bil tricide)  is highly effective drug to treat 
intestinal cestodiasis (teniasis, diphyllobothriasis, teniarinchiasis, and 
hymenolepiasis), extraintestinal trematodiasis, and cysticercosis. 
Praziquantel increases permeability of calcium in helminthic cell 
membranes. Calcium entrance causes a short-time increase of muscular 
activity which is replaced by spastic paralysis of helminths. Praziquantel is 
readily absorbed from the gastrointestinal tract, undergoes fast hepatic 
metabolism, and is being excreted by the kidneys. Side effects of 
praziquantel are dyspepsia, headache, and skin rash. The drug is 
contraindicated in first trimester of pregnancy and for nursing mothers.  
The extract of  the male fern  is obtained from the rhizome of this 
plant. The extract contains dezaspidin, dezaspidiol, and other derivatives of 
phloroglucinol. The taken orally drug is practically not absorbed from the 
gastrointestinal tract. However, the presence of fats can increase the 
gastrointestinal absorption of the extract that results in poisoning. The 
extract of the male fern causes the muscular paralysis in helminths, 
therefore, parasites can not attach to the intestinal wall. The extract of the 
male fern is used to treat teniasis, diphyllobothriasis, teniarinchiasis, and 
hymenolepiasis. Due to high toxicity, the treatment by the extract of the 
male fern is carried out according to certain regimen and only in the 
hospital. Two days before treatment, a special diet with easily digestible 
meatless products is prescribed to a patient. In the evening before the drug 
intake, a patient drinks a cup of tea with rusk. The laxative drug is 
prescribed for the night. In the morning, the patient receives the cleansing 
enema and takes the drug (required number of capsules within 30 minutes). 
The capsules are washed down by a solution of sodium hydrocarbonate. It 
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is necessary for pyloric relaxation and increase of drug evacuation rate 
from the stomach into the intestine. After 1–1.5 hours, the patient receives 
the laxative drug. If laxative effect does not develop in 3 hours, the patient 
receives the cleansing enema. Side effects of the extract of the male fern 
are headache, vomiting, diarrhea, convulsions, paralysis, respiratory 
depression, atrophy of the optic nerve, heart disorders, and collapse. Due to 
high toxicity, the extract of the male fern is used seldom.  
Mebendazole  may be used to treat some cases of cysticercosis. 
 
Drugs for Intestinal  Trematodiasis Treatment  
 
Ethylene tetrachloride  and praziquantel  are used to treat 
metagonimosis (caused by Metagonimus yokogawai).  
Ethylene tetrachloride  is taken orally. The drug absorption from 
the gastrointestinal tract is low. The special fat-free and carbohydrate-rich 
diet should bt used during 1–2 days to prepare a patient to treatment. Also, 
alcohol is contraindicated during this time. In 15–20 minutes after ethylene 
tetrachloride intake, the patient receives saline laxative drug. Ethylene 
tetrachloride is also effective in ancylostomiasis.  
  
Drugs for Extraintest inal Helminthias is Treatment 
 
Drugs for Extraintestinal  Nematodiasis Treatment  
 
Filariasis is the most common extraintestinal nematodiasis. There are 
several causative agents of filariasis: Wucherichia Bancrofti and Brugia 
malayi affect the lymphatic system; Loa Loa parasitizes in the 
subcutaneous fat; Onchocerca volvulus parasitizes in the subcutaneous fat 
and in the eyes. Other widely spread extraintestinal nematodiasis is 
trichinelliasis at which Trichinella spiralis affects the skeletal muscles 
(larval stage) and the intestine (mature stage).  
To treat extraintestinal nematodiasis, diethylcarbamazine  
(ditrazinum)  and ivermectin  are used.  
Diethylcarbamazine  is an effective drug for filariasis treatment 
(the highest activity against microfilariae). The drug is easily absorbed 
from the gastrointestinal tract, it undergoes partial biotransformation and is 
excreted in the urine within 2 days. Ditrazinum inhibits the ability of 
microfilariae to resist phagocytosis. Ditrazinum  exhibits a nematicidal 
effect. However diethylcarbamazine provides the marked therapeutic effect 
only at early stages of the disease. The side effects of diethylcarbamazine 
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are headache, weakness, nausea, and vomiting. These complications are 
caused by toxic influence of decomposition products of microfilariae and 
rapidly disappear.  
Ivermectin  is highly active againt microfilariae and Strongyloides 
stercolaris, but not active against macrofilariae. Ivermectin is semisynthetic 
macrocyclic lactone compound. The drug is taken orally. Therapeutic effect 
develops after a single intake. Ivermectin causes the flaccid paralysis of 
helminths due to inhibition of GABA. The highest drug activity develops 
when treating onchocercosis (blinding filarial disease or river blindness). 
The side effects of ivermectin are fever, drowsiness, dizziness, headache, 
bronchospasm, etc.  
There are no effective drugs for trichinelliasis treatment. Certain 
positive effect in this case is possible for mebendazole .  
 
Drugs for Extraintestinal  Trematodiasis Treatment  
 
Schistosomiasis is the most common extraintestinal trematodiasis. The 
causative agents of schistosomiasis are Schistosoma mansoni, Schistosoma 
haematobium, and Schistosoma japonicum. These parazites affect the blood 
vessels that results in disorders of internal organs (intestine, liver, lungs, 
spleen, urogenital system, etc.).  
The most effective drug for schistosomiasis treatment is 
praziquantel  (bil tricid) . The drug is also effective in other 
extraintestinal trematodoses:  
– opisthorchiasis (causative agent is Opisthorchis felineus which 
affects the liver and pancreas); 
– clonorchiosis (Clonorchis sinensis parasitizes also in the liver and 
pancreas); 
– paragonimiasis (Paragonimus Westermani affects the brain, lungs, 
and lymphatic system); 
– fascioliasis (Fasciola hepatica parasitizes in the liver and 
gallbladder).  
Besides, praziquantel is used to treat metagonimiasis. The 
pharmacological characteristics of praziquantel is given above. 
Antimony sodium tartrate  is a drug containing antimony. The 
drug is administered intravenously, slowly, daily during 20 days. Antimony 
sodium destroys helminth larvae which are located in eggs. Also, the drug 
interacts with thiol groups of enzymes, and due to this, inhibits the vital 
functions of helminths. Antimony sodium tartrate is a toxic agent and 
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commonly causes side effects. The drug may cause phlebitis. Accidental 
subcutaneous administration of its solution causes sharp pain and tissue 
oedema. Weakness, headache, extrasystoles, metallic taste, nausea, 
muscular and joint pain, hypotension, insomnia, skin rash, cough, chest 
pain, and anaphylaxis are also possible side effects of antimony sodium 
tartrate. The drug is contraindicated in patients with diseases of heart, liver, 
and kidneys, in pregnant women, and during menses. In case of drug 
overdose, unithiol is used as an antidote. 
Chloxilum  is an effective agent in treatment for opisthorchiasis and 
fascioliasis in which helminths affect the liver, bile ducts, and pancreas. 
Chloxilum reduces the helminth resistance to the action of helminth 
proteolytic enzymes that results in death of helminths. The drug is taken 
orally. Patient preparation to treatment lasts 1–2 days, and duration of 
therapy with chloxilum is 2 days. Within this time, a patient adheres to the 
fat-free diet and excludes alcohol. Therapeutic efficacy of chloxilum is 35–
40 %. In significant number of patients, only reduction in invasion severity 
is observed. The helminth eggs can be released from the body during 3 
months after treatment. Taken orally chloxilum is slowly and incompletely 
absorbed from the intestine. A main part of the taken dose is excreted from 
the intestine in feces during the first day. Another part of the drug, which 
has reached the systemic blood circulation, is accumulated in the body and 
excreted within 6–28 days. The side effects of chloxilum are headache, 
light inebriation, drowsiness, pain in the liver and heart, and allergic 
reactions. Chloxilum is contraindicated in patients with diseases of heart, 
liver, and in pregnant women.  
Bithionol  and emetine hydrochloride are used for treatment of 
fascioliasis. 
Bithionol is a drug of choice for paragonimiasis treatment. Typical 
side effect of this drug is diarrhea.  
 
Drugs for Extraintestinal  Cestodiasis Treatment  
 
In extraintestinal cestodiasis treatment, some success has been recently 
achieved. Thus, therapy with mebendazole  and albendazole  exhibits 
positive results in treatment for echinococcosis and cysticercosis. 
Praziquantel  is used to treat cysticercosis, but the drug is ineffective 
when helminths depoint in the spinal cord and into the cerebral ventricles.  
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Table 9 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product 
Mebendazolum Orally 0.1 g once (only for 
treatment of enterobiasis) or 
0.1–0.4 g  2–3 times a day 
Tablets 0.1 g  
Piperazini 
adipinas 
Orally 1.5–2.0 g 2 times a day Tablets 0.2 or 0.5 g  
Phenasalum Orally 2.0 g Tablets 0.25 g 
Ditrazini citras Orally 0.002 g/kg 3 times a 
day 
Tablets 0.05 or 0.1 g 
Praziquantel Orally 0.025–0.04 g/kg 
 
Tablets 0.6 g 
Chloxilum Orally 0.06 g/kg Powder  
 
 
Antitumoral Drugs 
 
Antitumoral drugs are agents with different chemical structure which 
are able to inhibit the division of malignant cells in various stages of cell 
cycle. These drugs are used in chemotherapy for different oncological 
diseases. According to medical statistics, malignant solid tumors and blood 
diseases rank second among the causes of human death.  
Nowadays, about 200 antitumoral drugs are used in oncology. But 
drugs which are fatally toxic for malignant cells and simultaneously safe 
for normal body cells are still not developed. Therefore, one of the most 
important principles for modern chemotherapy is a simultaneous use of 
several drugs with different chemical structures and mechanisms of action. 
This enables to increase antitumoral activity and to reduce the toxicity of 
the drugs.   
Classification of antitumoral drugs is as follows:  
1.    Cytotoxic drugs.  
1.1. Alkylating agents: 
– chloroethylamines: embichine (chlormethine),  sarcolysin  
(melphalan), dopanum (uramustine, chlorethylamino-
uracil),  chlorbutinum (chlorambucil ),  cyclophosphane  
(cyclophosphamide),  and  prospidine ; 
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– ethylenimines: thiophosphamide  (ThioTEPA), and  
thiodipine ; 
– methanesulphonic acid derivatives: myelosanum (busulfan),  
and  myelobromol ;  
– nitrosourea derivatives: nitrosomethylurea, lomustine, and  
carmustine . 
1.2. Antimetabolites:  
– folic acid antagonists: methotrexate ; 
– purine antagonists: mercaptopurine ; 
– pyrimidine antagonists: phthoruracilum (f luorouracil ) ,  
cytarabine, and  f torafur (tegafur) .  
1.3. Cytotoxic antibiotics: dactinomycin, rubomycin, carmino-
mycin, olivomycin,  bruneomycin, bleomycin,  
epirubicin, and  mitomycin .  
1.4. Cytotoxic drugs of plant origin:  
– Vinca rosea alkaloids: vinblastine and  vincrist ine ;  
– taxanes (alkaloids of yew-free): pacli taxel  (taxol),  
docetaxel ,  and  taxotere ; 
– podophyllotoxin (obteined from Podophyllum peltatum): 
etoposide, teniposide,  and  podophyll ine ;  
– alkaloids of Colchicum autumnale: colchamine  and  
colchicine .  
1.5. Other synthetic cytotoxic drugs: cisplatin, carboplatin,  
dacarbazine, and  procarbazine .   
2.    Hormones and their antagonists:  
– androgens: testosterone propionate , testenate, 
tetrasterone, and  medrotestrone propionate ;  
– antiandrogens: f lutamide and  cyproterone (androcur);  
– estrogens: fosfestrol, diethylstilbestrol,  and  ethinyl 
estradiol;  
– antiestrogens: tamoxifen and  toremifene ; 
– progestins: oxyprogesterone capronate  and medroxy-
progesterone acetate ; 
– analogues of gonadotropin-releasing hormone: goserelin and  
leuprorelin ; 
– inhibitors of aromatase: aminoglutethimide and  letrozole .  
– glucocorticoids: prednisolone and  dexamethasone .  
3.    Enzymes: L-asparaginase .  
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4.    Cytokins: 
– interferons: α-interferon ; 
– interleukins: aldesleukin .  
5.   Monoclonal antibodies: herceptin . 
6.   Tyrosine kinase inhibitors: imatinib, gefi t inib, and  
erlotinib .  
 
Most antitumoral drugs cause multiple side effects which restrict their 
clinical use. To prevent or reduce these side effects, the following drugs are 
used:  
1.    Drugs stimulating hemopoiesis (colony-stimulating factors). 
1.1. Drugs stimulating leucopoiesis: molgramostim (Leucomax) 
and  f i lgrastim .  
1.2. Drugs stimulating erythropoiesis: erythropoietins (epoetin alfa 
and epoetin beta). 
2.    Antiemetic drugs: ondansetron,  tropisetron, and  
metoclopramide .  
3.    Immunomodulators: interferons, interleukins, thymus 
preparations , and  levamisole .  
4.    Drugs which inhibit manifestations of carcinoid syndrome 
associated with malignant neuroendocrine tumors: ortreotide .  
5.    Drugs which prevent osteoporosis associated with tumor 
metastasis spread to bones: bisphosphonates (pamidronate ,  
clodronate, and  zoledronate).   
 
Alkylating Drugs 
 
Alkylating drugs include cytotoxic agents of different chemical 
strucrure with identical mechanism of action. It is believed that radicals of 
alkylating drugs form covalent bonds with different molecules of the cell. 
The bonds with guanine of DNA are the most important. As a result, the 
cross-linking of DNA strands occurs. DNA double helix loses its ability to 
diverge, gene mutations occur, and replication is violated.  
Embichin (chlormethine)  is the first drug of chloroethylamine 
subgroup. Like most drugs of this group, embochin is used to treat 
hemoblastoses (chronic leukemia, lymphogranulematosis, lymphosarcoma, 
reticulosarcoma, etc.).  
Sarcolysin (melphalan)  is chloroethylamine derivative. The drug 
is used in lymphosarcoma, reticulosarcoma, multiple myeloma, and some 
solid tumors (testicular seminoma, and Ewing sarcoma). In testicular 
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seminoma, sarcolysin is effective even in the presence of metastases. 
Sarcolysin is administered parenterally or taken orally.  
Cyclophosphane (cyclophosphamide)  is the most effective drug 
within chloroethylamine derivatives. It is a prodrug which is transformed in 
the human body into the metabolites with antitumoral activity. 
Cyclophosphane is used to treat hemoblastoses, multiple myeloma, 
testicular cancer, breast cancer, and small-cell lung cancer (small-cell 
carcinoma). Cyclophosphane causes a long-term remission in patients with 
lymphoid leukosis. The drug is administered parenterally and taken orally.  
Dopanum (uramustine)  and chlorbutinum (chlorambucil )  
are also used to treat hemoblastoses. Both drugs are taken orally. 
Prospidine  is chlorethylamine derivative which is used in laryngeal 
cancer treatment.  
Thiophosphamide (ThioTEPA)  is ethylenimine derivative which 
is used in treatment for hemoblastoses (chronic leukemia, 
lymphogranulomatosis, lymphosarcoma, reticulosarcoma) and solid tumors 
(testicular cancer and breast cancer).  
Methanesulphonic acid derivatives myelosanum (busulfan)  and 
myelobromol  are used in exacerbation of chronic myeloid leukemia. 
Both drugs are taken orally.   
Nitrosourea derivatives include such drugs as nitrosomethylurea , 
lomustine , and carmust ine . Nitrosomethylurea is effective at small-cell 
carcinoma and lymphogranulomatosis. Other drugs are used in treatment 
for brain cancer, colon and rectal carcer, Hodgkin's disease, and other 
lymphomas. Another representative of nitrosourea derivatives is 
fotemustine . The drug is used to treat malignant melanoma and primary 
brain tumors.  
Also in melanoma treatment, dacarbazine  and procarbazine  are 
used. These drugs are cytotoxic agents – derivatives of triazenes. 
Cisplatin  is platinum compound which is used to treat testicular 
tumors, ovary cancer, bladder cancer, squamous head and neck cancer, 
endometrial cancer, lymphomas, and non-small cell lung cancer. Like 
alkylating drugs, cisplatin chemically interact with DNA that results in 
violation of DNA function.  
All alkylating drugs are characterized by high toxicity. Therapy by 
these drugs is accompanied by nausea, vomiting, hemopoiesis depression 
(anemia, thrombocytopenia, and neutropenia), ulceration of gastrointestinal 
tract and bladder, etc. Intravenous administration of alkylating drugs can 
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cause thromoflebitis. Amenorea, impotention, and hair loss are also 
possible. At present, cytokins (filgrastim and molgrastim), erythropoietin, 
and some interleukins are used to stimulate hemopoiesis. Antibiotics are 
used to prevent and treat various infections.   
 
Antimetabolites  
 
Antimetabolites are structural analogues of natural metabolites: folic 
acid, purines, and pyrimidines. The mechanism of their action is based on 
the drug ability to compete with natural metabolites and replace them in the 
body compounds. Since antimetabolites cannot fulfil the normal 
physiological functions, their incorporation in molecules of nucleic acid 
blocks its normal synthesis. Antimetabolites are active only against 
dividing malignant cells. These drugs do not influence dormant stem cells 
of tumors. 
Folic acid antagonist methotrexate  and purine antagonist 
mercaptopurine  are mainly used in acute lymphoblastic leukemia 
treatment. Methotrexate has higher activity in children, but mercaptopurine 
– in adult patients. Besides, both drugs are used in uterine 
horionepitelioma. Methotrexate is also used in chemotherapy for such solid 
tumors as breast cancer. Both drugs are taken orally, and methotrexate is 
administered parenterally.  
Phthoruracilum (f luorouracil)  is a pyrimidine antagonist. The 
drug is used in therapy of solid tumors: cancer of stomach, pancreas, breast, 
and colon. Fluorouracil causes temporal tumor regression in some patients. 
Fluorouracil is administered intravenously. For peroral intake, capecitabine 
was created. It is a prodrug which, under the influence of thymidine 
phosphorylase, is transformed into fluorouracil.  
Ftorafur (tegafur)  is a less toxic drug than fluorouracil. The drug 
is used in breast cancer, cancer of stomach, colon, and rectum.  
Cytarabine  and thioguanine  are used in chemotherapy for acute 
myeloid and lymphoid leukemia.  
Antimetabolites are highly toxic drugs. Their side effects are nausea, 
vomiting, inhibition of hemopoiesis, lesions of gastrointestinal tract, hair 
loss, etc. Only mercaptopurine and thioguanine are relatively well tolerated 
by patients.  
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Cytotoxic Antibiotics  
 
Cytotoxic antibiotics are produced by different species of 
Streptomyces and Actinomycetes. These drugs have different chemical 
structure. Mechanism of action is associated with inhibition of synthesis 
and function of nucleic acids that results in suppression of cell division.  
Dactinomycin  is produced by actinomycetes. The drug is used in 
chemotherapy for horionepitelioma, Wilms’ tumor (nephroblastoma) of 
children, and lymphogranulomatosis. Dactinomycin is administered 
intravenously or into the body cavities.  
Olivomycin  is a derivative of aureolic acid which is produced by 
actinomycetes. Olivomycin is used in the treatment for seminoma, 
teratoblastoma, embryonal carcinoma, lymphoepithelioma, 
reticulosarcoma, and melanoma. The drug is administered intravenously or 
applied topically in ointments. 
Rubomycin , doxorubicin  (Adriamycin),  carminomycin  are 
anthracycline antitumor antibiotics. These drugs are used in the treatment 
for sarcomas of mesenchymal origin. Also, doxorubicin is used in bone 
sarcoma, breast, lungs’, bladder, thyroid, and ovarian cancer, etc. 
Rubomycin is used in treatment for acute leucosis, reticulosarcoma, and 
uterine horionepitelioma.  
Bleomycin  is cytotoxic glycopeptide antibiotic produced by 
Streptomyces verticillus. The drug is used in treatment for squamous cell 
carcinoma of the oral mucosa, tongue, tonsil, skin, and uterus. Also, 
bleomycin is used in lymphogranulomatosis and penile cancer.  
Bruneomycin  is used in treatment for lymphogranulomatosis, 
reticulo- and lymphosarcoma, and chronic lymphocytic leukemia.  
Cytotoxic antibiotics may be combined with other antitumoral drugs, 
except alkylating drugs and antimetabolites.   
It is necessary to notice that all cytotoxic antibiotics have also 
antibacterial activity, but it has no practical value. 
Cytotoxic antibiotics are drugs with high toxicity. Chemotherapy with 
them is accompanied by numerous side effects: appetite loss, nausea, 
vomiting, diarrhea, candidiasis, inhibition of hemopoiesis, hair loss, fever, 
hypotension, cardiotoxicity, allergic reactions, and anaphylactic shock.  
 
Antitumoral Drugs of  Plant Origin 
 
Vinblastine  and vincrist ine  are alkaloids of Vinca rosea. Their 
mechanism of action is associated with metaphase-blockage mitosis due to 
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disruption in formation and function of the microtubule spindle. It results in 
violation of DNA divergence to the poles of the cell, the following 
degradation of DNA strands, and cell death.  
Both drugs are used in the treatment for hemoblastoses (acute 
leukemia, reticulo- and lymphosarcoma, etc.), lymphogranulomatosis, 
breast cancer, neuroblastoma, etc. Vinca rosea alkaloids are commonly 
combined with other antitumoral drugs. Both drugs are administered 
intravenously. Their side effects are inhibition of hemopoiesis, 
nephrotoxicity, neurological disturbances (ataxia, violation of neuro-
muscular transmission), alopecia, jaundice, etc.  
Yew-tree (Taxus) preparations are pacli taxel  (taxol) and  
docetaxel  (Taxotere) . These drugs exhibit antimitotic activity due to 
interaction with tubulin. Taxones are used in the treatment for breast and 
ovarian cancer, small cell lung cancer, and epithelial tumors of the head 
and neck. The side effects of taxones are nausea, vomiting, diarrhea, 
neutropenia, thrombocytopenia, hypotension, etc.  
Podophyllum peltatum (mayapple) preparations are etoposide, 
teniposide, and podophyll ine . These drugs are used in the treatment 
for laryngeal and bladder papillomatosis, small cell lung cancer, Ewing's 
sarcoma, etc. 
Colchamine  and colchicine  are alkaloids of Colchicum autumnale 
and Colchicum speciosum. Colchamine is used topically in ointment in the 
treatment for skin cancer, esophagus, and stomach cancer (in the 
combination with sarcolysin). Colchamine kills malignant cells practically 
without damage of normal epithelial cells. Colchamine can cause skin 
rashes. After removing necrotic tissue, wounds may be healed with good 
cosmetic result.  
Besides, the following plant preparations are used as antitumoral 
agents: befungin, drugs of celandine, calendula, wild poppy, plantain, etc.  
 
Enzymes 
 
L-asparaginase  is enzyme which is used in the treatment for acute 
lymphoblastic leukemia and lymphosarcoma. This enzyme distroys  
L-asparagine. L-asparagine is amino acid which is required for the 
synthesis of proteins, RNA, and DNA. Side effects of L-asparaginase are 
neuro-, nephro- and hepatotoxicity, and affection of pancreas.  
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Hormonal Drugs and Their Analogues  
 
This group includes male and female sex hormones and their 
antagonists, and also glucocorticoids which play complementary role. Sex 
hormones are used in the treatment for malignant neoplasms of ovaries, 
uterus, prostate, and breast. There are evidences that under the influence of 
sex hormones, malignant cells do not die because hormonal drugs only 
slow down their division and metastasis.  
As a rule, chemotherapy with sex hormones is combined with surgical 
and radiation treatments.  
Androgens (testosterone propionate ,  testenate ,  
tetrasterone, medrote strone propionate ) are used to treat breast 
cancer in women with menstrual cycle and in the first 5 years after 
menopause. In these cases, androgens inhibit production of estrogens. The 
use of high androgen doses is accompanied by virilization (excess facial 
and body hair, baldness, acne, deepening of the voice, increased 
muscularity), dizziness, nausea, etc.  
Antiandrogens include such drugs as f lutamide  and cyproterone 
(androcur) . Their mechanism of action is associated with the inhibition 
of transport and binding of dihydrotestosterone with receptors in the 
prostatic cells. It results in slowing down tumoral cell growth in the 
prostate. Both drugs are taken orally. Antiandrogens exhibit high efficacy 
in prostate cancer and cause prolonged remission in the majority of 
patients. The drugs are well tolerated by patients. Prolonged anti-androgen 
therapy may be accompanied by the development of gynecomastia, but it 
does not affect sexual function.  
Estrogens (fosfestrol ,  diethylst i lbestrol ,  ethinylestradiol ) are 
used to treat breast cancer in women with menopause which lasts more than 
5 years. In these patients, estrogens inhibit the production of pituitary 
gonadotropins which indirectly stimulate the growth of tumoral cells.  
Besides, estrogens are used in the treatment for prostate cancer. In this 
case, estrogens inhibit the function of natural androgens. One of the drugs 
for prostate cancer treatment is fosfestrol (sodium salt of diphosphoric ether 
of diethylstilbestrol). Under the influence of acid phosphatase of tumoral 
cells, fosfestrol is transformed into diethylstilbestrol. Fosfestrol is taken 
orally or administered intravenously. Fosfestrol is characterized by fast 
efficacy development and low toxicity in contrast to diethylstilbestrol. The 
use of estrogens in males can cause feminization, dyspepsia, itchy skin, and 
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hemorrhagic rash. In 1–2 years of estrogen use, malignant cells lose the 
sensitivity to these agents.  
Antiestrogens (tamoxifen, toremifene) bind to estrogen receptors 
of neoplastic cells of the breast and prevent estrogen-induced tumor 
growth. Antiestrogens are used to treat estrogen-induced breast cancer, 
especially in postmenopausal women. The side effects of these drugs are 
vaginal hemorrhage, redness of the skin, vomiting, dermatitis, etc.    
At present, drugs inhibiting the synthesis of androgens are introduced 
in the medical practice. These drugs are aromatase inhibitors. In 
postmenopausal period, estrogens are synthesized from androgens which 
are produced by adrenal cortex. This process is regulated by enzyme 
aromatase. Inhibition of aromatase results in violation of estrogen 
synthesis.  
A group of aromatase inhibitors includes such drugs as letrozole 
(Femara),  anastrozole (Arimidex),  aminoglutethimide  
(Cytadren) , etc. Aromatase inhibitors are used to treat breast cancer and 
ovarian cancer in postmenopausal women and gynecomastia in men.  
Their side effects are headache, dyspepsia, skin rash, weakness, vaginal 
bleeding, etc.  
Progestins (oxyprogesterone caproate,  medroxyproges -
terone acetate ) are used to treat uterine cancer. Progestins cause the 
cancer regression in significant number of patients. 
Analogues of gonadotropin-releasing hormone (goserelin, 
leuprorelin) also exhibit the antitumoral activity. In case of continuous 
use, these drugs reduce the secretion of gonadotropins by the anterior 
pituitary and exhibit therapeutic effect in patients with prostate cancer.  
Glucocorticoids  and preparations of adrenocorticotropin  are 
commonly used to treat acute leukemia in children, lymphogranulomatosis, 
chronic lymphocytic leukemia, and lymphosarcoma.  
 
Cytokines  
 
Cytokines include interferons and interleukins. 
Recombinan t  human interferon α  is interferon which is used in 
the complex treatment for some tumors. The drug activates macrophages, 
T-lymphocytes, and T-killer cells. Recombinant human interferon α is 
effective in multiple myeloma, Kaposi’s sarcoma, renal cell carcinoma, etc. 
The drug is administered parenterally. Side effects of this drug are 
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headache, fever, myalgia, arthralgia, dyspepsia, blood dyscrasias, thyroid 
dysfunction, etc. 
Interleukin-2 (proleukin)  stimulates proliferation and 
differentiation of T-helpers and cytotoxic T-lymphocytes, activates 
macrophages, stimulates proliferation of B-lymphocytes. Proleukin is 
derived by genetic engineering. The drug is administered parenterally. Side 
effects are hypotension, pulmonary oedema, inhibition of hematopoiesis, 
nephrotoxicity, lesions of the central nervous system, and allergic reactions. 
 
Monoclonal Antibodies  
 
Monoclonal antibodies include trastuzumab (Herceptin)  and 
rituximab (Mabthera) . These drugs are produced by genetic 
engineering. Both drugs are administered intravenously. Monoclonal 
antibodies are used in complex chemotherapy for some oncological 
diseases. 
Herceptin  is an antibody against antigenic HER2-receptors of the 
breast malignant cells that results in cytotoxic effect. Overexpression of 
these receptors leads to proliferation and malignant transformation of the 
cells. Overexpression of HER2-protein is observed in 20–30 % of patients 
with breast cancer. Therapeutic indication for trastuzumab is metastatic 
breast cancer with HER2-protein overexpression.  
Rituximab  interacts with protein CD20 which is an antigen located 
on the membranes of B-cells of non-Hodgkin's lymphomas.  
Bevacizumab (Avastin)  is a monoclonal antibody preparation 
which blocks the vascular endothelial growth factor. The drug inhibits the 
growth of tumor vessels that violates its blood supply and slows down the 
tumoral growth. Avastin is administered intravenously. Bevacizumab is 
used in complex chemotherapy for colorectal cancer.  
The side effects of monoclonal antibodies are fever, nausea, vomiting, 
skin rash, headache, hypo- or hypertension, nephrotoxicity, oedemas, 
bronchospasms, a cough, lymphopenia, leukopenia, etc. 
 
Tyrosine Kinase Inhibitors  
 
Tyrosine kinase inhibitors include imatinib, gefi t inib, and 
erlotinib . It is a new group of antitumoral drugs. Tyrosine kinase is an 
important functional element of membrane receptors – growth factors of 
thrombocytes, epithelium, stem cells, vascular endothelium, nerves, etc. 
Besides, there are tyrosine kinases of the cytoplasmic and nuclear 
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localization. Tyrosine kinase regulates the growth and differentiation of 
cells and their apoptosis.  
The first representative of this group is imatinib . The drug blocks 
tyrosine kinase of the receptors for platelet-derived growth factor, stem cell 
factor, and cytoplasmic tyrosine kinase. Imatinib is used to treat chronic 
myelogenous leukemia and gastrointestinal stromal tumors. The drug is 
taken orally. Side effects of imatinib are nausea, vomiting, neutropenia, 
skin rash, etc.  
Gefit inib  blocks tyrosine kinase of the receptor for epidermal growth 
factor. The drug is used to treat non-small cell lung cancer and head cancer.  
Erlotinib  blocks several receptor tyrosine kinases, and it is used to 
treat non-small cell lung cancer.  
Sunitinib  is used to treat gastrointestinal stromal tumors and a clear-
cell subtype of renal cell carcinoma.  
 
Table 10 – Drugs for prescription 
 
Drug name 
(Latin) 
Single dose and route of 
administration 
Drug product 
Cyclophosphanum Orally, intramuscularly or 
intravenously 0.2 g once a 
day; 0.4 g once every 2 days 
Coated tablets 0.05 g; 
ampoules 0.1 or 0.2 g of 
powder for solution 
Chlorbutinum Orally 0.002–0.01 g once a 
day 
Tablets 0.002 or 0.005 g 
Myelosanum Orally 0.002–0.01 g once a 
day 
Tablets 0.002 g 
Mercaptopurinum Orally 0.001–0.00125 g/kg 
once a day  
Tablets 0.05 g 
Methotrexatum Orally, intramuscularly or 
intravenously 0.03 g 2 times 
in a week, or 0.05 g once in 
five days 
Coated tablets 0.0025 g; 
ampoules 0.005, 0.05 or 0.1 g 
of powder for solution 
Phthoruracilum Intravenously slowly or drop-
by-drop 0.01–0.015 g/kg once 
a day or once every 2 days 
Ampoules 5 ml of 5 % solu-
tion  
Vinblastinum 
(Rosevinum) 
Intravenously 0.00015–
0.0003 g/kg once per week 
Ampoules 0.005 or 0.01 g of 
powder for solution 
Vincristinum  Intravenously 0.00001–
0.00003 g/kg once per week 
Ampoules 1 or 5 ml of 
0.1 % solution;  
vials 0.0005 or 0.001 g of 
powder for solution 
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Radioprotectors. Radionuclide Decorporation Drugs  
 
Radioprotectors are drugs which are used in case of radiation threat, 
during radiotherapy of cancer patients, and in work with radionuclides. 
Radioprotectors reduce or prevent the destructive action of ionizing 
radiation.  
Radioprotectors are classified as follows:  
1. Sulfur-containing drugs.  
1.1. Sulfur-containing amino acids and their derivatives: cysteine, 
methionine, cysteamine hydrochloride ,  taurine, 
acetylcysteine . 
1.2. Other groups of sulfur-containing drugs: unithiol ,   
β-mercaptoethylamide ,  β-aminoethyl ,  isothiuronyl ,  
cystophos, gamaphos .  
2. Biogenic amines: serotonin adipate , mexamine, adrenaline .  
3. Amino acids and their derivatives: glutamic acid, asparaginic  
acid, asparcam, panangin . 
4. Derivatives of nucleotides and nucleosides: sodium nucleinate ,  
methyluracil ,  riboxinum, phosphadenum, ATP .  
5. Alcohols: butyl  alcohol .  
6. Vitamins: rutin, ascorbic acid, pyridoxine , tocopherol ,  
nicotinamide, methylmethionine sulfonium .  
7. Antioxidants.  
7.1. Antioxidants of direct action: tocopherol ,  ubiquinone .  
7.2. Antioxidants of indirect action: selenium-containing drugs, 
amino acids, zinc -containing drugs,  copper -
containing drugs,  caffeine .  
8. Biopolymers: zymosan .  
9. Estrogens: estradiol .  
10. Polysacharides: prodigiozan .  
11. Complexones: pentacinum, tetacinum-calcium .  
12. Sorbents: enterosorbent CKN, si l ica gel ,  activated 
carbon, carbolong,  carbalose .  
13. Herbal preparations: l iquid extract and t incture of  
ginseng, t inctures of  Aralia, Chinese schizandra,  
Eleutherococcus, polyphenolic compounds .  
14. Methemoglobin-forming drugs: sodium nitri te ,  methylene  
blue . 
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According to duration of action, there are short-acting and long-acting 
radioprotectors. Short-acting radioprotectors develop effect in 0.5–4 hours 
after administration. These drugs protect from single radiation or short-term 
high-level radiation. Short-acting radioprotectors are administered in 
maximal doses. This group includes sulfur-containing compounds, biogenic 
amines, and methemoglobin-forming drugs which disrupt tissue 
oxygenation.   
Long-acting radioprotectors are used to protect human body from a 
long-term effects of low-level radiation. These drugs are divided into drugs 
with hypoxic mechanism of action and drugs with non-hypoxic mechanism 
of action. Drugs with hypoxic mechanism of action are biogenic amines 
and methemoglobin-forming drugs. Drugs with non-hypoxic mechanism of 
action include sulfur-contaning compounds and drugs of other groups. 
Mexamine  and cysteamine hydrochloride  are drugs which are 
most commonly used to prevent and treat radiation sickness.  
The damaging effect of ionizing radiation is lower in hypoxia. The 
drugs causing vasoconstriction and reducing oxygen blood concentration 
cause hypoxia and inhibit lipid peroxidation. These properties are typical 
for biogenic amines. These drugs are used to treat and prevent radiation 
sickness.  
Mexamine is a biogenic amine which has a similar chemical structure 
to serotonin. Mexamine causes contraction of smooth muscles and provides 
sedating effect on the central nervous system. The drug is taken orally 30–
40 minutes prior to radiation therapy. Mexamine is well tolerated by 
patients.  
Sulfur-containing drugs contain SH2-groups and are the most active 
radioprotectors. Sulfur-containing drugs inhibit free radicals in cell bodies, 
form compounds of heavy metals, normalize protein metabolism on the 
DNA level, and increase cAMP concentration.   
Cysteamine hydrochloride is taken orally 1 hour prior to radiation 
therapy. The duration of the effect is 5 hours. The drug is used to prevent 
and treat chronic radiation sickness. Cysteamine hydrochloride is 
ineffective in cases of acute radiation sickness.  
Cyanides also exhibit radioprotective effect due to blockage of 
respiratory enzyme cytochrome oxidase which provides transport of the 
electrons from cytochrome to oxygen.  
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Estrogens increase human body resistance to ionizing radiation. These 
drugs protect the bone marrow, thyroid gland, decrease catabolic action of 
ionizing radiation, and activate the immunity (phagocytosis).  
Some macromolecular substances also have radioprotective activity 
(polysaccharides, nucleic acids, alcohols, and synthetic polymers). Their 
radioprotective effect arises 0.5–2 hours after intake and lasts up to 3 days. 
Mechanism of their action is based on stimulation of nucleic acid synthesis 
and bone marrow cell regeneration. Among glycans, zymosan  is 
characterised by the highest radioprotective activity. Zymosan protects 
hematopoiesis from negative influence of antitumoral drugs and ionizing 
radiation. The drug is administered intramuscularly in dose 1–2 ml on 
alternate days. The treatment course is 5–10 injections. 
Batilol  protects leukocyte and erythrocyte sprouts from ionixing 
radiation within 4–6 weeks. The drug is taken orally together with butter or 
vegetable oil which improve batilol absorption.  
Thesanum  is used in skin protection from ionizing radiation. 
Liniment of thesanum is applied on the skin prior to radiation session.  
Direct antioxidants are drugs with radiprotective properties: 
tocopherol ,  ascorbic acid , nicotinamide, riboflavin,  
pyridoxine , preparations of ginceng, Chinese magnolia,  
Manchurian Aralia,  Eleutherococcus , etc.  
Selenium  preparations are drugs with indirect antioxidant activity. 
Selenium stimulates enzymes of the antioxidant cellular system (activates 
glutathione peroxidase, and promotes synthesis of cytochrome C and 
ubiquinone).  
Besides, antioxidant properties are typical for compounds of zinc and 
copper, glutathione precursors, linoleic acid, and caffeine. 
Stimulators of leukopoiesis (sodium nucleinate  and  
methyluracil ) also provide radioprotective effect. Some radioprotective 
activity is typical for vasopressin, prostaglandins, and acetylcholine.  
Chelators (pentacinum, tetacinum-calcium,  and alginates), 
sorbents (activated carbon, carbolong, enterosorbent SKN, 
si l ica gel , etc.), pectins, vegetable fibers, and carboxymethyl cellulose 
bind radionuclides and provide their elimination from the body.  
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Targocid q.v. teicoplanin 38 
Tarivid q.v. ofloxacin 47, 48, 52, 54, 
55, 72  
Taurine 110 
Taxol q.v. paclitaxel 100, 105 
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Taxotere 100 
Tegafur q.v. ftorafur 100, 103 
Teicoplanin 38 
Teniposide 100, 105 
Terbinafine 86, 89, 90 
Testenate 100, 106 
Testosterone propionate 100, 106 
Tetacinum-calcium 11, 12, 110, 112 
Tetracycline 29, 30, 52, 81, 84 
Tetrasterone 100 
Theophylline 70 
Thioacetazone 55, 62, 72 
Thiodipine 100 
Thiophosphamide 100, 102 
Thiotepa q.v. thiophosphamide 100, 
102 
Thymol 6 
Ticarcillin 19 
Tienam 26, 27 
Tilorone q.v. amixin 70 
Tinidazole 82 
Tobramycin 33 
Tocopherol 110, 112 
Toremifene 100, 107 
Tosufloxacin 47 
Trastuzumab 108 
Trental 70 
Trichomonacide 82 
Trifluridine 66 
Tropisetron 101 
Ubiquinone 110, 112 
Undecinum 86, 90 
Unithiol 12, 83, 98, 110 
Urotropine q.v. 
hexamethylenetetramine 4, 12, 13 
Vagothyl 6 
Valacyclovir 65, 66 
Vancomycin 17, 38, 39 
Vermox q.v. mebendazole 92, 93, 
97, 98 
Vibramycin q.v. doxycycline 29–31, 
75 
Vidarabine 63, 65, 66 
Viferon 69, 70 
Vinblastine 100, 104 
Vincristine 100, 104 
Viomycin q.v. florimycin 54, 55, 60 
Vishnevsky ointment 6 
Vitravene 67 
Vormil q.v. albendazole 81, 82, 92, 
93, 98 
Wellferon 69, 70 
Wilkinson ointment 6 
Wood tar 3, 6 
Xeroform 4, 11 
Yellow mercury oxide 4, 11 
Zagam q.v. sparfloxacin 47, 48, 54 
Zalcitabine 67, 68 
Zanamivir 64, 65 
Zidovudine 63, 67, 68 
Zinc oxide 4 
Zinc sulfate 4, 10 
Zincundanum 86, 90 
Zoledronate 101 
Zovirax q.v. acyclovir 63, 65–67 
Zymosan 110, 112 
Zyvox q.v. linezolid 51 
β-mercaptoethylamide 110 
γ-Globulin 63 
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